'bilirubinémie'
(id=23618 ; fe=bilirubinémie ; type=1 ; niveau=50.067 ; luminosité=50 ; somme entrante=23617 creation date=2007-06-21 touchdate=2025-08-31 22:42:30.000)

≈ 2566 relations sortantes bilirubinémie -- r_associated #0: 289 / 1 -> médecine n1=bilirubinémie | n2=médecine | rel=r_associated | relid=0 | w=289 bilirubinémie -- r_associated #0: 136 / 0.471 -> bilirubine n1=bilirubinémie | n2=bilirubine | rel=r_associated | relid=0 | w=136 bilirubinémie -- r_associated #0: 136 / 0.471 -> hyperbilirubinémies n1=bilirubinémie | n2=hyperbilirubinémies | rel=r_associated | relid=0 | w=136 bilirubinémie -- r_associated #0: 135 / 0.467 -> hyperbilirubinémique n1=bilirubinémie | n2=hyperbilirubinémique | rel=r_associated | relid=0 | w=135 bilirubinémie -- r_associated #0: 130 / 0.45 -> processus pathologique n1=bilirubinémie | n2=processus pathologique | rel=r_associated | relid=0 | w=130 bilirubinémie -- r_associated #0: 110 / 0.381 -> sang n1=bilirubinémie | n2=sang | rel=r_associated | relid=0 | w=110 bilirubinémie -- r_associated #0: 106 / 0.367 -> bile n1=bilirubinémie | n2=bile | rel=r_associated | relid=0 | w=106 bilirubinémie -- r_associated #0: 106 / 0.367 -> ictère n1=bilirubinémie | n2=ictère | rel=r_associated | relid=0 | w=106 bilirubinémie -- r_associated #0: 106 / 0.367 -> ictère néonatal n1=bilirubinémie | n2=ictère néonatal | rel=r_associated | relid=0 | w=106 bilirubinémie -- r_associated #0: 106 / 0.367 -> syndrome de Gilbert n1=bilirubinémie | n2=syndrome de Gilbert | rel=r_associated | relid=0 | w=106 bilirubinémie -- r_associated #0: 106 / 0.367 -> système digestif n1=bilirubinémie | n2=système digestif | rel=r_associated | relid=0 | w=106 bilirubinémie -- r_associated #0: 105 / 0.363 -> augmentation de la bilirubine n1=bilirubinémie | n2=augmentation de la bilirubine | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> augmentation du taux de bilirubine n1=bilirubinémie | n2=augmentation du taux de bilirubine | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> bilirubine augmentée n1=bilirubinémie | n2=bilirubine augmentée | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> bilirubine élevée n1=bilirubinémie | n2=bilirubine élevée | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> bilirubinémie augmentée n1=bilirubinémie | n2=bilirubinémie augmentée | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:abnormal secretion or accumulation n1=bilirubinémie | n2=en:abnormal secretion or accumulation | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:acquired aminoacid metabolism disorder n1=bilirubinémie | n2=en:acquired aminoacid metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:albinism n1=bilirubinémie | n2=en:albinism | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:alcohol intolerance n1=bilirubinémie | n2=en:alcohol intolerance | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:amino acid metabolism disorder n1=bilirubinémie | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:amyloidosis n1=bilirubinémie | n2=en:amyloidosis | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:anemia n1=bilirubinémie | n2=en:anemia | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:anemia hemolytic indirect coombs positive n1=bilirubinémie | n2=en:anemia hemolytic indirect coombs positive | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:benign neoplasm n1=bilirubinémie | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:bilirubin value increased n1=bilirubinémie | n2=en:bilirubin value increased | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:carbohydrate metabolism disorder n1=bilirubinémie | n2=en:carbohydrate metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:chronic disease n1=bilirubinémie | n2=en:chronic disease | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:congenital metabolic disorder n1=bilirubinémie | n2=en:congenital metabolic disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:conjugated bilirubinaemia n1=bilirubinémie | n2=en:conjugated bilirubinaemia | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:deterioration of body part n1=bilirubinémie | n2=en:deterioration of body part | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:disabling disease n1=bilirubinémie | n2=en:disabling disease | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:disorder of mineral metabolism n1=bilirubinémie | n2=en:disorder of mineral metabolism | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:distortion or displacement of body part n1=bilirubinémie | n2=en:distortion or displacement of body part | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:ethanol metabolism disorder n1=bilirubinémie | n2=en:ethanol metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:gilbert syndrome n1=bilirubinémie | n2=en:gilbert syndrome | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:haemolyses nec n1=bilirubinémie | n2=en:haemolyses nec | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:hepatic: obstructive n1=bilirubinémie | n2=en:hepatic: obstructive | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:hereditary hyperbilirubinemia n1=bilirubinémie | n2=en:hereditary hyperbilirubinemia | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:hypervolemia n1=bilirubinémie | n2=en:hypervolemia | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:iatrogenic disease n1=bilirubinémie | n2=en:iatrogenic disease | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:impaired healing n1=bilirubinémie | n2=en:impaired healing | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:indirect hyperbilirubinemia n1=bilirubinémie | n2=en:indirect hyperbilirubinemia | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:inflammation or infection n1=bilirubinémie | n2=en:inflammation or infection | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:irritation/irritant n1=bilirubinémie | n2=en:irritation/irritant | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:jaundice n1=bilirubinémie | n2=en:jaundice | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:kernicterus n1=bilirubinémie | n2=en:kernicterus | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:laboratory abnormalities n1=bilirubinémie | n2=en:laboratory abnormalities | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:lipid metabolism disorder n1=bilirubinémie | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:liver function test n1=bilirubinémie | n2=en:liver function test | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:metabolic acidosis n1=bilirubinémie | n2=en:metabolic acidosis | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:metal metabolism disorder n1=bilirubinémie | n2=en:metal metabolism disorder | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:necrotic process n1=bilirubinémie | n2=en:necrotic process | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:neonatal transient jaundice n1=bilirubinémie | n2=en:neonatal transient jaundice | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:onset of illness n1=bilirubinémie | n2=en:onset of illness | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:porphyria n1=bilirubinémie | n2=en:porphyria | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:recurrence (disease attribute) n1=bilirubinémie | n2=en:recurrence (disease attribute) | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> en:rotor syndrome n1=bilirubinémie | n2=en:rotor syndrome | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> hyperbilirubinémie de type Rotor n1=bilirubinémie | n2=hyperbilirubinémie de type Rotor | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> ictère (jaunisse) n1=bilirubinémie | n2=ictère (jaunisse) | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 105 / 0.363 -> sang (hémoglobine) n1=bilirubinémie | n2=sang (hémoglobine) | rel=r_associated | relid=0 | w=105 bilirubinémie -- r_associated #0: 100 / 0.346 -> biologie de l'appareil digestif n1=bilirubinémie | n2=biologie de l'appareil digestif | rel=r_associated | relid=0 | w=100 bilirubinémie -- r_associated #0: 100 / 0.346 -> taux de la bilirubine dans le sang n1=bilirubinémie | n2=taux de la bilirubine dans le sang | rel=r_associated | relid=0 | w=100 bilirubinémie -- r_associated #0: 94 / 0.325 -> jaunisse n1=bilirubinémie | n2=jaunisse | rel=r_associated | relid=0 | w=94 bilirubinémie -- r_associated #0: 94 / 0.325 -> maladie n1=bilirubinémie | n2=maladie | rel=r_associated | relid=0 | w=94 bilirubinémie -- r_associated #0: 87 / 0.301 -> maladie (médecine) n1=bilirubinémie | n2=maladie (médecine) | rel=r_associated | relid=0 | w=87 bilirubinémie -- r_associated #0: 86 / 0.298 -> jaunisse (médecine) n1=bilirubinémie | n2=jaunisse (médecine) | rel=r_associated | relid=0 | w=86 bilirubinémie -- r_associated #0: 82 / 0.284 -> ictère nucléaire n1=bilirubinémie | n2=ictère nucléaire | rel=r_associated | relid=0 | w=82 bilirubinémie -- r_associated #0: 77 / 0.266 -> foie n1=bilirubinémie | n2=foie | rel=r_associated | relid=0 | w=77 bilirubinémie -- r_associated #0: 76 / 0.263 -> hyperbilirubinémie n1=bilirubinémie | n2=hyperbilirubinémie | rel=r_associated | relid=0 | w=76 bilirubinémie -- r_associated #0: 75 / 0.26 -> excès n1=bilirubinémie | n2=excès | rel=r_associated | relid=0 | w=75 bilirubinémie -- r_associated #0: 74 / 0.256 -> acide glycuronique n1=bilirubinémie | n2=acide glycuronique | rel=r_associated | relid=0 | w=74 bilirubinémie -- r_associated #0: 74 / 0.256 -> b n1=bilirubinémie | n2=b | rel=r_associated | relid=0 | w=74 bilirubinémie -- r_associated #0: 74 / 0.256 -> un/le mal n1=bilirubinémie | n2= un/le mal | rel=r_associated | relid=0 | w=74 bilirubinémie -- r_associated #0: 73 / 0.253 -> M n1=bilirubinémie | n2=M | rel=r_associated | relid=0 | w=73 bilirubinémie -- r_associated #0: 72 / 0.249 -> B n1=bilirubinémie | n2=B | rel=r_associated | relid=0 | w=72 bilirubinémie -- r_associated #0: 72 / 0.249 -> pathologie n1=bilirubinémie | n2=pathologie | rel=r_associated | relid=0 | w=72 bilirubinémie -- r_associated #0: 70 / 0.242 -> hyperbilirubinémie type 2 n1=bilirubinémie | n2=hyperbilirubinémie type 2 | rel=r_associated | relid=0 | w=70 bilirubinémie -- r_associated #0: 70 / 0.242 -> maladie (médecine, être humain) n1=bilirubinémie | n2=maladie (médecine, être humain) | rel=r_associated | relid=0 | w=70 bilirubinémie -- r_associated #0: 67 / 0.232 -> hyperbilirubinémie acquise n1=bilirubinémie | n2=hyperbilirubinémie acquise | rel=r_associated | relid=0 | w=67 bilirubinémie -- r_associated #0: 65 / 0.225 -> en:increased bilirubin level (finding) n1=bilirubinémie | n2=en:increased bilirubin level (finding) | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie aggravée n1=bilirubinémie | n2=hyperbilirubinémie aggravée | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie conjuguée n1=bilirubinémie | n2=hyperbilirubinémie conjuguée | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de la prématurité n1=bilirubinémie | n2=hyperbilirubinémie de la prématurité | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de type 1 n1=bilirubinémie | n2=hyperbilirubinémie de type 1 | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de type 2 n1=bilirubinémie | n2=hyperbilirubinémie de type 2 | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de type i n1=bilirubinémie | n2=hyperbilirubinémie de type i | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de type ii n1=bilirubinémie | n2=hyperbilirubinémie de type ii | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie de type indirect bénin n1=bilirubinémie | n2=hyperbilirubinémie de type indirect bénin | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie des nouveau-nés n1=bilirubinémie | n2=hyperbilirubinémie des nouveau-nés | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie directe des nouveau-nés n1=bilirubinémie | n2=hyperbilirubinémie directe des nouveau-nés | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie directe du nouveau-né n1=bilirubinémie | n2=hyperbilirubinémie directe du nouveau-né | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie du nouveau-né n1=bilirubinémie | n2=hyperbilirubinémie du nouveau-né | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie extracorporelle n1=bilirubinémie | n2=hyperbilirubinémie extracorporelle | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie héréditaire n1=bilirubinémie | n2=hyperbilirubinémie héréditaire | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie indirecte des nouveau-nés n1=bilirubinémie | n2=hyperbilirubinémie indirecte des nouveau-nés | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie indirecte du nouveau-né n1=bilirubinémie | n2=hyperbilirubinémie indirecte du nouveau-né | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie néonatale n1=bilirubinémie | n2=hyperbilirubinémie néonatale | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie non conjuguée n1=bilirubinémie | n2=hyperbilirubinémie non conjuguée | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie non conjuguée héréditaire n1=bilirubinémie | n2=hyperbilirubinémie non conjuguée héréditaire | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie non conjuguée prémenstruelle cyclique n1=bilirubinémie | n2=hyperbilirubinémie non conjuguée prémenstruelle cyclique | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 65 / 0.225 -> hyperbilirubinémie obstructive n1=bilirubinémie | n2=hyperbilirubinémie obstructive | rel=r_associated | relid=0 | w=65 bilirubinémie -- r_associated #0: 60 / 0.208 -> medicament n1=bilirubinémie | n2=medicament | rel=r_associated | relid=0 | w=60 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:abnormal biliary tract morphology n1=bilirubinémie | n2=en:abnormal biliary tract morphology | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:abnormal biliary tract physiology n1=bilirubinémie | n2=en:abnormal biliary tract physiology | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:abnormal liver function test n1=bilirubinémie | n2=en:abnormal liver function test | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:abnormal metabolic state in diabetes mellitus n1=bilirubinémie | n2=en:abnormal metabolic state in diabetes mellitus | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acquired anterior capsular pigmentation n1=bilirubinémie | n2=en:acquired anterior capsular pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acquired disorder of skin color n1=bilirubinémie | n2=en:acquired disorder of skin color | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acquired hyperbilirubinemia n1=bilirubinémie | n2=en:acquired hyperbilirubinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acquired porphyria n1=bilirubinémie | n2=en:acquired porphyria | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acral overgrowth n1=bilirubinémie | n2=en:acral overgrowth | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acromegaly n1=bilirubinémie | n2=en:acromegaly | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acute disease n1=bilirubinémie | n2=en:acute disease | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:acute metabolic disorder n1=bilirubinémie | n2=en:acute metabolic disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:adrenocortical insufficiency neonatal n1=bilirubinémie | n2=en:adrenocortical insufficiency neonatal | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:albinotic fundus n1=bilirubinémie | n2=en:albinotic fundus | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:alkalosis n1=bilirubinémie | n2=en:alkalosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:alkaptonuric ochronosis n1=bilirubinémie | n2=en:alkaptonuric ochronosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:alstrom syndrome n1=bilirubinémie | n2=en:alstrom syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:amelogenesis imperfecta pigmented hypomaturation type n1=bilirubinémie | n2=en:amelogenesis imperfecta pigmented hypomaturation type | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:amyloidogenesis n1=bilirubinémie | n2=en:amyloidogenesis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:anterior corneal pigmentation n1=bilirubinémie | n2=en:anterior corneal pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:application site pigmentation changes n1=bilirubinémie | n2=en:application site pigmentation changes | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:arrhythmia n1=bilirubinémie | n2=en:arrhythmia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:ascites n1=bilirubinémie | n2=en:ascites | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:aspects of mortality statistics n1=bilirubinémie | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:aspects of radionuclide imaging n1=bilirubinémie | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:atypical pigmented lesion n1=bilirubinémie | n2=en:atypical pigmented lesion | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:avitaminosis n1=bilirubinémie | n2=en:avitaminosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:azotemia n1=bilirubinémie | n2=en:azotemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:bilirubinemia aggravated n1=bilirubinémie | n2=en:bilirubinemia aggravated | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:bilirubinuria n1=bilirubinémie | n2=en:bilirubinuria | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:blood pigmentation of cornea n1=bilirubinémie | n2=en:blood pigmentation of cornea | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:brain diseases, metabolic n1=bilirubinémie | n2=en:brain diseases, metabolic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:bsp test abnormal n1=bilirubinémie | n2=en:bsp test abnormal | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:calcium metabolism disorders n1=bilirubinémie | n2=en:calcium metabolism disorders | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:calcium/phosphate abnormality n1=bilirubinémie | n2=en:calcium/phosphate abnormality | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cancer cell growth regulation n1=bilirubinémie | n2=en:cancer cell growth regulation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cantu syndrome n1=bilirubinémie | n2=en:cantu syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:carcinogen effect in offspring n1=bilirubinémie | n2=en:carcinogen effect in offspring | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:catabolic state n1=bilirubinémie | n2=en:catabolic state | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:central hyperthyroidism n1=bilirubinémie | n2=en:central hyperthyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholangitis n1=bilirubinémie | n2=en:cholangitis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholangitis, sclerosing n1=bilirubinémie | n2=en:cholangitis, sclerosing | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholecystitis n1=bilirubinémie | n2=en:cholecystitis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholestasis n1=bilirubinémie | n2=en:cholestasis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholestasis and jaundice n1=bilirubinémie | n2=en:cholestasis and jaundice | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholestasis in newborn n1=bilirubinémie | n2=en:cholestasis in newborn | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cholestatic hepatitis n1=bilirubinémie | n2=en:cholestatic hepatitis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:chromatolysis n1=bilirubinémie | n2=en:chromatolysis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:chromatosis n1=bilirubinémie | n2=en:chromatosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:chromosome disorder n1=bilirubinémie | n2=en:chromosome disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:chronic metabolic disorder n1=bilirubinémie | n2=en:chronic metabolic disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:citrate toxicity n1=bilirubinémie | n2=en:citrate toxicity | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:clinical manifestation of enzyme deficiency n1=bilirubinémie | n2=en:clinical manifestation of enzyme deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:col1a1 associated connective tissue disorder n1=bilirubinémie | n2=en:col1a1 associated connective tissue disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:combined oxidative phosphorylation deficiency 1 n1=bilirubinémie | n2=en:combined oxidative phosphorylation deficiency 1 | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:comorbidity n1=bilirubinémie | n2=en:comorbidity | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:complication aspects n1=bilirubinémie | n2=en:complication aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:congenital hyperthyroidism n1=bilirubinémie | n2=en:congenital hyperthyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:congenital hypopigmentation of choroid n1=bilirubinémie | n2=en:congenital hypopigmentation of choroid | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:congenital hypothyroidism n1=bilirubinémie | n2=en:congenital hypothyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:congenital pigmentary skin anomalies n1=bilirubinémie | n2=en:congenital pigmentary skin anomalies | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:crystal arthropathy n1=bilirubinémie | n2=en:crystal arthropathy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:cytogenetic abnormality n1=bilirubinémie | n2=en:cytogenetic abnormality | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:death n1=bilirubinémie | n2=en:death | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:degeneration n1=bilirubinémie | n2=en:degeneration | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:dehydration n1=bilirubinémie | n2=en:dehydration | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:delayed graft function n1=bilirubinémie | n2=en:delayed graft function | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:diagnosis aspect n1=bilirubinémie | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:direct bilirubin measurement n1=bilirubinémie | n2=en:direct bilirubin measurement | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:direct coombs test positive n1=bilirubinémie | n2=en:direct coombs test positive | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:direct reacting bilirubin n1=bilirubinémie | n2=en:direct reacting bilirubin | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disease of mucous membrane n1=bilirubinémie | n2=en:disease of mucous membrane | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of aromatic amino acid metabolism n1=bilirubinémie | n2=en:disorder of aromatic amino acid metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of fluid and/or electrolyte n1=bilirubinémie | n2=en:disorder of fluid and/or electrolyte | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of ketone metabolism n1=bilirubinémie | n2=en:disorder of ketone metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of lipoprotein and/or lipid metabolism n1=bilirubinémie | n2=en:disorder of lipoprotein and/or lipid metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of osmoregulation n1=bilirubinémie | n2=en:disorder of osmoregulation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorder of pyrimidine metabolism n1=bilirubinémie | n2=en:disorder of pyrimidine metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disorders of porphyrin and bilirubin metabolism n1=bilirubinémie | n2=en:disorders of porphyrin and bilirubin metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:disseminated intravascular coagulation adverse event n1=bilirubinémie | n2=en:disseminated intravascular coagulation adverse event | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:dna repair-deficiency disorders n1=bilirubinémie | n2=en:dna repair-deficiency disorders | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:drug-induced pigmentation n1=bilirubinémie | n2=en:drug-induced pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:drugs in tissues n1=bilirubinémie | n2=en:drugs in tissues | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:dysmotility n1=bilirubinémie | n2=en:dysmotility | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:elevated alkaline phosphatase n1=bilirubinémie | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:endocrine and metabolic disturbances specific to the fetus and newborn n1=bilirubinémie | n2=en:endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:enzyme inhibition disorder n1=bilirubinémie | n2=en:enzyme inhibition disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:erythromelanosis follicularis of face and/or neck n1=bilirubinémie | n2=en:erythromelanosis follicularis of face and/or neck | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:erythropenia n1=bilirubinémie | n2=en:erythropenia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:etiology aspects n1=bilirubinémie | n2=en:etiology aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:extravasation of diagnostic and therapeutic materials n1=bilirubinémie | n2=en:extravasation of diagnostic and therapeutic materials | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:extravascular hemolysis n1=bilirubinémie | n2=en:extravascular hemolysis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:femoracetabular impingement n1=bilirubinémie | n2=en:femoracetabular impingement | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:fibrosis n1=bilirubinémie | n2=en:fibrosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:gallbladder pain adverse event n1=bilirubinémie | n2=en:gallbladder pain adverse event | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:gamma-glutamyltransferase increased n1=bilirubinémie | n2=en:gamma-glutamyltransferase increased | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:general pathology n1=bilirubinémie | n2=en:general pathology | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:genetic aspects n1=bilirubinémie | n2=en:genetic aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:genomic instability n1=bilirubinémie | n2=en:genomic instability | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:germ cell depletion n1=bilirubinémie | n2=en:germ cell depletion | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:gliosis n1=bilirubinémie | n2=en:gliosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:glucose metabolism abnormal n1=bilirubinémie | n2=en:glucose metabolism abnormal | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:glucose metabolism disorder n1=bilirubinémie | n2=en:glucose metabolism disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:goiter n1=bilirubinémie | n2=en:goiter | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:graft-versus-tumor induction n1=bilirubinémie | n2=en:graft-versus-tumor induction | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:haemolysis neonatal n1=bilirubinémie | n2=en:haemolysis neonatal | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemoglobinemia n1=bilirubinémie | n2=en:hemoglobinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemolytic anemia n1=bilirubinémie | n2=en:hemolytic anemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemolytic anemia direct coombs negative n1=bilirubinémie | n2=en:hemolytic anemia direct coombs negative | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemolytic anemia direct coombs positive n1=bilirubinémie | n2=en:hemolytic anemia direct coombs positive | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemolytic anemia indirect coombs neg n1=bilirubinémie | n2=en:hemolytic anemia indirect coombs neg | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemolytic jaundice n1=bilirubinémie | n2=en:hemolytic jaundice | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemorrhage n1=bilirubinémie | n2=en:hemorrhage | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemorrhagic disorders n1=bilirubinémie | n2=en:hemorrhagic disorders | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemosiderin pigmentation of skin due to venous insufficiency n1=bilirubinémie | n2=en:hemosiderin pigmentation of skin due to venous insufficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemosiderinuria n1=bilirubinémie | n2=en:hemosiderinuria | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hemosiderosis n1=bilirubinémie | n2=en:hemosiderosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hepatic encephalopathy n1=bilirubinémie | n2=en:hepatic encephalopathy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperammonemia n1=bilirubinémie | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperamylasemia n1=bilirubinémie | n2=en:hyperamylasemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypercatabolism n1=bilirubinémie | n2=en:hypercatabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperchloremia n1=bilirubinémie | n2=en:hyperchloremia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperchromic lesions of pinta n1=bilirubinémie | n2=en:hyperchromic lesions of pinta | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypercreatininaemia n1=bilirubinémie | n2=en:hypercreatininaemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperlipoproteinemia n1=bilirubinémie | n2=en:hyperlipoproteinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperlysinemia n1=bilirubinémie | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypermelanosis following phototherapy for neonatal jaundice n1=bilirubinémie | n2=en:hypermelanosis following phototherapy for neonatal jaundice | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperoxalaemia n1=bilirubinémie | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperphosphatasaemia n1=bilirubinémie | n2=en:hyperphosphatasaemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperpigmentation of eyelids n1=bilirubinémie | n2=en:hyperpigmentation of eyelids | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperpipecolatemia n1=bilirubinémie | n2=en:hyperpipecolatemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyperthyroidism n1=bilirubinémie | n2=en:hyperthyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypoaldosteronemia n1=bilirubinémie | n2=en:hypoaldosteronemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypoalphalipoproteinemia n1=bilirubinémie | n2=en:hypoalphalipoproteinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypochloremia (disorder) n1=bilirubinémie | n2=en:hypochloremia (disorder) | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypomagnesemia n1=bilirubinémie | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypometabolism n1=bilirubinémie | n2=en:hypometabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hyponatremia n1=bilirubinémie | n2=en:hyponatremia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypophosphatasia n1=bilirubinémie | n2=en:hypophosphatasia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypoplasia n1=bilirubinémie | n2=en:hypoplasia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypoplastic anemia n1=bilirubinémie | n2=en:hypoplastic anemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypothyroidism n1=bilirubinémie | n2=en:hypothyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:hypovolemia n1=bilirubinémie | n2=en:hypovolemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:icterus gravis of pregnancy n1=bilirubinémie | n2=en:icterus gravis of pregnancy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:idarubicin n1=bilirubinémie | n2=en:idarubicin | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:idarubicin hydrochloride n1=bilirubinémie | n2=en:idarubicin hydrochloride | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:idiopathic n1=bilirubinémie | n2=en:idiopathic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:immunology aspects n1=bilirubinémie | n2=en:immunology aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:impaired cell membrane integrity n1=bilirubinémie | n2=en:impaired cell membrane integrity | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:impaired cytoskeletal integrity n1=bilirubinémie | n2=en:impaired cytoskeletal integrity | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:incontinentia pigmenti n1=bilirubinémie | n2=en:incontinentia pigmenti | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:increased biliverdin n1=bilirubinémie | n2=en:increased biliverdin | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:indirect coombs test positive n1=bilirubinémie | n2=en:indirect coombs test positive | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:infection n1=bilirubinémie | n2=en:infection | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:infectious process n1=bilirubinémie | n2=en:infectious process | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:inflammation n1=bilirubinémie | n2=en:inflammation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:inherited disorder of bilirubin metabolism n1=bilirubinémie | n2=en:inherited disorder of bilirubin metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:injection site pigmentation change n1=bilirubinémie | n2=en:injection site pigmentation change | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:injection site reaction n1=bilirubinémie | n2=en:injection site reaction | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:intoxication n1=bilirubinémie | n2=en:intoxication | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:intraoperative complication n1=bilirubinémie | n2=en:intraoperative complication | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:invasion n1=bilirubinémie | n2=en:invasion | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:jaundice (not of newborn) n1=bilirubinémie | n2=en:jaundice (not of newborn) | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:jaundice extrahepatic obstructive n1=bilirubinémie | n2=en:jaundice extrahepatic obstructive | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lactose intolerance n1=bilirubinémie | n2=en:lactose intolerance | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:langerhans cell histiocytosis n1=bilirubinémie | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lentigo - freckle n1=bilirubinémie | n2=en:lentigo - freckle | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:leukoderma n1=bilirubinémie | n2=en:leukoderma | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lipids abnormal n1=bilirubinémie | n2=en:lipids abnormal | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lipodystrophy n1=bilirubinémie | n2=en:lipodystrophy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lithiasis n1=bilirubinémie | n2=en:lithiasis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:liver tender n1=bilirubinémie | n2=en:liver tender | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:local exogenous pigmentation of oral soft tissue n1=bilirubinémie | n2=en:local exogenous pigmentation of oral soft tissue | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:localized metabolic disorder n1=bilirubinémie | n2=en:localized metabolic disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:lysosomal storage disease n1=bilirubinémie | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:macroamylasemia n1=bilirubinémie | n2=en:macroamylasemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:maleformatio ectodermalis generalisata of bafverstedt n1=bilirubinémie | n2=en:maleformatio ectodermalis generalisata of bafverstedt | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:medulloadrenal hyperfunction n1=bilirubinémie | n2=en:medulloadrenal hyperfunction | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:megaloblastic anemia n1=bilirubinémie | n2=en:megaloblastic anemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:megaloblastic anemia due to folate deficiency n1=bilirubinémie | n2=en:megaloblastic anemia due to folate deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:melanin pigmentation of eye n1=bilirubinémie | n2=en:melanin pigmentation of eye | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:melanodermatitis toxica lichenoides n1=bilirubinémie | n2=en:melanodermatitis toxica lichenoides | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:melanosis n1=bilirubinémie | n2=en:melanosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:melasma n1=bilirubinémie | n2=en:melasma | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:mesangiolysis n1=bilirubinémie | n2=en:mesangiolysis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metabolic bone disorder n1=bilirubinémie | n2=en:metabolic bone disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metabolic disorder of fetus n1=bilirubinémie | n2=en:metabolic disorder of fetus | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metabolic disorder of transport n1=bilirubinémie | n2=en:metabolic disorder of transport | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metabolic disorders nec n1=bilirubinémie | n2=en:metabolic disorders nec | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metabolic syndrome n1=bilirubinémie | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:metastasis n1=bilirubinémie | n2=en:metastasis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:methionine adenosyltransferase deficiency n1=bilirubinémie | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:mineralocorticoid deficiency n1=bilirubinémie | n2=en:mineralocorticoid deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:mitochondrial cytopathy n1=bilirubinémie | n2=en:mitochondrial cytopathy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:mitochondrial enzyme deficiency n1=bilirubinémie | n2=en:mitochondrial enzyme deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:mottled pigmentation n1=bilirubinémie | n2=en:mottled pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:myositic disorders n1=bilirubinémie | n2=en:myositic disorders | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:necrosis adrenal cortex n1=bilirubinémie | n2=en:necrosis adrenal cortex | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neonatal hyperbilirubinemia n1=bilirubinémie | n2=en:neonatal hyperbilirubinemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neonatal jaundice n1=bilirubinémie | n2=en:neonatal jaundice | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neoplastic processes n1=bilirubinémie | n2=en:neoplastic processes | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neovascularization n1=bilirubinémie | n2=en:neovascularization | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:nerve degeneration n1=bilirubinémie | n2=en:nerve degeneration | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neurocutaneous melanosis sequence n1=bilirubinémie | n2=en:neurocutaneous melanosis sequence | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neuronal ceroid lipofuscinosis type 3 n1=bilirubinémie | n2=en:neuronal ceroid lipofuscinosis type 3 | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:neurotropism n1=bilirubinémie | n2=en:neurotropism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:no drug effect n1=bilirubinémie | n2=en:no drug effect | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:normocytic anemia n1=bilirubinémie | n2=en:normocytic anemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:nursing therapy n1=bilirubinémie | n2=en:nursing therapy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:nutritional and metabolic disorders in diseases classified elsewhere n1=bilirubinémie | n2=en:nutritional and metabolic disorders in diseases classified elsewhere | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:nutritional disorder n1=bilirubinémie | n2=en:nutritional disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:obstructive jaundice n1=bilirubinémie | n2=en:obstructive jaundice | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:ochronosis n1=bilirubinémie | n2=en:ochronosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:oncosis n1=bilirubinémie | n2=en:oncosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:other disorders of amino-acid metabolism n1=bilirubinémie | n2=en:other disorders of amino-acid metabolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:other metabolic disorders n1=bilirubinémie | n2=en:other metabolic disorders | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pallor n1=bilirubinémie | n2=en:pallor | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pancreatic trypsinogen deficiency n1=bilirubinémie | n2=en:pancreatic trypsinogen deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:parasitology n1=bilirubinémie | n2=en:parasitology | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:parenteral nutrition associated liver disease n1=bilirubinémie | n2=en:parenteral nutrition associated liver disease | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pathogenesis n1=bilirubinémie | n2=en:pathogenesis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pathological accumulation of air in tissues n1=bilirubinémie | n2=en:pathological accumulation of air in tissues | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:peri-nipple pigmentation n1=bilirubinémie | n2=en:peri-nipple pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:periorbital hypermelanosis n1=bilirubinémie | n2=en:periorbital hypermelanosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:permissiveness n1=bilirubinémie | n2=en:permissiveness | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:peutz-jeghers syndrome n1=bilirubinémie | n2=en:peutz-jeghers syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:phosphorus metabolic disorder n1=bilirubinémie | n2=en:phosphorus metabolic disorder | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pigment nephropathy n1=bilirubinémie | n2=en:pigment nephropathy | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pigmentation n1=bilirubinémie | n2=en:pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pituitary hypothyroidism n1=bilirubinémie | n2=en:pituitary hypothyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:poikiloderma of civatte n1=bilirubinémie | n2=en:poikiloderma of civatte | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:polydipsia n1=bilirubinémie | n2=en:polydipsia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:polysyndactyly n1=bilirubinémie | n2=en:polysyndactyly | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:polyuria n1=bilirubinémie | n2=en:polyuria | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:postcholecystectomy syndrome n1=bilirubinémie | n2=en:postcholecystectomy syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:postoperative complications n1=bilirubinémie | n2=en:postoperative complications | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:postprocedural hypothyroidism n1=bilirubinémie | n2=en:postprocedural hypothyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:potassium abnormality n1=bilirubinémie | n2=en:potassium abnormality | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pre-fetal/death n1=bilirubinémie | n2=en:pre-fetal/death | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:primary hyperthyroidism n1=bilirubinémie | n2=en:primary hyperthyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:primary hypothyroidism n1=bilirubinémie | n2=en:primary hypothyroidism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:prognosis n1=bilirubinémie | n2=en:prognosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:protein aggregation, pathological n1=bilirubinémie | n2=en:protein aggregation, pathological | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:proteostasis deficiencies n1=bilirubinémie | n2=en:proteostasis deficiencies | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pseudoatrophoderma colli n1=bilirubinémie | n2=en:pseudoatrophoderma colli | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pseudogout n1=bilirubinémie | n2=en:pseudogout | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:pseudophaeochromocytoma n1=bilirubinémie | n2=en:pseudophaeochromocytoma | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:psychogenic n1=bilirubinémie | n2=en:psychogenic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:purine-pyrimidine metabolism, inborn errors n1=bilirubinémie | n2=en:purine-pyrimidine metabolism, inborn errors | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:refeeding syndrome n1=bilirubinémie | n2=en:refeeding syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:refractory anemia n1=bilirubinémie | n2=en:refractory anemia | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:remission/regression n1=bilirubinémie | n2=en:remission/regression | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:retinal depigmentation n1=bilirubinémie | n2=en:retinal depigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:retropneumoperitoneum n1=bilirubinémie | n2=en:retropneumoperitoneum | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:riehl's melanosis n1=bilirubinémie | n2=en:riehl's melanosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:roentgenographic n1=bilirubinémie | n2=en:roentgenographic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:rowley-rosenberg syndrome n1=bilirubinémie | n2=en:rowley-rosenberg syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:schambergs disease n1=bilirubinémie | n2=en:schambergs disease | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:schistosomal pigment deposition n1=bilirubinémie | n2=en:schistosomal pigment deposition | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:serum bilirubin raised n1=bilirubinémie | n2=en:serum bilirubin raised | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:serum total bilirubin measurement n1=bilirubinémie | n2=en:serum total bilirubin measurement | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:shock n1=bilirubinémie | n2=en:shock | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:skin discoloration n1=bilirubinémie | n2=en:skin discoloration | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:skin diseases, metabolic n1=bilirubinémie | n2=en:skin diseases, metabolic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:skin pigmentation n1=bilirubinémie | n2=en:skin pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:sphingolipidosis n1=bilirubinémie | n2=en:sphingolipidosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:stauffer's syndrome n1=bilirubinémie | n2=en:stauffer's syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:stromal corneal pigmentation n1=bilirubinémie | n2=en:stromal corneal pigmentation | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:suppuration n1=bilirubinémie | n2=en:suppuration | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:surgical aspects n1=bilirubinémie | n2=en:surgical aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:symptoms concerning nutrition, metabolism, and development n1=bilirubinémie | n2=en:symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:synthetic defect of bile acids n1=bilirubinémie | n2=en:synthetic defect of bile acids | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:taxonomic n1=bilirubinémie | n2=en:taxonomic | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:therapeutic aspects n1=bilirubinémie | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:thyroid storm n1=bilirubinémie | n2=en:thyroid storm | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:tissue lysis n1=bilirubinémie | n2=en:tissue lysis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:tumor embolism n1=bilirubinémie | n2=en:tumor embolism | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:tumor lysis syndrome n1=bilirubinémie | n2=en:tumor lysis syndrome | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:universal acquired melanosis n1=bilirubinémie | n2=en:universal acquired melanosis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:urine bilirubin tests n1=bilirubinémie | n2=en:urine bilirubin tests | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:use of ultrasonography n1=bilirubinémie | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:veterinary aspects n1=bilirubinémie | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:viruses n1=bilirubinémie | n2=en:viruses | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:vitiligo iridis n1=bilirubinémie | n2=en:vitiligo iridis | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:water intoxication n1=bilirubinémie | n2=en:water intoxication | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:water-electrolyte imbalance n1=bilirubinémie | n2=en:water-electrolyte imbalance | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:yang deficiency n1=bilirubinémie | n2=en:yang deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> en:yin deficiency n1=bilirubinémie | n2=en:yin deficiency | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> m n1=bilirubinémie | n2=m | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 55 / 0.19 -> medecine n1=bilirubinémie | n2=medecine | rel=r_associated | relid=0 | w=55 bilirubinémie -- r_associated #0: 51 / 0.176 -> augmentation n1=bilirubinémie | n2=augmentation | rel=r_associated | relid=0 | w=51 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:5' 10' methylenetetrahydrofolate reductase deficiency n1=bilirubinémie | n2=en:5' 10' methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:abnormal transit or circulation n1=bilirubinémie | n2=en:abnormal transit or circulation | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:acquired hypopigmentation of choroid n1=bilirubinémie | n2=en:acquired hypopigmentation of choroid | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:addison's disease n1=bilirubinémie | n2=en:addison's disease | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:alcohol-induced pseudo-cushing's syndrome n1=bilirubinémie | n2=en:alcohol-induced pseudo-cushing's syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:anemia due to vitamin b>6< deficiency n1=bilirubinémie | n2=en:anemia due to vitamin b>6< deficiency | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:aplastic anemia n1=bilirubinémie | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:argyria n1=bilirubinémie | n2=en:argyria | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:atrial remodeling n1=bilirubinémie | n2=en:atrial remodeling | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:bilirubin n1=bilirubinémie | n2=en:bilirubin | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:blood bilirubin measurement n1=bilirubinémie | n2=en:blood bilirubin measurement | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:carnosinemia n1=bilirubinémie | n2=en:carnosinemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:carotene pigmentation of skin n1=bilirubinémie | n2=en:carotene pigmentation of skin | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:carotenemia n1=bilirubinémie | n2=en:carotenemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:circumscribed hypermelanosis n1=bilirubinémie | n2=en:circumscribed hypermelanosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:crystal nephropathy n1=bilirubinémie | n2=en:crystal nephropathy | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:cushing syndrome n1=bilirubinémie | n2=en:cushing syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:cystic fibrosis n1=bilirubinémie | n2=en:cystic fibrosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:deficiency of bile secretion n1=bilirubinémie | n2=en:deficiency of bile secretion | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:direct hyperbilirubinemia n1=bilirubinémie | n2=en:direct hyperbilirubinemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disease attributes n1=bilirubinémie | n2=en:disease attributes | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorder of beta alanine, carnosine and/or homocarnosine metabolism n1=bilirubinémie | n2=en:disorder of beta alanine, carnosine and/or homocarnosine metabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorder of glycoprotein metabolism n1=bilirubinémie | n2=en:disorder of glycoprotein metabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorder of glycosaminoglycan metabolism n1=bilirubinémie | n2=en:disorder of glycosaminoglycan metabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorder of iodine metabolism n1=bilirubinémie | n2=en:disorder of iodine metabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorders of bilirubin excretion n1=bilirubinémie | n2=en:disorders of bilirubin excretion | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism n1=bilirubinémie | n2=en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorders of lipoprotein metabolism and other lipidaemias n1=bilirubinémie | n2=en:disorders of lipoprotein metabolism and other lipidaemias | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:disorders of sphingolipid metabolism and other lipid storage disorders n1=bilirubinémie | n2=en:disorders of sphingolipid metabolism and other lipid storage disorders | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:drug pigmentation n1=bilirubinémie | n2=en:drug pigmentation | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ectasia n1=bilirubinémie | n2=en:ectasia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ectopic hyperthyroidism n1=bilirubinémie | n2=en:ectopic hyperthyroidism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:electrolyte disorder n1=bilirubinémie | n2=en:electrolyte disorder | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:enzymology n1=bilirubinémie | n2=en:enzymology | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:enzymopathy n1=bilirubinémie | n2=en:enzymopathy | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:epidemiologic n1=bilirubinémie | n2=en:epidemiologic | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:erythrocytic maturation arrest n1=bilirubinémie | n2=en:erythrocytic maturation arrest | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ethnologic n1=bilirubinémie | n2=en:ethnologic | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:extravasation n1=bilirubinémie | n2=en:extravasation | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:fluid imbalance n1=bilirubinémie | n2=en:fluid imbalance | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:glucocorticoid deficiency n1=bilirubinémie | n2=en:glucocorticoid deficiency | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:glucose-6-phosphate dehydrogenase deficiency anemia n1=bilirubinémie | n2=en:glucose-6-phosphate dehydrogenase deficiency anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:gout n1=bilirubinémie | n2=en:gout | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:granuloma n1=bilirubinémie | n2=en:granuloma | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hemoglobinuria n1=bilirubinémie | n2=en:hemoglobinuria | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hepatocellular jaundice n1=bilirubinémie | n2=en:hepatocellular jaundice | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:heterotopic ossification n1=bilirubinémie | n2=en:heterotopic ossification | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hyalinization n1=bilirubinémie | n2=en:hyalinization | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hyperbilirubinaemia n1=bilirubinémie | n2=en:hyperbilirubinaemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypercreatinaemia n1=bilirubinémie | n2=en:hypercreatinaemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hyperlipasaemia n1=bilirubinémie | n2=en:hyperlipasaemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypermagnesemia n1=bilirubinémie | n2=en:hypermagnesemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypermelanosis due to hodgkin's disease n1=bilirubinémie | n2=en:hypermelanosis due to hodgkin's disease | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypermelanosis of the eyelids due to hyperthyroidism n1=bilirubinémie | n2=en:hypermelanosis of the eyelids due to hyperthyroidism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypermetabolism n1=bilirubinémie | n2=en:hypermetabolism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypernatremia n1=bilirubinémie | n2=en:hypernatremia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hyperplasia n1=bilirubinémie | n2=en:hyperplasia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypersensitivity process n1=bilirubinémie | n2=en:hypersensitivity process | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypocellular bone marrow n1=bilirubinémie | n2=en:hypocellular bone marrow | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:hypochromic anemia n1=bilirubinémie | n2=en:hypochromic anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:iatrogenic n1=bilirubinémie | n2=en:iatrogenic | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ictotest (bilirubin) tab (not for oral use) n1=bilirubinémie | n2=en:ictotest (bilirubin) tab (not for oral use) | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:in cerebrospinal fluid n1=bilirubinémie | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:intravascular hemolysis n1=bilirubinémie | n2=en:intravascular hemolysis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:iron metabolism disorders n1=bilirubinémie | n2=en:iron metabolism disorders | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:karyomegaly n1=bilirubinémie | n2=en:karyomegaly | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:kidney crystallization n1=bilirubinémie | n2=en:kidney crystallization | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:leukocytosis n1=bilirubinémie | n2=en:leukocytosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:long term adverse effects n1=bilirubinémie | n2=en:long term adverse effects | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:macrocytic anemia n1=bilirubinémie | n2=en:macrocytic anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:macular pigment deposit n1=bilirubinémie | n2=en:macular pigment deposit | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:malabsorption syndrome n1=bilirubinémie | n2=en:malabsorption syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:malakoplakia n1=bilirubinémie | n2=en:malakoplakia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:malarial pigment deposition n1=bilirubinémie | n2=en:malarial pigment deposition | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:marine lenhart syndrome n1=bilirubinémie | n2=en:marine lenhart syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:medical complication n1=bilirubinémie | n2=en:medical complication | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:metabolic disorders following abortion and ectopic and molar pregnancy n1=bilirubinémie | n2=en:metabolic disorders following abortion and ectopic and molar pregnancy | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:microbiological n1=bilirubinémie | n2=en:microbiological | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:microcytic anemia n1=bilirubinémie | n2=en:microcytic anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:mitochondrial damage n1=bilirubinémie | n2=en:mitochondrial damage | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:muscle weakness n1=bilirubinémie | n2=en:muscle weakness | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:neointima n1=bilirubinémie | n2=en:neointima | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:nickel metabolic disorder n1=bilirubinémie | n2=en:nickel metabolic disorder | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:nutritional management n1=bilirubinémie | n2=en:nutritional management | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ochronotic arthritis n1=bilirubinémie | n2=en:ochronotic arthritis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ocular icterus n1=bilirubinémie | n2=en:ocular icterus | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:other disorders of fluid, electrolyte and acid-base balance n1=bilirubinémie | n2=en:other disorders of fluid, electrolyte and acid-base balance | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:other specified metabolic disorders n1=bilirubinémie | n2=en:other specified metabolic disorders | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:other symptoms concerning nutrition, metabolism, and development n1=bilirubinémie | n2=en:other symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:other transitory neonatal endocrine and metabolic disturbances n1=bilirubinémie | n2=en:other transitory neonatal endocrine and metabolic disturbances | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:oxalosis n1=bilirubinémie | n2=en:oxalosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:physiopathological n1=bilirubinémie | n2=en:physiopathological | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:pigmented oral mucosal lesion n1=bilirubinémie | n2=en:pigmented oral mucosal lesion | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:pigmented purpuric lichenoid dermatitis of gougerot and blum n1=bilirubinémie | n2=en:pigmented purpuric lichenoid dermatitis of gougerot and blum | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:pigmented skin lesion n1=bilirubinémie | n2=en:pigmented skin lesion | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:poikilodermatomyositis n1=bilirubinémie | n2=en:poikilodermatomyositis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:porphyruria n1=bilirubinémie | n2=en:porphyruria | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:postprocedural endocrine and metabolic disorders, not elsewhere classified n1=bilirubinémie | n2=en:postprocedural endocrine and metabolic disorders, not elsewhere classified | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:psychology qualifier n1=bilirubinémie | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:radiotherapeutic n1=bilirubinémie | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:rehabilitation aspects n1=bilirubinémie | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:respiratory aspiration n1=bilirubinémie | n2=en:respiratory aspiration | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:salt-wasting syndrome of infancy n1=bilirubinémie | n2=en:salt-wasting syndrome of infancy | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:scleroderma-associated hypermelanosis n1=bilirubinémie | n2=en:scleroderma-associated hypermelanosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:sclerosis n1=bilirubinémie | n2=en:sclerosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:siadh n1=bilirubinémie | n2=en:siadh | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:skin hyperpigmentation n1=bilirubinémie | n2=en:skin hyperpigmentation | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:skin hypopigmentation n1=bilirubinémie | n2=en:skin hypopigmentation | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:speckled lentiginous nevus n1=bilirubinémie | n2=en:speckled lentiginous nevus | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:spot pigmented n1=bilirubinémie | n2=en:spot pigmented | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:tertiary hypothyroidism n1=bilirubinémie | n2=en:tertiary hypothyroidism | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:thyrotoxic periodic paralysis n1=bilirubinémie | n2=en:thyrotoxic periodic paralysis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:tonicity disorder n1=bilirubinémie | n2=en:tonicity disorder | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:tophus n1=bilirubinémie | n2=en:tophus | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:toxic goiter n1=bilirubinémie | n2=en:toxic goiter | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:toxic nodular goiter n1=bilirubinémie | n2=en:toxic nodular goiter | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:tumor-associated process n1=bilirubinémie | n2=en:tumor-associated process | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:ulceration n1=bilirubinémie | n2=en:ulceration | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn n1=bilirubinémie | n2=en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:uremia n1=bilirubinémie | n2=en:uremia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:urticaria pigmentosa/maculopapular cutaneous mastocytosis n1=bilirubinémie | n2=en:urticaria pigmentosa/maculopapular cutaneous mastocytosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:vascular remodeling n1=bilirubinémie | n2=en:vascular remodeling | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:venous thrombosis n1=bilirubinémie | n2=en:venous thrombosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:vitamin b12 deficiency anemia n1=bilirubinémie | n2=en:vitamin b12 deficiency anemia | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:vulvovaginal hypermelanosis n1=bilirubinémie | n2=en:vulvovaginal hypermelanosis | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:wasting syndrome n1=bilirubinémie | n2=en:wasting syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:xeroderma pigmentosum n1=bilirubinémie | n2=en:xeroderma pigmentosum | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:yellow complexion n1=bilirubinémie | n2=en:yellow complexion | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:yellow nail syndrome n1=bilirubinémie | n2=en:yellow nail syndrome | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 50 / 0.173 -> en:zinc deficiency disorder n1=bilirubinémie | n2=en:zinc deficiency disorder | rel=r_associated | relid=0 | w=50 bilirubinémie -- r_associated #0: 45 / 0.156 -> bilirubine libre n1=bilirubinémie | n2=bilirubine libre | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:abnormal growth and differentiation n1=bilirubinémie | n2=en:abnormal growth and differentiation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:acid-base imbalance n1=bilirubinémie | n2=en:acid-base imbalance | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:adrenal atrophy n1=bilirubinémie | n2=en:adrenal atrophy | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:adrenal crisis n1=bilirubinémie | n2=en:adrenal crisis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:adrenal insufficiency neonatal n1=bilirubinémie | n2=en:adrenal insufficiency neonatal | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:adrenocortical insufficiency n1=bilirubinémie | n2=en:adrenocortical insufficiency | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:anemia, hereditary spherocytic hemolytic n1=bilirubinémie | n2=en:anemia, hereditary spherocytic hemolytic | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:argyria of skin n1=bilirubinémie | n2=en:argyria of skin | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:autoimmune n1=bilirubinémie | n2=en:autoimmune | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:autoimmune process n1=bilirubinémie | n2=en:autoimmune process | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:bilirubin test kit n1=bilirubinémie | n2=en:bilirubin test kit | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:biliuria n1=bilirubinémie | n2=en:biliuria | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cafe au lait spot n1=bilirubinémie | n2=en:cafe au lait spot | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cardiotoxicity n1=bilirubinémie | n2=en:cardiotoxicity | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cell death process n1=bilirubinémie | n2=en:cell death process | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cell stress process n1=bilirubinémie | n2=en:cell stress process | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:channelopathies n1=bilirubinémie | n2=en:channelopathies | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:chemically induced n1=bilirubinémie | n2=en:chemically induced | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cholelithiasis n1=bilirubinémie | n2=en:cholelithiasis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cholestasis of pregnancy n1=bilirubinémie | n2=en:cholestasis of pregnancy | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:collagen-vascular disease n1=bilirubinémie | n2=en:collagen-vascular disease | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:conjunctival pigmentation n1=bilirubinémie | n2=en:conjunctival pigmentation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cortisol deficiency n1=bilirubinémie | n2=en:cortisol deficiency | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:cushingoid n1=bilirubinémie | n2=en:cushingoid | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:diabetes mellitus n1=bilirubinémie | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:dihydrouracil dehydrogenase deficiency n1=bilirubinémie | n2=en:dihydrouracil dehydrogenase deficiency | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disease or disorder n1=bilirubinémie | n2=en:disease or disorder | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disease progression n1=bilirubinémie | n2=en:disease progression | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disorder of acid-base balance n1=bilirubinémie | n2=en:disorder of acid-base balance | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disorder of blood gas n1=bilirubinémie | n2=en:disorder of blood gas | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disorder of neurometabolic regulation n1=bilirubinémie | n2=en:disorder of neurometabolic regulation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:disorder of protein metabolism n1=bilirubinémie | n2=en:disorder of protein metabolism | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:dubin-johnson syndrome n1=bilirubinémie | n2=en:dubin-johnson syndrome | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:dysbiosis n1=bilirubinémie | n2=en:dysbiosis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:electrolyte depletion n1=bilirubinémie | n2=en:electrolyte depletion | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:electrolytes abnormal n1=bilirubinémie | n2=en:electrolytes abnormal | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:emaciation n1=bilirubinémie | n2=en:emaciation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:embryologic n1=bilirubinémie | n2=en:embryologic | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:endocrine and/or metabolic disorder specific to the fetus or newborn n1=bilirubinémie | n2=en:endocrine and/or metabolic disorder specific to the fetus or newborn | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:enzyme induction n1=bilirubinémie | n2=en:enzyme induction | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:exposure as collected domain n1=bilirubinémie | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:growth disorders n1=bilirubinémie | n2=en:growth disorders | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hematologic and lymphocytic disorder n1=bilirubinémie | n2=en:hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:historical aspects qualifier n1=bilirubinémie | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:host-parasite relationship n1=bilirubinémie | n2=en:host-parasite relationship | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:host-tumor interaction n1=bilirubinémie | n2=en:host-tumor interaction | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hypercortisolemia n1=bilirubinémie | n2=en:hypercortisolemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hyperlactemia n1=bilirubinémie | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hyperlipidemia n1=bilirubinémie | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hypopigmentation of eyelid n1=bilirubinémie | n2=en:hypopigmentation of eyelid | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hypoproteinemia n1=bilirubinémie | n2=en:hypoproteinemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:hypothyroidic goitre n1=bilirubinémie | n2=en:hypothyroidic goitre | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:idarubicin hydrochloride 10mg powder for injection solution vial n1=bilirubinémie | n2=en:idarubicin hydrochloride 10mg powder for injection solution vial | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:impaired tissue integrity n1=bilirubinémie | n2=en:impaired tissue integrity | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:in blood n1=bilirubinémie | n2=en:in blood | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:in urine n1=bilirubinémie | n2=en:in urine | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:induced termination of pregnancy complicated by metabolic disorder n1=bilirubinémie | n2=en:induced termination of pregnancy complicated by metabolic disorder | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:intravasation n1=bilirubinémie | n2=en:intravasation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:iron-deficiency anemia n1=bilirubinémie | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:ischemia n1=bilirubinémie | n2=en:ischemia | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:lab error false positive n1=bilirubinémie | n2=en:lab error false positive | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:labial melanin incontinence n1=bilirubinémie | n2=en:labial melanin incontinence | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:lentigo n1=bilirubinémie | n2=en:lentigo | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:leukoaraiosis n1=bilirubinémie | n2=en:leukoaraiosis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:malignant neoplasm n1=bilirubinémie | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:march hemoglobinuria n1=bilirubinémie | n2=en:march hemoglobinuria | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:melanoderma (disorder) n1=bilirubinémie | n2=en:melanoderma (disorder) | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:menstrual disorder n1=bilirubinémie | n2=en:menstrual disorder | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:mercury pigmentation of skin n1=bilirubinémie | n2=en:mercury pigmentation of skin | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:metabolic and genetic disorder affecting the liver n1=bilirubinémie | n2=en:metabolic and genetic disorder affecting the liver | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:metabolic aspects n1=bilirubinémie | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:metabolic disorder following molar and/or ectopic pregnancy n1=bilirubinémie | n2=en:metabolic disorder following molar and/or ectopic pregnancy | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:metabolic renal disease n1=bilirubinémie | n2=en:metabolic renal disease | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:microgliosis n1=bilirubinémie | n2=en:microgliosis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:mitochondrial diseases n1=bilirubinémie | n2=en:mitochondrial diseases | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:myxedema coma n1=bilirubinémie | n2=en:myxedema coma | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:north american indian intrahepatic cholestasis n1=bilirubinémie | n2=en:north american indian intrahepatic cholestasis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:nutritional and metabolic cardiomyopathy n1=bilirubinémie | n2=en:nutritional and metabolic cardiomyopathy | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:organic acid metabolism disorder n1=bilirubinémie | n2=en:organic acid metabolism disorder | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:other disorders of carbohydrate metabolism n1=bilirubinémie | n2=en:other disorders of carbohydrate metabolism | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pathological developmental process n1=bilirubinémie | n2=en:pathological developmental process | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:penile hypermelanosis n1=bilirubinémie | n2=en:penile hypermelanosis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pharmacotherapeutic n1=bilirubinémie | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pigmentary change in skin n1=bilirubinémie | n2=en:pigmentary change in skin | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pigmentation changes nec n1=bilirubinémie | n2=en:pigmentation changes nec | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pigmented scar n1=bilirubinémie | n2=en:pigmented scar | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:precancerous melanosis n1=bilirubinémie | n2=en:precancerous melanosis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:progressive familial intrahepatic cholestasis n1=bilirubinémie | n2=en:progressive familial intrahepatic cholestasis | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:pseudomembrane formation n1=bilirubinémie | n2=en:pseudomembrane formation | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:radiation damage n1=bilirubinémie | n2=en:radiation damage | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:rbc count low n1=bilirubinémie | n2=en:rbc count low | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:renal secondary osteodystrophia fibrosa n1=bilirubinémie | n2=en:renal secondary osteodystrophia fibrosa | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:secondary adrenal insufficiency n1=bilirubinémie | n2=en:secondary adrenal insufficiency | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:serum indirect bilirubin n1=bilirubinémie | n2=en:serum indirect bilirubin | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:teratogenic effect n1=bilirubinémie | n2=en:teratogenic effect | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:thyroid associated opthalmopathies n1=bilirubinémie | n2=en:thyroid associated opthalmopathies | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> en:thyrotoxic cardiomyopathy n1=bilirubinémie | n2=en:thyrotoxic cardiomyopathy | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 45 / 0.156 -> foie (anatomie) n1=bilirubinémie | n2=foie (anatomie) | rel=r_associated | relid=0 | w=45 bilirubinémie -- r_associated #0: 44 / 0.152 -> en:bilirubinemia n1=bilirubinémie | n2=en:bilirubinemia | rel=r_associated | relid=0 | w=44 bilirubinémie -- r_associated #0: 40 / 0.138 -> élévation de bilirubine n1=bilirubinémie | n2=élévation de bilirubine | rel=r_associated | relid=0 | w=40 bilirubinémie -- r_associated #0: 40 / 0.138 -> en:metaplasia n1=bilirubinémie | n2=en:metaplasia | rel=r_associated | relid=0 | w=40 bilirubinémie -- r_associated #0: 40 / 0.138 -> en:pathological aspects n1=bilirubinémie | n2=en:pathological aspects | rel=r_associated | relid=0 | w=40 bilirubinémie -- r_associated #0: 35 / 0.121 -> concentration sanguine n1=bilirubinémie | n2=concentration sanguine | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:acantholysis n1=bilirubinémie | n2=en:acantholysis | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:allergic reaction n1=bilirubinémie | n2=en:allergic reaction | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:arterial thrombosis n1=bilirubinémie | n2=en:arterial thrombosis | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:biliary tract abnormality n1=bilirubinémie | n2=en:biliary tract abnormality | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:depigmentation n1=bilirubinémie | n2=en:depigmentation | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:disorder of steroid metabolism n1=bilirubinémie | n2=en:disorder of steroid metabolism | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:enzyme abnormality (nos) n1=bilirubinémie | n2=en:enzyme abnormality (nos) | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:erythrocyte vacuolization n1=bilirubinémie | n2=en:erythrocyte vacuolization | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:granulomatosis, orofacial n1=bilirubinémie | n2=en:granulomatosis, orofacial | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:hyperbilirubinemia n1=bilirubinémie | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:metabolic disorder n1=bilirubinémie | n2=en:metabolic disorder | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:pathologic hemolysis n1=bilirubinémie | n2=en:pathologic hemolysis | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:proteinosis n1=bilirubinémie | n2=en:proteinosis | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:skin pigmentation disorder n1=bilirubinémie | n2=en:skin pigmentation disorder | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:traumatic n1=bilirubinémie | n2=en:traumatic | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:tumor immunity n1=bilirubinémie | n2=en:tumor immunity | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> en:vitiligo n1=bilirubinémie | n2=en:vitiligo | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 35 / 0.121 -> médicament n1=bilirubinémie | n2=médicament | rel=r_associated | relid=0 | w=35 bilirubinémie -- r_associated #0: 30 / 0.104 -> en:abnormal melanin pigmentation n1=bilirubinémie | n2=en:abnormal melanin pigmentation | rel=r_associated | relid=0 | w=30 bilirubinémie -- r_associated #0: 30 / 0.104 -> en:fibroplasia n1=bilirubinémie | n2=en:fibroplasia | rel=r_associated | relid=0 | w=30 bilirubinémie -- r_associated #0: 30 / 0.104 -> en:hyperuricemia n1=bilirubinémie | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=30 bilirubinémie -- r_associated #0: 30 / 0.104 -> en:pathologic process n1=bilirubinémie | n2=en:pathologic process | rel=r_associated | relid=0 | w=30 bilirubinémie -- r_associated #0: 30 / 0.104 -> en:postinflammatory skin pigmentation change n1=bilirubinémie | n2=en:postinflammatory skin pigmentation change | rel=r_associated | relid=0 | w=30 bilirubinémie -- r_associated #0: 25 / 0.087 -> en:increased bilirubin (patient b) n1=bilirubinémie | n2=en:increased bilirubin (patient b) | rel=r_associated | relid=0 | w=25 bilirubinémie -- r_associated #0: 23 / 0.08 -> bilirubinémies n1=bilirubinémie | n2=bilirubinémies | rel=r_associated | relid=0 | w=23 bilirubinémie -- r_associated #0: 20 / 0.069 -> bilirubinémie du nouveau-né n1=bilirubinémie | n2=bilirubinémie du nouveau-né | rel=r_associated | relid=0 | w=20 bilirubinémie -- r_associated #0: 20 / 0.069 -> bilirubinémique n1=bilirubinémie | n2=bilirubinémique | rel=r_associated | relid=0 | w=20 bilirubinémie -- r_associated #0: 16 / 0.055 -> bilirubine conjuguée n1=bilirubinémie | n2=bilirubine conjuguée | rel=r_associated | relid=0 | w=16 bilirubinémie -- r_associated #0: 16 / 0.055 -> bilirubine non conjuguée n1=bilirubinémie | n2=bilirubine non conjuguée | rel=r_associated | relid=0 | w=16 bilirubinémie -- r_associated #0: 16 / 0.055 -> fièvre n1=bilirubinémie | n2=fièvre | rel=r_associated | relid=0 | w=16 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilieuse n1=bilirubinémie | n2=bilieuse | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilieuse hémoglobinurique n1=bilirubinémie | n2=bilieuse hémoglobinurique | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilieuse hémoglobinurique (fièvre) n1=bilirubinémie | n2=bilieuse hémoglobinurique (fièvre) | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilifuscine n1=bilirubinémie | n2=bilifuscine | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> biligénèse n1=bilirubinémie | n2=biligénèse | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> biligraphie n1=bilirubinémie | n2=biligraphie | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> biligraphie intraveineuse n1=bilirubinémie | n2=biligraphie intraveineuse | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilirubinamnie n1=bilirubinémie | n2=bilirubinamnie | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilirubine directe n1=bilirubinémie | n2=bilirubine directe | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilirubine indirecte n1=bilirubinémie | n2=bilirubine indirecte | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> bilirubinurie n1=bilirubinémie | n2=bilirubinurie | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> biliverdine n1=bilirubinémie | n2=biliverdine | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> biliverdinoglobine n1=bilirubinémie | n2=biliverdinoglobine | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> en:bilieuse hemoglobinurique fever n1=bilirubinémie | n2=en:bilieuse hemoglobinurique fever | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> en:direct-reacting bilirubin n1=bilirubinémie | n2=en:direct-reacting bilirubin | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> en:icterus neonatorum n1=bilirubinémie | n2=en:icterus neonatorum | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> en:indirect-reacting bilirubin n1=bilirubinémie | n2=en:indirect-reacting bilirubin | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> fiévre bilieuse hémoglobinurique n1=bilirubinémie | n2=fiévre bilieuse hémoglobinurique | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> hémoglobinurique n1=bilirubinémie | n2=hémoglobinurique | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 15 / 0.052 -> ictère des nouveau-nés n1=bilirubinémie | n2=ictère des nouveau-nés | rel=r_associated | relid=0 | w=15 bilirubinémie -- r_associated #0: 11 / 0.038 -> cholestase n1=bilirubinémie | n2=cholestase | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 11 / 0.038 -> hémolyse intravasculaire n1=bilirubinémie | n2=hémolyse intravasculaire | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 11 / 0.038 -> hémorragie n1=bilirubinémie | n2=hémorragie | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 11 / 0.038 -> ictère obstructif n1=bilirubinémie | n2=ictère obstructif | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 11 / 0.038 -> maladie métabolique n1=bilirubinémie | n2=maladie métabolique | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 11 / 0.038 -> pigment n1=bilirubinémie | n2=pigment | rel=r_associated | relid=0 | w=11 bilirubinémie -- r_associated #0: 10 / 0.035 -> à la mort n1=bilirubinémie | n2=à la mort | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> à la vie n1=bilirubinémie | n2=à la vie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> à vie n1=bilirubinémie | n2=à vie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> a-bêta-lipoprotéinémie n1=bilirubinémie | n2=a-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> abêtalipoprotéinémie n1=bilirubinémie | n2=abêtalipoprotéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acidémie glutarique de type 1 n1=bilirubinémie | n2=acidémie glutarique de type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acido-cétose n1=bilirubinémie | n2=acido-cétose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acidocétose n1=bilirubinémie | n2=acidocétose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acidurie dicarboxylique n1=bilirubinémie | n2=acidurie dicarboxylique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acidurie glutarique n1=bilirubinémie | n2=acidurie glutarique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acidurie glutarique de type 1 n1=bilirubinémie | n2=acidurie glutarique de type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acromégalie n1=bilirubinémie | n2=acromégalie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> acromegaly n1=bilirubinémie | n2=acromegaly | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> agrégation des plaquettes diminuée n1=bilirubinémie | n2=agrégation des plaquettes diminuée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> agrégation plaquettaire sai diminuée n1=bilirubinémie | n2=agrégation plaquettaire sai diminuée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> albinisme n1=bilirubinémie | n2=albinisme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> albinisme oculocutané avec mèches noires, troubles intestinaux et surdité congénitale de perception n1=bilirubinémie | n2=albinisme oculocutané avec mèches noires, troubles intestinaux et surdité congénitale de perception | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> alcalose n1=bilirubinémie | n2=alcalose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> altération de l'état général n1=bilirubinémie | n2=altération de l'état général | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> amaigrissement pathologique n1=bilirubinémie | n2=amaigrissement pathologique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ammoniaque diminué n1=bilirubinémie | n2=ammoniaque diminué | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie aplasique n1=bilirubinémie | n2=anémie aplasique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie aplasique non précisée n1=bilirubinémie | n2=anémie aplasique non précisée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie aplastique n1=bilirubinémie | n2=anémie aplastique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie ferriprive n1=bilirubinémie | n2=anémie ferriprive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie hémolytique n1=bilirubinémie | n2=anémie hémolytique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie hypoplasique n1=bilirubinémie | n2=anémie hypoplasique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie hypoplastique n1=bilirubinémie | n2=anémie hypoplastique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie médullaire n1=bilirubinémie | n2=anémie médullaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie par aplasie médullaire n1=bilirubinémie | n2=anémie par aplasie médullaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie par atteinte isolée de la lignée rouge n1=bilirubinémie | n2=anémie par atteinte isolée de la lignée rouge | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie par carence en fer n1=bilirubinémie | n2=anémie par carence en fer | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie par hypoplasie médullaire n1=bilirubinémie | n2=anémie par hypoplasie médullaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anémie sidéroblastique n1=bilirubinémie | n2=anémie sidéroblastique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anomalie chromosomique n1=bilirubinémie | n2=anomalie chromosomique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anomalie cytogénétique n1=bilirubinémie | n2=anomalie cytogénétique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anomalies du métabolisme du fer n1=bilirubinémie | n2=anomalies du métabolisme du fer | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> anormalité des chromosomes n1=bilirubinémie | n2=anormalité des chromosomes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie de globules rouges purs n1=bilirubinémie | n2=aplasie de globules rouges purs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie des globules rouges purs n1=bilirubinémie | n2=aplasie des globules rouges purs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie érythrocytaire n1=bilirubinémie | n2=aplasie érythrocytaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie isolée de la lignée rouge n1=bilirubinémie | n2=aplasie isolée de la lignée rouge | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie médullaire n1=bilirubinémie | n2=aplasie médullaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie médullaire (causes d') n1=bilirubinémie | n2=aplasie médullaire (causes d') | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> aplasie primitive de la lignée rouge n1=bilirubinémie | n2=aplasie primitive de la lignée rouge | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arrêt de la maturation des globules rouges n1=bilirubinémie | n2=arrêt de la maturation des globules rouges | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arrêt de la maturation érythrocytaire n1=bilirubinémie | n2=arrêt de la maturation érythrocytaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arrêt de la maturation érythroïde n1=bilirubinémie | n2=arrêt de la maturation érythroïde | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arrêt de maturation des cellules érythroïdes n1=bilirubinémie | n2=arrêt de maturation des cellules érythroïdes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arylsulfatase B (déficit en) n1=bilirubinémie | n2=arylsulfatase B (déficit en) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arythmie n1=bilirubinémie | n2=arythmie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> arythmie cardiaque n1=bilirubinémie | n2=arythmie cardiaque | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> atrophie généralisée n1=bilirubinémie | n2=atrophie généralisée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> atrophie nutritionnelle n1=bilirubinémie | n2=atrophie nutritionnelle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> auto immune n1=bilirubinémie | n2=auto immune | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> auto-immun n1=bilirubinémie | n2=auto-immun | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> Auto-immun n1=bilirubinémie | n2=Auto-immun | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> auto-immune n1=bilirubinémie | n2=auto-immune | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> autoimmune n1=bilirubinémie | n2=autoimmune | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> avitaminose n1=bilirubinémie | n2=avitaminose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> avitaminose D n1=bilirubinémie | n2=avitaminose D | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> avitaminose d n1=bilirubinémie | n2=avitaminose d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> azote non protéinique augmenté n1=bilirubinémie | n2=azote non protéinique augmenté | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> azote non protéique augmenté n1=bilirubinémie | n2=azote non protéique augmenté | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> azotémie n1=bilirubinémie | n2=azotémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> bicarbonate sérique augmenté n1=bilirubinémie | n2=bicarbonate sérique augmenté | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> biochimie n1=bilirubinémie | n2=biochimie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> biologie n1=bilirubinémie | n2=biologie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> blastome n1=bilirubinémie | n2=blastome | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> blocage de maturation érythrocytaire n1=bilirubinémie | n2=blocage de maturation érythrocytaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cachexie n1=bilirubinémie | n2=cachexie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cachexie maligne n1=bilirubinémie | n2=cachexie maligne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> calcium normal n1=bilirubinémie | n2=calcium normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> calciurie n1=bilirubinémie | n2=calciurie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cancers n1=bilirubinémie | n2=cancers | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> carence en vit d n1=bilirubinémie | n2=carence en vit d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> carence en vitamine D n1=bilirubinémie | n2=carence en vitamine D | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> carence en vitamine d n1=bilirubinémie | n2=carence en vitamine d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cas de décès n1=bilirubinémie | n2=cas de décès | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cétoacidose n1=bilirubinémie | n2=cétoacidose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> chimie n1=bilirubinémie | n2=chimie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> choc circulatoire n1=bilirubinémie | n2=choc circulatoire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> choc d'origine vasculaire n1=bilirubinémie | n2=choc d'origine vasculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> choc non précisé n1=bilirubinémie | n2=choc non précisé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> choléstase n1=bilirubinémie | n2=choléstase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cholestase intrahépatique progressive familiale de type 1 n1=bilirubinémie | n2=cholestase intrahépatique progressive familiale de type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cholestases intrahépatiques progressives familiales n1=bilirubinémie | n2=cholestases intrahépatiques progressives familiales | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cholestérol normal n1=bilirubinémie | n2=cholestérol normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cholestérol sanguin élevé n1=bilirubinémie | n2=cholestérol sanguin élevé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> cholostase n1=bilirubinémie | n2=cholostase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> coagulation intravasculaire disséminée n1=bilirubinémie | n2=coagulation intravasculaire disséminée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> Coagulopathie intravasculaire disséminée n1=bilirubinémie | n2=Coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> coagulopathie intravasculaire disséminée n1=bilirubinémie | n2=coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus (rein de) n1=bilirubinémie | n2=collapsus (rein de) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus cardiaque n1=bilirubinémie | n2=collapsus cardiaque | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus cardio-vasculaire n1=bilirubinémie | n2=collapsus cardio-vasculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus cardiovasculaire n1=bilirubinémie | n2=collapsus cardiovasculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus circulatoire n1=bilirubinémie | n2=collapsus circulatoire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus de la circulation périphérique n1=bilirubinémie | n2=collapsus de la circulation périphérique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus vasculaire n1=bilirubinémie | n2=collapsus vasculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> collapsus vasculaire périphérique n1=bilirubinémie | n2=collapsus vasculaire périphérique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> coma hépatique n1=bilirubinémie | n2=coma hépatique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> coma myxoedémateux n1=bilirubinémie | n2=coma myxoedémateux | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> death n1=bilirubinémie | n2=death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> défaillance circulatoire n1=bilirubinémie | n2=défaillance circulatoire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> défaillance circulatoire périphérique n1=bilirubinémie | n2=défaillance circulatoire périphérique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> défaillance de la circulation périphérique n1=bilirubinémie | n2=défaillance de la circulation périphérique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> déficit en biotinidase n1=bilirubinémie | n2=déficit en biotinidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> déficit en prolidase n1=bilirubinémie | n2=déficit en prolidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> déficit en vitamine D n1=bilirubinémie | n2=déficit en vitamine D | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> dépigmentation n1=bilirubinémie | n2=dépigmentation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> déplétion électrolytique n1=bilirubinémie | n2=déplétion électrolytique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> dépression médullaire osseuse n1=bilirubinémie | n2=dépression médullaire osseuse | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> diabète (accidents vasculaires cérébraux du) n1=bilirubinémie | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> diabète bronzé n1=bilirubinémie | n2=diabète bronzé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> diabète sucré n1=bilirubinémie | n2=diabète sucré | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> diabète sucré de type 2 avec surdité n1=bilirubinémie | n2=diabète sucré de type 2 avec surdité | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale n1=bilirubinémie | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> disease n1=bilirubinémie | n2=disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> disorder n1=bilirubinémie | n2=disorder | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> dyslipémie n1=bilirubinémie | n2=dyslipémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> dysrythmie cardiaque n1=bilirubinémie | n2=dysrythmie cardiaque | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> dysrythmie cardiaque non précisée n1=bilirubinémie | n2=dysrythmie cardiaque non précisée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> eau (intoxication par l') n1=bilirubinémie | n2=eau (intoxication par l') | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> émaciation n1=bilirubinémie | n2=émaciation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> embole de tumeur n1=bilirubinémie | n2=embole de tumeur | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> embole tumoral n1=bilirubinémie | n2=embole tumoral | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> embolie tumorale n1=bilirubinémie | n2=embolie tumorale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:'compensated hypothyroidism' with increased tsh and normal t4 n1=bilirubinémie | n2=en:'compensated hypothyroidism' with increased tsh and normal t4 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:'rectilinear profiles' ultrastructurally in cells n1=bilirubinémie | n2=en:'rectilinear profiles' ultrastructurally in cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:1.61- and 1.76-mb microduplication of 3q29 n1=bilirubinémie | n2=en:1.61- and 1.76-mb microduplication of 3q29 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:2-aminoadipic aciduria n1=bilirubinémie | n2=en:2-aminoadipic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:3-methylglutaconic aciduria n1=bilirubinémie | n2=en:3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:3-methylglutaconic aciduria (3-mgc) n1=bilirubinémie | n2=en:3-methylglutaconic aciduria (3-mgc) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:3-methylglutaric aciduria n1=bilirubinémie | n2=en:3-methylglutaric aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:3-methylglutaric aciduria (3-mga) n1=bilirubinémie | n2=en:3-methylglutaric aciduria (3-mga) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:4-hydroxycyclohexylacetic aciduria (adults) n1=bilirubinémie | n2=en:4-hydroxycyclohexylacetic aciduria (adults) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:4-hydroxyphenylacetic aciduria n1=bilirubinémie | n2=en:4-hydroxyphenylacetic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:4-hydroxyphenylactic aciduria n1=bilirubinémie | n2=en:4-hydroxyphenylactic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) n1=bilirubinémie | n2=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:4-hydroxyphenylpyruvic aciduria n1=bilirubinémie | n2=en:4-hydroxyphenylpyruvic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:5-alpha-reductase-2 enzyme deficiency n1=bilirubinémie | n2=en:5-alpha-reductase-2 enzyme deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:5-hiaa csf may be normal or decreased n1=bilirubinémie | n2=en:5-hiaa csf may be normal or decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:5' nucleotidase measurement n1=bilirubinémie | n2=en:5' nucleotidase measurement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:5'nucleotidase decreased n1=bilirubinémie | n2=en:5'nucleotidase decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:a small minority of patients have translocations and inversions involving 16p13.3 n1=bilirubinémie | n2=en:a small minority of patients have translocations and inversions involving 16p13.3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:a subset of group b patients have absence of pc protein and mrna n1=bilirubinémie | n2=en:a subset of group b patients have absence of pc protein and mrna | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abacterial leukocyturia n1=bilirubinémie | n2=en:abacterial leukocyturia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abetalipoproteinemia n1=bilirubinémie | n2=en:abetalipoproteinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abetalipoproteinemia (lab finding) n1=bilirubinémie | n2=en:abetalipoproteinemia (lab finding) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal blood prolactin n1=bilirubinémie | n2=en:abnormal blood prolactin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal bone marrow karyotype, t(8,21) n1=bilirubinémie | n2=en:abnormal bone marrow karyotype, t(8,21) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal cartilage collagen on em n1=bilirubinémie | n2=en:abnormal cartilage collagen on em | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal columnization of chondrocytes n1=bilirubinémie | n2=en:abnormal columnization of chondrocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal dystrophin on muscle biopsy n1=bilirubinémie | n2=en:abnormal dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal eeg in 25% hospitalized patients n1=bilirubinémie | n2=en:abnormal eeg in 25% hospitalized patients | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) n1=bilirubinémie | n2=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal glycosylation of serum transferrin, type 1 pattern n1=bilirubinémie | n2=en:abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal hematology test result n1=bilirubinémie | n2=en:abnormal hematology test result | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal igfr1 function n1=bilirubinémie | n2=en:abnormal igfr1 function | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal isoelectric focusing of serum transferrin n1=bilirubinémie | n2=en:abnormal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) n1=bilirubinémie | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) n1=bilirubinémie | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) n1=bilirubinémie | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) n1=bilirubinémie | n2=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal karyotype in 3 patients involving distal 6p n1=bilirubinémie | n2=en:abnormal karyotype in 3 patients involving distal 6p | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal lipid profile n1=bilirubinémie | n2=en:abnormal lipid profile | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver enzymes (1 patient) n1=bilirubinémie | n2=en:abnormal liver enzymes (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver enzymes (rare) n1=bilirubinémie | n2=en:abnormal liver enzymes (rare) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver enzymes in those with hepatic cysts or fibrosis n1=bilirubinémie | n2=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver enzymes, intermittent n1=bilirubinémie | n2=en:abnormal liver enzymes, intermittent | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver enzymes, intermittent (1 patient) n1=bilirubinémie | n2=en:abnormal liver enzymes, intermittent (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver function tests (in some patients) n1=bilirubinémie | n2=en:abnormal liver function tests (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver function tests (less common) n1=bilirubinémie | n2=en:abnormal liver function tests (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal liver function tests (sgot, sgpt) n1=bilirubinémie | n2=en:abnormal liver function tests (sgot, sgpt) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal myelination in sural nerve biopsies n1=bilirubinémie | n2=en:abnormal myelination in sural nerve biopsies | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal n-glycosylation of transferrin n1=bilirubinémie | n2=en:abnormal n-glycosylation of transferrin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal nasal potential difference n1=bilirubinémie | n2=en:abnormal nasal potential difference | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal oral glucose tolerance n1=bilirubinémie | n2=en:abnormal oral glucose tolerance | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) n1=bilirubinémie | n2=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal phospholipid profile n1=bilirubinémie | n2=en:abnormal phospholipid profile | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia n1=bilirubinémie | n2=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal response to human chorionic gonadotropin indicates decreased testosterone n1=bilirubinémie | n2=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal schilling test (not normalized by addition of intrinsic factor) n1=bilirubinémie | n2=en:abnormal schilling test (not normalized by addition of intrinsic factor) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal secretin test n1=bilirubinémie | n2=en:abnormal secretin test | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum glycoproteins n1=bilirubinémie | n2=en:abnormal serum glycoproteins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum lipoprotein levels (in 3 of 10 patients) n1=bilirubinémie | n2=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum liver enzyme levels n1=bilirubinémie | n2=en:abnormal serum liver enzyme levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum protein electrophoresis (elevated alpha-2 band) n1=bilirubinémie | n2=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum transferrin pattern (in some patients) n1=bilirubinémie | n2=en:abnormal serum transferrin pattern (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) n1=bilirubinémie | n2=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem n1=bilirubinémie | n2=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal transaminases (1 patient) n1=bilirubinémie | n2=en:abnormal transaminases (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) n1=bilirubinémie | n2=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) n1=bilirubinémie | n2=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormal urinary oligosaccharides n1=bilirubinémie | n2=en:abnormal urinary oligosaccharides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormality of nucleobase metabolism n1=bilirubinémie | n2=en:abnormality of nucleobase metabolism | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormality of superoxide metabolism n1=bilirubinémie | n2=en:abnormality of superoxide metabolism | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormally low cerebrospinal fluid cystatin c n1=bilirubinémie | n2=en:abnormally low cerebrospinal fluid cystatin c | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins n1=bilirubinémie | n2=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absence of cd59 expression on red cells n1=bilirubinémie | n2=en:absence of cd59 expression on red cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absence of chylomicrons in lymph and plasma n1=bilirubinémie | n2=en:absence of chylomicrons in lymph and plasma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absence of cpt ii protein n1=bilirubinémie | n2=en:absence of cpt ii protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absence of emerin by immunohistochemistry on muscle biopsy n1=bilirubinémie | n2=en:absence of emerin by immunohistochemistry on muscle biopsy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absence of hepatic udp-glucuronyl-transferase n1=bilirubinémie | n2=en:absence of hepatic udp-glucuronyl-transferase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent 7-dehydrocholesterol n1=bilirubinémie | n2=en:absent 7-dehydrocholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent alkyl-dhap synthase activity n1=bilirubinémie | n2=en:absent alkyl-dhap synthase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent anti-insulin receptor antibodies n1=bilirubinémie | n2=en:absent anti-insulin receptor antibodies | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent axonal flare response to intradermal histamine injection n1=bilirubinémie | n2=en:absent axonal flare response to intradermal histamine injection | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent ch50 activity in complete c4 deficiency n1=bilirubinémie | n2=en:absent ch50 activity in complete c4 deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent dystrophin on muscle biopsy n1=bilirubinémie | n2=en:absent dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees n1=bilirubinémie | n2=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent igg2 subclass n1=bilirubinémie | n2=en:absent igg2 subclass | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent or severely reduced levels of serum immunoglobulins n1=bilirubinémie | n2=en:absent or severely reduced levels of serum immunoglobulins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent platelet agglutination in presence of ristocetin n1=bilirubinémie | n2=en:absent platelet agglutination in presence of ristocetin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent pro alpha 2(i) chain synthesis (fibroblasts) n1=bilirubinémie | n2=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 n1=bilirubinémie | n2=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:absent/reduced free proteins and absent total protein s n1=bilirubinémie | n2=en:absent/reduced free proteins and absent total protein s | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:accumulation of cholesterol esters in various tissues n1=bilirubinémie | n2=en:accumulation of cholesterol esters in various tissues | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:accumulation of guanidinoacetate in brain n1=bilirubinémie | n2=en:accumulation of guanidinoacetate in brain | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids n1=bilirubinémie | n2=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) n1=bilirubinémie | n2=en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts n1=bilirubinémie | n2=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts n1=bilirubinémie | n2=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acetylcholinesterase staining reveals nerve trunk hypertrophy n1=bilirubinémie | n2=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:achroocytosis n1=bilirubinémie | n2=en:achroocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acth normal n1=bilirubinémie | n2=en:acth normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acute hyperammonemia n1=bilirubinémie | n2=en:acute hyperammonemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acute myelogenous leukemia (aml-m6) n1=bilirubinémie | n2=en:acute myelogenous leukemia (aml-m6) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency n1=bilirubinémie | n2=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:acylglycinuria n1=bilirubinémie | n2=en:acylglycinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:addison disease n1=bilirubinémie | n2=en:addison disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Addison disease n1=bilirubinémie | n2=en:Addison disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Addison's disease n1=bilirubinémie | n2=en:Addison's disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:adenylosuccinase deficiency (finding) n1=bilirubinémie | n2=en:adenylosuccinase deficiency (finding) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:adrenocorticotropic hormone, increased n1=bilirubinémie | n2=en:adrenocorticotropic hormone, increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) n1=bilirubinémie | n2=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:agammaglobulinemia n1=bilirubinémie | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alanine aminotransferase abnormal n1=bilirubinémie | n2=en:alanine aminotransferase abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alanine aminotransferase measurement n1=bilirubinémie | n2=en:alanine aminotransferase measurement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alcalosis n1=bilirubinémie | n2=en:alcalosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aldolase a deficiency n1=bilirubinémie | n2=en:aldolase a deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aldosterone level increased above normal n1=bilirubinémie | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alkaline phosphatase decreased n1=bilirubinémie | n2=en:alkaline phosphatase decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alkaline phosphatase normal n1=bilirubinémie | n2=en:alkaline phosphatase normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alkaline phosphatase serum increased n1=bilirubinémie | n2=en:alkaline phosphatase serum increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma n1=bilirubinémie | n2=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alpha fetoprotein increased n1=bilirubinémie | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alpha ketoadipic aciduria n1=bilirubinémie | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts n1=bilirubinémie | n2=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aminoaciduria (1 patient) n1=bilirubinémie | n2=en:aminoaciduria (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aminoaciduria (less common) n1=bilirubinémie | n2=en:aminoaciduria (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aminoaciduria, intermittent n1=bilirubinémie | n2=en:aminoaciduria, intermittent | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aminoaciduria, mild (in some patients) n1=bilirubinémie | n2=en:aminoaciduria, mild (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aminoadipic semialdehyde synthase (aass) deficiency n1=bilirubinémie | n2=en:aminoadipic semialdehyde synthase (aass) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ammonia decreased n1=bilirubinémie | n2=en:ammonia decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:amorphous hyaline substance (skin biopsy and visceral organs) n1=bilirubinémie | n2=en:amorphous hyaline substance (skin biopsy and visceral organs) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) n1=bilirubinémie | n2=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) n1=bilirubinémie | n2=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:and cerebellar ataxia due to duplication of mitochondrial DNA n1=bilirubinémie | n2=en:and cerebellar ataxia due to duplication of mitochondrial DNA | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:androgens increased n1=bilirubinémie | n2=en:androgens increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:anomalies of cholesterol levels n1=bilirubinémie | n2=en:anomalies of cholesterol levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:anti-ds dna antibody n1=bilirubinémie | n2=en:anti-ds dna antibody | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:anti-factor viii positive n1=bilirubinémie | n2=en:anti-factor viii positive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:anti-ssb positive n1=bilirubinémie | n2=en:anti-ssb positive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:anti-tissue transglutaminase antibodies (anti-ttg) n1=bilirubinémie | n2=en:anti-tissue transglutaminase antibodies (anti-ttg) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:antineutrophil antibody positivity n1=bilirubinémie | n2=en:antineutrophil antibody positivity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:antineutrophil cytoplasmic antibody n1=bilirubinémie | n2=en:antineutrophil cytoplasmic antibody | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:antiphospholipid antibody n1=bilirubinémie | n2=en:antiphospholipid antibody | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:antiribonuclear protein positive n1=bilirubinémie | n2=en:antiribonuclear protein positive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:appropriately increased serum 1,25-dihydroxyvitamin d3 n1=bilirubinémie | n2=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:argininosuccinic aciduria n1=bilirubinémie | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:arylsulfatase b deficiency in fibroblasts and white blood cells n1=bilirubinémie | n2=en:arylsulfatase b deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aspartate aminotransferase abnormal n1=bilirubinémie | n2=en:aspartate aminotransferase abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aspartate aminotransferase decreased n1=bilirubinémie | n2=en:aspartate aminotransferase decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aspartate aminotransferase increased n1=bilirubinémie | n2=en:aspartate aminotransferase increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:aspartate aminotransferase measurement n1=bilirubinémie | n2=en:aspartate aminotransferase measurement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:associated with serum anti-phospholipid antibodies in about 50% of patients n1=bilirubinémie | n2=en:associated with serum anti-phospholipid antibodies in about 50% of patients | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:atrial abnormalities on electrocardiogram n1=bilirubinémie | n2=en:atrial abnormalities on electrocardiogram | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:auto-immune n1=bilirubinémie | n2=en:auto-immune | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:avitaminosis D n1=bilirubinémie | n2=en:avitaminosis D | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:axonemes show normal structure n1=bilirubinémie | n2=en:axonemes show normal structure | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:b lymphocytopenia n1=bilirubinémie | n2=en:b lymphocytopenia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat n1=bilirubinémie | n2=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ballooned neurons n1=bilirubinémie | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:basophilia n1=bilirubinémie | n2=en:basophilia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Bassen-Kornzweig disease n1=bilirubinémie | n2=en:Bassen-Kornzweig disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Bassen-Kornzweig's disease n1=bilirubinémie | n2=en:Bassen-Kornzweig's disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:benign growth n1=bilirubinémie | n2=en:benign growth | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:benign tumor n1=bilirubinémie | n2=en:benign tumor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:benign tumour n1=bilirubinémie | n2=en:benign tumour | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:beta-galactosidase deficiency in fibroblasts and white blood cells n1=bilirubinémie | n2=en:beta-galactosidase deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:beta-glucuronidase deficiency in fibroblasts and leukocytes n1=bilirubinémie | n2=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bicarbonaturia n1=bilirubinémie | n2=en:bicarbonaturia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bile duct pressure increased n1=bilirubinémie | n2=en:bile duct pressure increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bile output decreased n1=bilirubinémie | n2=en:bile output decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bile shows increased cholesterol/phospholipid ratio n1=bilirubinémie | n2=en:bile shows increased cholesterol/phospholipid ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bilirubin conjugated abnormal n1=bilirubinémie | n2=en:bilirubin conjugated abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bilirubin conjugated increased n1=bilirubinémie | n2=en:bilirubin conjugated increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bilirubin in sample n1=bilirubinémie | n2=en:bilirubin in sample | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bilirubin may or may not be increased n1=bilirubinémie | n2=en:bilirubin may or may not be increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:biliverdine n1=bilirubinémie | n2=en:biliverdine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:biologic degeneration n1=bilirubinémie | n2=en:biologic degeneration | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:biotinidase deficiency n1=bilirubinémie | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:blood bilirubin abnormal n1=bilirubinémie | n2=en:blood bilirubin abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:blood bilirubin decreased n1=bilirubinémie | n2=en:blood bilirubin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:blood bilirubin unconjugated increased n1=bilirubinémie | n2=en:blood bilirubin unconjugated increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:blood urea nitrogen increased n1=bilirubinémie | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:blunted cortisol response to adrenocorticotropic hormone (acth) n1=bilirubinémie | n2=en:blunted cortisol response to adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bone marrow depression n1=bilirubinémie | n2=en:bone marrow depression | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bone marrow hypoplasia (in some patients) n1=bilirubinémie | n2=en:bone marrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:borderline elevated low-density lipoprotein n1=bilirubinémie | n2=en:borderline elevated low-density lipoprotein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) n1=bilirubinémie | n2=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:breastfed offspring have transient decrease of plasma zinc levels n1=bilirubinémie | n2=en:breastfed offspring have transient decrease of plasma zinc levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:broad tissue deposition of amylopectin-like material n1=bilirubinémie | n2=en:broad tissue deposition of amylopectin-like material | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bromosulfophthalein test - secondary rise at 90 minutes n1=bilirubinémie | n2=en:bromosulfophthalein test - secondary rise at 90 minutes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:bromosulphthalein test normal n1=bilirubinémie | n2=en:bromosulphthalein test normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:c-band karyotype shows 'railroad track' appearance n1=bilirubinémie | n2=en:c-band karyotype shows 'railroad track' appearance | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cachexia n1=bilirubinémie | n2=en:cachexia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cachexy n1=bilirubinémie | n2=en:cachexy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:calcium normal n1=bilirubinémie | n2=en:calcium normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:calciuria n1=bilirubinémie | n2=en:calciuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cardiac arrhythmia n1=bilirubinémie | n2=en:cardiac arrhythmia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cardiac arrythmia n1=bilirubinémie | n2=en:cardiac arrythmia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:carnitine palmitoyltransferase ii deficiency (25% of controls) n1=bilirubinémie | n2=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) n1=bilirubinémie | n2=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cd4+/cd8+ ratio often reversed n1=bilirubinémie | n2=en:cd4+/cd8+ ratio often reversed | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cell studies show increased dna breakage n1=bilirubinémie | n2=en:cell studies show increased dna breakage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation n1=bilirubinémie | n2=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cellular arrest at g2 of the cell cycle n1=bilirubinémie | n2=en:cellular arrest at g2 of the cell cycle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cerebrospinal fluid lymphocytosis n1=bilirubinémie | n2=en:cerebrospinal fluid lymphocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ceruloplasmin decreased n1=bilirubinémie | n2=en:ceruloplasmin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva n1=bilirubinémie | n2=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) n1=bilirubinémie | n2=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:child-pugh-turcotte score increased n1=bilirubinémie | n2=en:child-pugh-turcotte score increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cholesterol low n1=bilirubinémie | n2=en:cholesterol low | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cholesterol normal n1=bilirubinémie | n2=en:cholesterol normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chondroitin 4-, 6-sulfate excretion in urine n1=bilirubinémie | n2=en:chondroitin 4-, 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chondroitin 6-sulfate excretion in urine n1=bilirubinémie | n2=en:chondroitin 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal aberration n1=bilirubinémie | n2=en:chromosomal aberration | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal abnormality n1=bilirubinémie | n2=en:chromosomal abnormality | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal instability n1=bilirubinémie | n2=en:chromosomal instability | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal mosaicism in cultured cells n1=bilirubinémie | n2=en:chromosomal mosaicism in cultured cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding n1=bilirubinémie | n2=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal rearrangement n1=bilirubinémie | n2=en:chromosomal rearrangement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus n1=bilirubinémie | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus n1=bilirubinémie | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosome 11q23.3 deletion n1=bilirubinémie | n2=en:chromosome 11q23.3 deletion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosome deletion extending from 8q24.11 to 8q24.13 n1=bilirubinémie | n2=en:chromosome deletion extending from 8q24.11 to 8q24.13 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) n1=bilirubinémie | n2=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chromosome inversion - inv2(p12q14) in 2 patients n1=bilirubinémie | n2=en:chromosome inversion - inv2(p12q14) in 2 patients | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chronic hypoxemia n1=bilirubinémie | n2=en:chronic hypoxemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:chylomicronemia, refractory fasting n1=bilirubinémie | n2=en:chylomicronemia, refractory fasting | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cilia may also be static, with slow activity n1=bilirubinémie | n2=en:cilia may also be static, with slow activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cilia show inner and outer dynein arm defects n1=bilirubinémie | n2=en:cilia show inner and outer dynein arm defects | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cilia show nonflexible and hyperkinetic beating of axonemes n1=bilirubinémie | n2=en:cilia show nonflexible and hyperkinetic beating of axonemes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:circulatory collapse n1=bilirubinémie | n2=en:circulatory collapse | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:circulatory shock n1=bilirubinémie | n2=en:circulatory shock | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:coagulopathy (inr = 2.2 - 3.5) n1=bilirubinémie | n2=en:coagulopathy (inr = 2.2 - 3.5) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:complex organic aciduria n1=bilirubinémie | n2=en:complex organic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:continuous urinary iodine loss n1=bilirubinémie | n2=en:continuous urinary iodine loss | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cortisol does not decrease on dexamethasone suppression test n1=bilirubinémie | n2=en:cortisol does not decrease on dexamethasone suppression test | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:creatine kinase levels may normalize with disease progression n1=bilirubinémie | n2=en:creatine kinase levels may normalize with disease progression | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:creatine kinase normal between episodes n1=bilirubinémie | n2=en:creatine kinase normal between episodes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:creatine phosphokinase increased n1=bilirubinémie | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:creatine phosphokinase serum increased n1=bilirubinémie | n2=en:creatine phosphokinase serum increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:csf pleocytosis, particularly of lymphocytes n1=bilirubinémie | n2=en:csf pleocytosis, particularly of lymphocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material n1=bilirubinémie | n2=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cutaneous anergy n1=bilirubinémie | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cystathionine beta-synthase deficiency disease n1=bilirubinémie | n2=en:cystathionine beta-synthase deficiency disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cystathioninuria (lab finding) n1=bilirubinémie | n2=en:cystathioninuria (lab finding) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytochrome c oxidase deficiency in skeletal muscle and brain n1=bilirubinémie | n2=en:cytochrome c oxidase deficiency in skeletal muscle and brain | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytogenetic breakpoints range from 10q23.3-q26.2 n1=bilirubinémie | n2=en:cytogenetic breakpoints range from 10q23.3-q26.2 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytogenetic deletion of chromosome 17p13.3 n1=bilirubinémie | n2=en:cytogenetic deletion of chromosome 17p13.3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytogenetic deletion of chromosome 19q13 n1=bilirubinémie | n2=en:cytogenetic deletion of chromosome 19q13 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) n1=bilirubinémie | n2=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 n1=bilirubinémie | n2=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytomegalovirus infection n1=bilirubinémie | n2=en:cytomegalovirus infection | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytoplasmic lamellar concentric inclusions n1=bilirubinémie | n2=en:cytoplasmic lamellar concentric inclusions | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) n1=bilirubinémie | n2=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:cytosolic phosphoenolpyruvate carboxykinase deficiency n1=bilirubinémie | n2=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:d-2-hydroxyglutaric aciduria n1=bilirubinémie | n2=en:d-2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decrease or absence of cathepsin d (ctsd) protein immunostaining n1=bilirubinémie | n2=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) n1=bilirubinémie | n2=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf n1=bilirubinémie | n2=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased acetyl-coa carboxylase activity n1=bilirubinémie | n2=en:decreased acetyl-coa carboxylase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased acid beta galactosidase protein and activity n1=bilirubinémie | n2=en:decreased acid beta galactosidase protein and activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased acid sphingomyelinase activity n1=bilirubinémie | n2=en:decreased acid sphingomyelinase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased acid sphingomyelinase activity (less than 5%) n1=bilirubinémie | n2=en:decreased acid sphingomyelinase activity (less than 5%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activities of multiple sulfatases n1=bilirubinémie | n2=en:decreased activities of multiple sulfatases | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex n1=bilirubinémie | n2=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase n1=bilirubinémie | n2=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of 2-oxoacid dehydrogenases n1=bilirubinémie | n2=en:decreased activity of 2-oxoacid dehydrogenases | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) n1=bilirubinémie | n2=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) n1=bilirubinémie | n2=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase n1=bilirubinémie | n2=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of aromatic l-amino acid decarboxylase (aadc) n1=bilirubinémie | n2=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of coenzyme q10-dependent respiratory chain complexes n1=bilirubinémie | n2=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of complement factor d n1=bilirubinémie | n2=en:decreased activity of complement factor d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of cytochrome c oxidase in muscle and fibroblasts n1=bilirubinémie | n2=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of dihydrofolate reductase n1=bilirubinémie | n2=en:decreased activity of dihydrofolate reductase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of galactocerebrosidase n1=bilirubinémie | n2=en:decreased activity of galactocerebrosidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes n1=bilirubinémie | n2=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase n1=bilirubinémie | n2=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of mitochondrial complex i n1=bilirubinémie | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of mitochondrial respiratory chain complex i n1=bilirubinémie | n2=en:decreased activity of mitochondrial respiratory chain complex i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of mitochondrial respiratory complexes n1=bilirubinémie | n2=en:decreased activity of mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v n1=bilirubinémie | n2=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of mitochondrial respiratory complexes i, iii, and iv n1=bilirubinémie | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of nadph oxidase n1=bilirubinémie | n2=en:decreased activity of nadph oxidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of phosphoglycerate kinase 1 n1=bilirubinémie | n2=en:decreased activity of phosphoglycerate kinase 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of ppt1 n1=bilirubinémie | n2=en:decreased activity of ppt1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of pyruvate dehydrogenase complex n1=bilirubinémie | n2=en:decreased activity of pyruvate dehydrogenase complex | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values n1=bilirubinémie | n2=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh n1=bilirubinémie | n2=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of the pdh phosphatase n1=bilirubinémie | n2=en:decreased activity of the pdh phosphatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of the pyruvate dehydrogenase (pdh) complex n1=bilirubinémie | n2=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of thiopurine s-methyltransferase n1=bilirubinémie | n2=en:decreased activity of thiopurine s-methyltransferase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of thymidine phosphorylase n1=bilirubinémie | n2=en:decreased activity of thymidine phosphorylase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of triosephosphate isomerase n1=bilirubinémie | n2=en:decreased activity of triosephosphate isomerase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased activity of tyrosine hydroxylase n1=bilirubinémie | n2=en:decreased activity of tyrosine hydroxylase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased adenosylcobalamin n1=bilirubinémie | n2=en:decreased adenosylcobalamin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased adiponectin n1=bilirubinémie | n2=en:decreased adiponectin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased agt activity n1=bilirubinémie | n2=en:decreased agt activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) n1=bilirubinémie | n2=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased alpha-n-acetylgalactosaminidase protein n1=bilirubinémie | n2=en:decreased alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased aminoacylase-1 activity n1=bilirubinémie | n2=en:decreased aminoacylase-1 activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased amount and activity of mitochondrial complexes i and iv n1=bilirubinémie | n2=en:decreased amount and activity of mitochondrial complexes i and iv | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased apoa-i and apoa-ii n1=bilirubinémie | n2=en:decreased apoa-i and apoa-ii | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts n1=bilirubinémie | n2=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased asparagine levels (in some patients) n1=bilirubinémie | n2=en:decreased asparagine levels (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased atp synthase in muscle, heart, liver, and brain n1=bilirubinémie | n2=en:decreased atp synthase in muscle, heart, liver, and brain | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased axonal flare response after intradermal histamine injection n1=bilirubinémie | n2=en:decreased axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased b cells n1=bilirubinémie | n2=en:decreased b cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased beta-galactosidase activity n1=bilirubinémie | n2=en:decreased beta-galactosidase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased beta-glucocerebrosidase protein and activity n1=bilirubinémie | n2=en:decreased beta-glucocerebrosidase protein and activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes n1=bilirubinémie | n2=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased beta-thromboglobulin n1=bilirubinémie | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased blood levels of cationic amino acids n1=bilirubinémie | n2=en:decreased blood levels of cationic amino acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased c3 antigen n1=bilirubinémie | n2=en:decreased c3 antigen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased carnitine palmitoyltransferase ii (cpt2) activity n1=bilirubinémie | n2=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cerebrospinal fluid folic acid n1=bilirubinémie | n2=en:decreased cerebrospinal fluid folic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cholesterol (less common) n1=bilirubinémie | n2=en:decreased cholesterol (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased ciliary motility n1=bilirubinémie | n2=en:decreased ciliary motility | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased circulating aldosterone level n1=bilirubinémie | n2=en:decreased circulating aldosterone level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased circulating cortisol level n1=bilirubinémie | n2=en:decreased circulating cortisol level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased circulating renin level n1=bilirubinémie | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased clot retraction n1=bilirubinémie | n2=en:decreased clot retraction | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cobalamin in liver, kidney, and cultured fibroblasts n1=bilirubinémie | n2=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased complement factor d n1=bilirubinémie | n2=en:decreased complement factor d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased conversion of beta-carotene to vitamin a (retinol) n1=bilirubinémie | n2=en:decreased conversion of beta-carotene to vitamin a (retinol) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased copper, iron, zinc n1=bilirubinémie | n2=en:decreased copper, iron, zinc | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) n1=bilirubinémie | n2=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased coq10 levels in lymphoblasts or fibroblasts n1=bilirubinémie | n2=en:decreased coq10 levels in lymphoblasts or fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cortisol-binding globulin n1=bilirubinémie | n2=en:decreased cortisol-binding globulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cpt1 activity n1=bilirubinémie | n2=en:decreased cpt1 activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) n1=bilirubinémie | n2=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) n1=bilirubinémie | n2=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) n1=bilirubinémie | n2=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf arginine n1=bilirubinémie | n2=en:decreased csf arginine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf ferritin despite normal serum ferritin levels n1=bilirubinémie | n2=en:decreased csf ferritin despite normal serum ferritin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf folate n1=bilirubinémie | n2=en:decreased csf folate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf glycine n1=bilirubinémie | n2=en:decreased csf glycine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf homovanillic acid (hva) n1=bilirubinémie | n2=en:decreased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf hypocretin n1=bilirubinémie | n2=en:decreased csf hypocretin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf methyltetrahydrofolate (mthf) n1=bilirubinémie | n2=en:decreased csf methyltetrahydrofolate (mthf) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf pyridoxal n1=bilirubinémie | n2=en:decreased csf pyridoxal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf serine n1=bilirubinémie | n2=en:decreased csf serine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate n1=bilirubinémie | n2=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle n1=bilirubinémie | n2=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased dermal hydroxylysine content n1=bilirubinémie | n2=en:decreased dermal hydroxylysine content | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity n1=bilirubinémie | n2=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity n1=bilirubinémie | n2=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased dna excision repair n1=bilirubinémie | n2=en:decreased dna excision repair | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased dna polymerase-gamma (polg, 174763) activity n1=bilirubinémie | n2=en:decreased dna polymerase-gamma (polg, 174763) activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) n1=bilirubinémie | n2=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values n1=bilirubinémie | n2=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased erythrocyte plasmalogen n1=bilirubinémie | n2=en:decreased erythrocyte plasmalogen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells n1=bilirubinémie | n2=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased expression of gpi-anchored proteins on blood cells n1=bilirubinémie | n2=en:decreased expression of gpi-anchored proteins on blood cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased factor xi n1=bilirubinémie | n2=en:decreased factor xi | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fbp1 enzyme activity n1=bilirubinémie | n2=en:decreased fbp1 enzyme activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibrillin-1 immunostaining in the dermis n1=bilirubinémie | n2=en:decreased fibrillin-1 immunostaining in the dermis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibrinogen (in some patients) n1=bilirubinémie | n2=en:decreased fibrinogen (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibroblast alpha-mannosidase n1=bilirubinémie | n2=en:decreased fibroblast alpha-mannosidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibroblast arylsulfatase a n1=bilirubinémie | n2=en:decreased fibroblast arylsulfatase a | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibroblast beta-hexosaminidase n1=bilirubinémie | n2=en:decreased fibroblast beta-hexosaminidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fibroblast iduronate sulfatase n1=bilirubinémie | n2=en:decreased fibroblast iduronate sulfatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased formation of complex (tri-, tetra-antennary) n-glycans n1=bilirubinémie | n2=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased free t(3)/free t(4) n1=bilirubinémie | n2=en:decreased free t(3)/free t(4) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased fumarate hydratase activity n1=bilirubinémie | n2=en:decreased fumarate hydratase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased galactokinase activity n1=bilirubinémie | n2=en:decreased galactokinase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased glomerular filtration rate (gfr) n1=bilirubinémie | n2=en:decreased glomerular filtration rate (gfr) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased glutamine in bodily fluids n1=bilirubinémie | n2=en:decreased glutamine in bodily fluids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased glycerol kinase activity n1=bilirubinémie | n2=en:decreased glycerol kinase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased grhpr activity n1=bilirubinémie | n2=en:decreased grhpr activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased gtp cyclohydrolase i activity (about 20% of normal) n1=bilirubinémie | n2=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased hdl cholesterol n1=bilirubinémie | n2=en:decreased hdl cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) n1=bilirubinémie | n2=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased hepatic udp-glucuronyl-transferase activity n1=bilirubinémie | n2=en:decreased hepatic udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased hexokinase activity in red blood cells n1=bilirubinémie | n2=en:decreased hexokinase activity in red blood cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased high molecular weight plasma factor viii/ vwf multimers n1=bilirubinémie | n2=en:decreased high molecular weight plasma factor viii/ vwf multimers | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf n1=bilirubinémie | n2=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased iga, igg, igm n1=bilirubinémie | n2=en:decreased iga, igg, igm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased insulin receptor binding n1=bilirubinémie | n2=en:decreased insulin receptor binding | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased intracellular fmr protein n1=bilirubinémie | n2=en:decreased intracellular fmr protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased lecithin:cholesterol acyltransferase mass and activity n1=bilirubinémie | n2=en:decreased lecithin:cholesterol acyltransferase mass and activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of cellular and mitochondrial fes-containing proteins n1=bilirubinémie | n2=en:decreased levels of cellular and mitochondrial fes-containing proteins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) n1=bilirubinémie | n2=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of component x protein of the pdh complex n1=bilirubinémie | n2=en:decreased levels of component x protein of the pdh complex | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of cpt2 protein n1=bilirubinémie | n2=en:decreased levels of cpt2 protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of csf hypocretin (hcrt, 602358) n1=bilirubinémie | n2=en:decreased levels of csf hypocretin (hcrt, 602358) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of plasma factor viii n1=bilirubinémie | n2=en:decreased levels of plasma factor viii | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of plasma vwf antigen n1=bilirubinémie | n2=en:decreased levels of plasma vwf antigen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of serum vitamin b12 n1=bilirubinémie | n2=en:decreased levels of serum vitamin b12 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased levels of the e2 subunit protein n1=bilirubinémie | n2=en:decreased levels of the e2 subunit protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased lipid-linked oligosaccharides (llo) n1=bilirubinémie | n2=en:decreased lipid-linked oligosaccharides (llo) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased liver homogentisate 1,2-dioxygenase activity n1=bilirubinémie | n2=en:decreased liver homogentisate 1,2-dioxygenase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased long-chain fatty acid oxidation n1=bilirubinémie | n2=en:decreased long-chain fatty acid oxidation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes n1=bilirubinémie | n2=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased metabolism of thiopurine drugs n1=bilirubinémie | n2=en:decreased metabolism of thiopurine drugs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased methionine synthase activity n1=bilirubinémie | n2=en:decreased methionine synthase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased methylmalonyl-coa mutase activity n1=bilirubinémie | n2=en:decreased methylmalonyl-coa mutase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial complex i n1=bilirubinémie | n2=en:decreased mitochondrial complex i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) n1=bilirubinémie | n2=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial complex iii activity in liver and fibroblasts n1=bilirubinémie | n2=en:decreased mitochondrial complex iii activity in liver and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial complex iii activity seen in muscle n1=bilirubinémie | n2=en:decreased mitochondrial complex iii activity seen in muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial complex v assembly n1=bilirubinémie | n2=en:decreased mitochondrial complex v assembly | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial nadp(h) n1=bilirubinémie | n2=en:decreased mitochondrial nadp(h) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial respiratory chain complex (2p21del) n1=bilirubinémie | n2=en:decreased mitochondrial respiratory chain complex (2p21del) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle n1=bilirubinémie | n2=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased mucosal alkaline phosphatase n1=bilirubinémie | n2=en:decreased mucosal alkaline phosphatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes n1=bilirubinémie | n2=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased nasal nitric oxide n1=bilirubinémie | n2=en:decreased nasal nitric oxide | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased natural killer cells n1=bilirubinémie | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased neopterin and biopterin in urine n1=bilirubinémie | n2=en:decreased neopterin and biopterin in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased nk cells (in some patients) n1=bilirubinémie | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased number of igf1 receptors (igf1r, 147370) on cell surface n1=bilirubinémie | n2=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased numbers of t regulatory cells n1=bilirubinémie | n2=en:decreased numbers of t regulatory cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent alpha-n-acetylgalactosaminidase activity n1=bilirubinémie | n2=en:decreased or absent alpha-n-acetylgalactosaminidase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent alpha-n-acetylgalactosaminidase protein n1=bilirubinémie | n2=en:decreased or absent alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent apolipoprotein a-i n1=bilirubinémie | n2=en:decreased or absent apolipoprotein a-i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent d-bifunctional protein activity and protein n1=bilirubinémie | n2=en:decreased or absent d-bifunctional protein activity and protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent dihydropteridine reductase activity n1=bilirubinémie | n2=en:decreased or absent dihydropteridine reductase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent dihydropyrimidine dehydrogenase activity n1=bilirubinémie | n2=en:decreased or absent dihydropyrimidine dehydrogenase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent glycogen branching enzyme activity n1=bilirubinémie | n2=en:decreased or absent glycogen branching enzyme activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent histidase activity n1=bilirubinémie | n2=en:decreased or absent histidase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent peroxisome acyl-coa oxidase activity and protein n1=bilirubinémie | n2=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent pts activity n1=bilirubinémie | n2=en:decreased or absent pts activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid n1=bilirubinémie | n2=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent serum citrulline n1=bilirubinémie | n2=en:decreased or absent serum citrulline | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or absent udp-glucuronyl-transferase activity n1=bilirubinémie | n2=en:decreased or absent udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or increased serum testosterone n1=bilirubinémie | n2=en:decreased or increased serum testosterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or low-normal serum parathyroid hormone (pth) n1=bilirubinémie | n2=en:decreased or low-normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or normal plasma insulin n1=bilirubinémie | n2=en:decreased or normal plasma insulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or normal serum c3 n1=bilirubinémie | n2=en:decreased or normal serum c3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or normal serum factor b n1=bilirubinémie | n2=en:decreased or normal serum factor b | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased or normal serum factor i n1=bilirubinémie | n2=en:decreased or normal serum factor i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased palmitate oxidation n1=bilirubinémie | n2=en:decreased palmitate oxidation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased peroxisomal fatty acid beta-oxidation n1=bilirubinémie | n2=en:decreased peroxisomal fatty acid beta-oxidation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased phgdh activity (fibroblasts) n1=bilirubinémie | n2=en:decreased phgdh activity (fibroblasts) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased phk activity in liver n1=bilirubinémie | n2=en:decreased phk activity in liver | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) n1=bilirubinémie | n2=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) n1=bilirubinémie | n2=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased phytanic acid oxidase activity n1=bilirubinémie | n2=en:decreased phytanic acid oxidase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma and urinary guanidinoacetate (gaa) n1=bilirubinémie | n2=en:decreased plasma and urinary guanidinoacetate (gaa) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma and urinary ornithine n1=bilirubinémie | n2=en:decreased plasma and urinary ornithine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma apolipoprotein c-ii n1=bilirubinémie | n2=en:decreased plasma apolipoprotein c-ii | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma arginine n1=bilirubinémie | n2=en:decreased plasma arginine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma esterified cholesterol n1=bilirubinémie | n2=en:decreased plasma esterified cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma glycine n1=bilirubinémie | n2=en:decreased plasma glycine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma hdl (<1/10 of normal levels) n1=bilirubinémie | n2=en:decreased plasma hdl (<1/10 of normal levels) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma lysine, glutamic acid, and glutamine n1=bilirubinémie | n2=en:decreased plasma lysine, glutamic acid, and glutamine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma serine n1=bilirubinémie | n2=en:decreased plasma serine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma total and free carnitine n1=bilirubinémie | n2=en:decreased plasma total and free carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma total cholesterol n1=bilirubinémie | n2=en:decreased plasma total cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma triglycerides n1=bilirubinémie | n2=en:decreased plasma triglycerides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasma zinc levels n1=bilirubinémie | n2=en:decreased plasma zinc levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasmalogens n1=bilirubinémie | n2=en:decreased plasmalogens | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasminogen activity n1=bilirubinémie | n2=en:decreased plasminogen activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased plasminogen antigen n1=bilirubinémie | n2=en:decreased plasminogen antigen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased platelet derived growth factor n1=bilirubinémie | n2=en:decreased platelet derived growth factor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased prpp synthetase activity in erythrocytes and fibroblasts n1=bilirubinémie | n2=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased pyruvate carboxylase (pc) activity (less than 5%) n1=bilirubinémie | n2=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased renal calcium excretion n1=bilirubinémie | n2=en:decreased renal calcium excretion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) n1=bilirubinémie | n2=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased scad activity n1=bilirubinémie | n2=en:decreased scad activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum 18-ohb n1=bilirubinémie | n2=en:decreased serum 18-ohb | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum acth n1=bilirubinémie | n2=en:decreased serum acth | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum alpha-2 macroglobulin levels n1=bilirubinémie | n2=en:decreased serum alpha-2 macroglobulin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum and salivary lactoferrin has been described in 1 family n1=bilirubinémie | n2=en:decreased serum and salivary lactoferrin has been described in 1 family | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum androgens n1=bilirubinémie | n2=en:decreased serum androgens | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum bun n1=bilirubinémie | n2=en:decreased serum bun | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum c3 (atypical hus) n1=bilirubinémie | n2=en:decreased serum c3 (atypical hus) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum carnitine in acute stage n1=bilirubinémie | n2=en:decreased serum carnitine in acute stage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum ceruloplasmin n1=bilirubinémie | n2=en:decreased serum ceruloplasmin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum cholesterol (in some) n1=bilirubinémie | n2=en:decreased serum cholesterol (in some) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum cobalamin n1=bilirubinémie | n2=en:decreased serum cobalamin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum complement factor h n1=bilirubinémie | n2=en:decreased serum complement factor h | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum factor b (atypical hus) n1=bilirubinémie | n2=en:decreased serum factor b (atypical hus) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum factor h (atypical hus) n1=bilirubinémie | n2=en:decreased serum factor h (atypical hus) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum factor i (atypical hus) n1=bilirubinémie | n2=en:decreased serum factor i (atypical hus) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum follicle-stimulating hormone (fsh) n1=bilirubinémie | n2=en:decreased serum follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum free thyroxine n1=bilirubinémie | n2=en:decreased serum free thyroxine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum glucosyltransferase (ggt) activity n1=bilirubinémie | n2=en:decreased serum glucosyltransferase (ggt) activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum haptoglobin n1=bilirubinémie | n2=en:decreased serum haptoglobin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum iga n1=bilirubinémie | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum igm n1=bilirubinémie | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum insulin-like growth factor-1 (igf1, 147440) n1=bilirubinémie | n2=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum insulin-like growth factor-1 (igf1) n1=bilirubinémie | n2=en:decreased serum insulin-like growth factor-1 (igf1) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum iron (in some patients) n1=bilirubinémie | n2=en:decreased serum iron (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum l-transferrin (heterozygous patient) n1=bilirubinémie | n2=en:decreased serum l-transferrin (heterozygous patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum leptin n1=bilirubinémie | n2=en:decreased serum leptin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum luteinizing hormone (lh) n1=bilirubinémie | n2=en:decreased serum luteinizing hormone (lh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum rt3 n1=bilirubinémie | n2=en:decreased serum rt3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum thiamine pyrophosphate n1=bilirubinémie | n2=en:decreased serum thiamine pyrophosphate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum thyroxine (t4) n1=bilirubinémie | n2=en:decreased serum thyroxine (t4) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum trypsinogen n1=bilirubinémie | n2=en:decreased serum trypsinogen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased serum vitamin a n1=bilirubinémie | n2=en:decreased serum vitamin a | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity n1=bilirubinémie | n2=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased sulfite oxidase activity n1=bilirubinémie | n2=en:decreased sulfite oxidase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased sulfite oxidase activity in fibroblasts n1=bilirubinémie | n2=en:decreased sulfite oxidase activity in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased switched memory b cells n1=bilirubinémie | n2=en:decreased switched memory b cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased t cells n1=bilirubinémie | n2=en:decreased t cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased telomerase activity n1=bilirubinémie | n2=en:decreased telomerase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased testosterone level n1=bilirubinémie | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased tetrahydrobiopterin (bh4) in csf n1=bilirubinémie | n2=en:decreased tetrahydrobiopterin (bh4) in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased tetrasialo-transferrin n1=bilirubinémie | n2=en:decreased tetrasialo-transferrin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased tetrasialotransferrin levels n1=bilirubinémie | n2=en:decreased tetrasialotransferrin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased thrombospondin n1=bilirubinémie | n2=en:decreased thrombospondin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased tissue and serum alkaline phosphatase n1=bilirubinémie | n2=en:decreased tissue and serum alkaline phosphatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased tissue total and free carnitine n1=bilirubinémie | n2=en:decreased tissue total and free carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid n1=bilirubinémie | n2=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased transferrin increased serum iron n1=bilirubinémie | n2=en:decreased transferrin increased serum iron | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased ubiquinone-10 n1=bilirubinémie | n2=en:decreased ubiquinone-10 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased udp-glcnac n1=bilirubinémie | n2=en:decreased udp-glcnac | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased urinary calcium and phosphate excretion n1=bilirubinémie | n2=en:decreased urinary calcium and phosphate excretion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) n1=bilirubinémie | n2=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased urinary sulfate n1=bilirubinémie | n2=en:decreased urinary sulfate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased urocanic acid in blood, urine, and skin cells n1=bilirubinémie | n2=en:decreased urocanic acid in blood, urine, and skin cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased very long-chain acyl-coa dehydrogenase protein and activity n1=bilirubinémie | n2=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased von willebrand factor n1=bilirubinémie | n2=en:decreased von willebrand factor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased whole blood serotonin n1=bilirubinémie | n2=en:decreased whole blood serotonin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased xanthine dehydrogenase activity n1=bilirubinémie | n2=en:decreased xanthine dehydrogenase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:decreased-absent intestinal mucosa lactase activity n1=bilirubinémie | n2=en:decreased-absent intestinal mucosa lactase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in chylomicron secretion n1=bilirubinémie | n2=en:defect in chylomicron secretion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in double-stranded dna repair n1=bilirubinémie | n2=en:defect in double-stranded dna repair | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in mitochondrial and peroxisomal fission n1=bilirubinémie | n2=en:defect in mitochondrial and peroxisomal fission | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in n- and o-glycosylation n1=bilirubinémie | n2=en:defect in n- and o-glycosylation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in oxidative phosphorylation n1=bilirubinémie | n2=en:defect in oxidative phosphorylation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defect in retrograde intraflagellar transport in cilia n1=bilirubinémie | n2=en:defect in retrograde intraflagellar transport in cilia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective (ca2+) mobilization in t cells n1=bilirubinémie | n2=en:defective (ca2+) mobilization in t cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective bile acid metabolism n1=bilirubinémie | n2=en:defective bile acid metabolism | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective DNA repair n1=bilirubinémie | n2=en:defective DNA repair | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective dna repair n1=bilirubinémie | n2=en:defective dna repair | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective dna repair after ultraviolet radiation damage n1=bilirubinémie | n2=en:defective dna repair after ultraviolet radiation damage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective glcnac-pi synthesis n1=bilirubinémie | n2=en:defective glcnac-pi synthesis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defective t-cell proliferative responses (in some patients) n1=bilirubinémie | n2=en:defective t-cell proliferative responses (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:defibrination syndrome n1=bilirubinémie | n2=en:defibrination syndrome | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of alpha-1,4-glucosidase (acid maltase) n1=bilirubinémie | n2=en:deficiency of alpha-1,4-glucosidase (acid maltase) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of creatine phosphate in brain n1=bilirubinémie | n2=en:deficiency of creatine phosphate in brain | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of fat-soluble vitamins n1=bilirubinémie | n2=en:deficiency of fat-soluble vitamins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of glycoprotein (gp)iib-iiia complex n1=bilirubinémie | n2=en:deficiency of glycoprotein (gp)iib-iiia complex | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle n1=bilirubinémie | n2=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of laminin in basement membranes n1=bilirubinémie | n2=en:deficiency of laminin in basement membranes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts n1=bilirubinémie | n2=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts n1=bilirubinémie | n2=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of saposins a, b, c, and d n1=bilirubinémie | n2=en:deficiency of saposins a, b, c, and d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency of serum properdin p factor n1=bilirubinémie | n2=en:deficiency of serum properdin p factor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of cytochrome b(-245) n1=bilirubinémie | n2=en:deficiency or absence of cytochrome b(-245) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of p22-phox (608508) protein n1=bilirubinémie | n2=en:deficiency or absence of p22-phox (608508) protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of p47-phox protein (type i) n1=bilirubinémie | n2=en:deficiency or absence of p47-phox protein (type i) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of p67-phox protein (type ii) n1=bilirubinémie | n2=en:deficiency or absence of p67-phox protein (type ii) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of p91-phox (300481) protein n1=bilirubinémie | n2=en:deficiency or absence of p91-phox (300481) protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficiency or absence of p91-phox protein n1=bilirubinémie | n2=en:deficiency or absence of p91-phox protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficient efflux of intracellular cholesterol n1=bilirubinémie | n2=en:deficient efflux of intracellular cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficient fibroblast aicar-tf activity n1=bilirubinémie | n2=en:deficient fibroblast aicar-tf activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase n1=bilirubinémie | n2=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts n1=bilirubinémie | n2=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dehydroepiandrosterone (dhea) at upper level of normal range n1=bilirubinémie | n2=en:dehydroepiandrosterone (dhea) at upper level of normal range | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:delayed oxidation of acetaldehyde n1=bilirubinémie | n2=en:delayed oxidation of acetaldehyde | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye n1=bilirubinémie | n2=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes n1=bilirubinémie | n2=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine n1=bilirubinémie | n2=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma n1=bilirubinémie | n2=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes n1=bilirubinémie | n2=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:depletion of mtdna (skeletal muscle, fibroblasts) n1=bilirubinémie | n2=en:depletion of mtdna (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dermatan and heparan sulfate excretion in urine n1=bilirubinémie | n2=en:dermatan and heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dermatan sulfate excretion in urine n1=bilirubinémie | n2=en:dermatan sulfate excretion in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease n1=bilirubinémie | n2=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease n1=bilirubinémie | n2=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dhea sulfotransferase below limit of detection n1=bilirubinémie | n2=en:dhea sulfotransferase below limit of detection | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:di- and trihydroxycholestanoic acid accumulation n1=bilirubinémie | n2=en:di- and trihydroxycholestanoic acid accumulation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diabetes bronze n1=bilirubinémie | n2=en:diabetes bronze | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diagnosis by exposing muscle biopsy to caffeine and/or halothane n1=bilirubinémie | n2=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) n1=bilirubinémie | n2=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dicarboxylic aciduria n1=bilirubinémie | n2=en:dicarboxylic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diffuse deposition of calcium oxalate in various tissues n1=bilirubinémie | n2=en:diffuse deposition of calcium oxalate in various tissues | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diffuse intravascular coagulation n1=bilirubinémie | n2=en:diffuse intravascular coagulation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dilated rough endoplasmic reticulum (rer) n1=bilirubinémie | n2=en:dilated rough endoplasmic reticulum (rer) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dimethylglycine dehydrogenase (dmgdh) deficiency n1=bilirubinémie | n2=en:dimethylglycine dehydrogenase (dmgdh) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diminished lymphocyte response to phytohemaglutinin n1=bilirubinémie | n2=en:diminished lymphocyte response to phytohemaglutinin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:direct coombs test negative n1=bilirubinémie | n2=en:direct coombs test negative | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disease n1=bilirubinémie | n2=en:disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disorder n1=bilirubinémie | n2=en:disorder | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disorganized growth plate cartilage n1=bilirubinémie | n2=en:disorganized growth plate cartilage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disproportionate work-related increase in blood lactate and pyruvate n1=bilirubinémie | n2=en:disproportionate work-related increase in blood lactate and pyruvate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disseminated intravascular coagulation n1=bilirubinémie | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:distal xp22.3 segmental monosomy n1=bilirubinémie | n2=en:distal xp22.3 segmental monosomy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination n1=bilirubinémie | n2=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material n1=bilirubinémie | n2=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency n1=bilirubinémie | n2=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency n1=bilirubinémie | n2=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Dubin-Johnson's syndrome n1=bilirubinémie | n2=en:Dubin-Johnson's syndrome | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Dubin-Sprinz disease n1=bilirubinémie | n2=en:Dubin-Sprinz disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:duplication or deletion at 11p15.5 n1=bilirubinémie | n2=en:duplication or deletion at 11p15.5 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:dyskinetic ciliary motility n1=bilirubinémie | n2=en:dyskinetic ciliary motility | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:echocardiogram abnormal n1=bilirubinémie | n2=en:echocardiogram abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electrolyte disturbances from intractable diarrhea n1=bilirubinémie | n2=en:electrolyte disturbances from intractable diarrhea | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electrolyturia (1 patient) n1=bilirubinémie | n2=en:electrolyturia (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of foam cells shows lamellar inclusions n1=bilirubinémie | n2=en:electron microscopy of foam cells shows lamellar inclusions | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms n1=bilirubinémie | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme n1=bilirubinémie | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms n1=bilirubinémie | n2=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms n1=bilirubinémie | n2=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links n1=bilirubinémie | n2=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished n1=bilirubinémie | n2=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 1,25(oh)2 d3 n1=bilirubinémie | n2=en:elevated 1,25(oh)2 d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 17-hydroxyprogesterone n1=bilirubinémie | n2=en:elevated 17-hydroxyprogesterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 2-ketoglutarate (urine) n1=bilirubinémie | n2=en:elevated 2-ketoglutarate (urine) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 3-hydroxypropionic acid n1=bilirubinémie | n2=en:elevated 3-hydroxypropionic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 3-methylcitric acid n1=bilirubinémie | n2=en:elevated 3-methylcitric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 7-dehydrocholesterol n1=bilirubinémie | n2=en:elevated 7-dehydrocholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 8-dehydrocholesterol n1=bilirubinémie | n2=en:elevated 8-dehydrocholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated 8(9)-cholestenol n1=bilirubinémie | n2=en:elevated 8(9)-cholestenol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated acth n1=bilirubinémie | n2=en:elevated acth | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated afp (endodermal sinus tumor) n1=bilirubinémie | n2=en:elevated afp (endodermal sinus tumor) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated alkaline phosphatase (if more than one affected site) n1=bilirubinémie | n2=en:elevated alkaline phosphatase (if more than one affected site) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) n1=bilirubinémie | n2=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated alkaline phosphatase of bone origin n1=bilirubinémie | n2=en:elevated alkaline phosphatase of bone origin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated alpha-ketoglutarate (in most patients) n1=bilirubinémie | n2=en:elevated alpha-ketoglutarate (in most patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated ammonia n1=bilirubinémie | n2=en:elevated ammonia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated androstenedione n1=bilirubinémie | n2=en:elevated androstenedione | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated androstenedione and testosterone n1=bilirubinémie | n2=en:elevated androstenedione and testosterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated anti-cyclic citrullinated peptide antibody level n1=bilirubinémie | n2=en:elevated anti-cyclic citrullinated peptide antibody level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated antinuclear antibody (ana) (speckled pattern) n1=bilirubinémie | n2=en:elevated antinuclear antibody (ana) (speckled pattern) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated apoa-i (1.8x normal) in homozygotes n1=bilirubinémie | n2=en:elevated apoa-i (1.8x normal) in homozygotes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) n1=bilirubinémie | n2=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated ast and ldh, especially infantile-onset n1=bilirubinémie | n2=en:elevated ast and ldh, especially infantile-onset | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated bilirubin (bilirubinemia) n1=bilirubinémie | n2=en:elevated bilirubin (bilirubinemia) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated biopterin in csf n1=bilirubinémie | n2=en:elevated biopterin in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated blood spot hydroxybutyryl carnitine n1=bilirubinémie | n2=en:elevated blood spot hydroxybutyryl carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated calcitonin n1=bilirubinémie | n2=en:elevated calcitonin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated cerebrospinal fluid (csf) protein n1=bilirubinémie | n2=en:elevated cerebrospinal fluid (csf) protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts n1=bilirubinémie | n2=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated circulating parathyroid hormone (pth) level n1=bilirubinémie | n2=en:elevated circulating parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated creatine kinase (in some patients) n1=bilirubinémie | n2=en:elevated creatine kinase (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated crp n1=bilirubinémie | n2=en:elevated crp | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) n1=bilirubinémie | n2=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated csf/plasma glycine ratio n1=bilirubinémie | n2=en:elevated csf/plasma glycine ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) n1=bilirubinémie | n2=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated dihydrobiopterin in csf n1=bilirubinémie | n2=en:elevated dihydrobiopterin in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte adenosine deaminase n1=bilirubinémie | n2=en:elevated erythrocyte adenosine deaminase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte adenosine deaminase (eada) n1=bilirubinémie | n2=en:elevated erythrocyte adenosine deaminase (eada) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte adenosine deaminase activity n1=bilirubinémie | n2=en:elevated erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte aicar (zmp) n1=bilirubinémie | n2=en:elevated erythrocyte aicar (zmp) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte sedimentation rate (esr) n1=bilirubinémie | n2=en:elevated erythrocyte sedimentation rate (esr) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated erythrocyte sedimentation rate (mean 90mm/h) n1=bilirubinémie | n2=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated fasting glucose n1=bilirubinémie | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated fasting triglycerides (seen in heterozygotes as well) n1=bilirubinémie | n2=en:elevated fasting triglycerides (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated fecal levels of protoporphyrin and coproporphyrin at all times n1=bilirubinémie | n2=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated ferritin l subunit n1=bilirubinémie | n2=en:elevated ferritin l subunit | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated fibroblast free sialic acid n1=bilirubinémie | n2=en:elevated fibroblast free sialic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated free carnitine n1=bilirubinémie | n2=en:elevated free carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated gamma-glutamyltransferase n1=bilirubinémie | n2=en:elevated gamma-glutamyltransferase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated gamma-glutamyltransferase (ggt) n1=bilirubinémie | n2=en:elevated gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated gastrin concentration n1=bilirubinémie | n2=en:elevated gastrin concentration | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated hcg (choriocarcinoma) n1=bilirubinémie | n2=en:elevated hcg (choriocarcinoma) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated hcg or afp or both (embryonal carcinoma) n1=bilirubinémie | n2=en:elevated hcg or afp or both (embryonal carcinoma) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated hdl (2-6x normal) in homozygotes n1=bilirubinémie | n2=en:elevated hdl (2-6x normal) in homozygotes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated hepatic transaminases n1=bilirubinémie | n2=en:elevated hepatic transaminases | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated il1-beta n1=bilirubinémie | n2=en:elevated il1-beta | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated il6 n1=bilirubinémie | n2=en:elevated il6 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated inflammatory markers n1=bilirubinémie | n2=en:elevated inflammatory markers | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated l-2-hydroxyglutaric acid (urine) n1=bilirubinémie | n2=en:elevated l-2-hydroxyglutaric acid (urine) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated lathosterol n1=bilirubinémie | n2=en:elevated lathosterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated leukotriene e(4) n1=bilirubinémie | n2=en:elevated leukotriene e(4) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated levels of vitamin b12 n1=bilirubinémie | n2=en:elevated levels of vitamin b12 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated liver enzymes level n1=bilirubinémie | n2=en:elevated liver enzymes level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated liver function tests n1=bilirubinémie | n2=en:elevated liver function tests | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated liver transaminases n1=bilirubinémie | n2=en:elevated liver transaminases | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated long-chain acylcarnitine species (in some patients) n1=bilirubinémie | n2=en:elevated long-chain acylcarnitine species (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated mchc n1=bilirubinémie | n2=en:elevated mchc | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma acth n1=bilirubinémie | n2=en:elevated plasma acth | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma adrenocorticotropic hormone (acth) n1=bilirubinémie | n2=en:elevated plasma adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma alloisoleucine n1=bilirubinémie | n2=en:elevated plasma alloisoleucine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma ammonia n1=bilirubinémie | n2=en:elevated plasma ammonia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma and urine inorganic pyrophosphate (ppi) n1=bilirubinémie | n2=en:elevated plasma and urine inorganic pyrophosphate (ppi) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma and urine succinylacetone n1=bilirubinémie | n2=en:elevated plasma and urine succinylacetone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) n1=bilirubinémie | n2=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) n1=bilirubinémie | n2=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma campesterol n1=bilirubinémie | n2=en:elevated plasma campesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma cholestanol n1=bilirubinémie | n2=en:elevated plasma cholestanol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma citrulline (citrullinemia) n1=bilirubinémie | n2=en:elevated plasma citrulline (citrullinemia) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma desmosterol n1=bilirubinémie | n2=en:elevated plasma desmosterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma estrogen n1=bilirubinémie | n2=en:elevated plasma estrogen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma follicle stimulating hormone (fsh) n1=bilirubinémie | n2=en:elevated plasma follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma galactose (galactosemia) n1=bilirubinémie | n2=en:elevated plasma galactose (galactosemia) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma insulin n1=bilirubinémie | n2=en:elevated plasma insulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma luteinizing hormone (lh) n1=bilirubinémie | n2=en:elevated plasma luteinizing hormone (lh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma methionine (methioninemia) n1=bilirubinémie | n2=en:elevated plasma methionine (methioninemia) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma ornithine (~10-fold) n1=bilirubinémie | n2=en:elevated plasma ornithine (~10-fold) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma propionylcarnitine n1=bilirubinémie | n2=en:elevated plasma propionylcarnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated plasma stigmasterol n1=bilirubinémie | n2=en:elevated plasma stigmasterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated pregnenolone n1=bilirubinémie | n2=en:elevated pregnenolone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated progesterone n1=bilirubinémie | n2=en:elevated progesterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated propionate n1=bilirubinémie | n2=en:elevated propionate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated pth (parathyroid hormone) n1=bilirubinémie | n2=en:elevated pth (parathyroid hormone) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated resting serum lactate, increased with exercise n1=bilirubinémie | n2=en:elevated resting serum lactate, increased with exercise | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated sed rate n1=bilirubinémie | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated sepiapterin in csf n1=bilirubinémie | n2=en:elevated sepiapterin in csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum alkaline phosphatase during hyperplastic callus formation n1=bilirubinémie | n2=en:elevated serum alkaline phosphatase during hyperplastic callus formation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum alpha-fetoprotein n1=bilirubinémie | n2=en:elevated serum alpha-fetoprotein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum alpha-fetoprotein (dominant) n1=bilirubinémie | n2=en:elevated serum alpha-fetoprotein (dominant) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum angiotensin-converting enzyme (ace) n1=bilirubinémie | n2=en:elevated serum angiotensin-converting enzyme (ace) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum bile acids n1=bilirubinémie | n2=en:elevated serum bile acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum glutamic oxaloacetic transaminase (sgot) n1=bilirubinémie | n2=en:elevated serum glutamic oxaloacetic transaminase (sgot) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum glutamic pyruvic transaminase (sgpt) n1=bilirubinémie | n2=en:elevated serum glutamic pyruvic transaminase (sgpt) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum insulin-to-c-peptide ratio n1=bilirubinémie | n2=en:elevated serum insulin-to-c-peptide ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum iron and iron binding capacity n1=bilirubinémie | n2=en:elevated serum iron and iron binding capacity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum lactate n1=bilirubinémie | n2=en:elevated serum lactate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum levels of adenosine n1=bilirubinémie | n2=en:elevated serum levels of adenosine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum levels of follicle stimulating hormone (fsh) n1=bilirubinémie | n2=en:elevated serum levels of follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum levels of luteinizing hormone (lh) n1=bilirubinémie | n2=en:elevated serum levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum n,n-dimethylglycine (dmg) n1=bilirubinémie | n2=en:elevated serum n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum parathyroid hormone (pth) n1=bilirubinémie | n2=en:elevated serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum parathyroid hormone (pth) level n1=bilirubinémie | n2=en:elevated serum parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum phosphate in heterozygotes n1=bilirubinémie | n2=en:elevated serum phosphate in heterozygotes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum phosphorus n1=bilirubinémie | n2=en:elevated serum phosphorus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum protein n1=bilirubinémie | n2=en:elevated serum protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum transaminase levels n1=bilirubinémie | n2=en:elevated serum transaminase levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum transaminases during infections n1=bilirubinémie | n2=en:elevated serum transaminases during infections | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum transferrin saturation n1=bilirubinémie | n2=en:elevated serum transferrin saturation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated serum uric acid concentrations n1=bilirubinémie | n2=en:elevated serum uric acid concentrations | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated sweat chloride n1=bilirubinémie | n2=en:elevated sweat chloride | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated sweat chloride (some) n1=bilirubinémie | n2=en:elevated sweat chloride (some) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated testosterone n1=bilirubinémie | n2=en:elevated testosterone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated total bilirubin n1=bilirubinémie | n2=en:elevated total bilirubin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated total cholesterol (seen in heterozygotes as well) n1=bilirubinémie | n2=en:elevated total cholesterol (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated uric acid on urinalysis (in some patients) n1=bilirubinémie | n2=en:elevated uric acid on urinalysis (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary 2-ethylhydracrylate n1=bilirubinémie | n2=en:elevated urinary 2-ethylhydracrylate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary 3-methylglutaconate n1=bilirubinémie | n2=en:elevated urinary 3-methylglutaconate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary 3-methylglutarate n1=bilirubinémie | n2=en:elevated urinary 3-methylglutarate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary 7 alpha-hydroxylated bile alcohols n1=bilirubinémie | n2=en:elevated urinary 7 alpha-hydroxylated bile alcohols | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary and csf ribitol and d-arabitol n1=bilirubinémie | n2=en:elevated urinary and csf ribitol and d-arabitol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary delta-aminolevulinic acid n1=bilirubinémie | n2=en:elevated urinary delta-aminolevulinic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary delta-aminolevulinic acid and porphyrins n1=bilirubinémie | n2=en:elevated urinary delta-aminolevulinic acid and porphyrins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary free sialic acid (n-acetylneuraminic acid) n1=bilirubinémie | n2=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary mevalonic acid n1=bilirubinémie | n2=en:elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary n,n-dimethylglycine (dmg) n1=bilirubinémie | n2=en:elevated urinary n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary ornithine, lysine, arginine n1=bilirubinémie | n2=en:elevated urinary ornithine, lysine, arginine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary pge(2) levels n1=bilirubinémie | n2=en:elevated urinary pge(2) levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary phosphoethanolamine n1=bilirubinémie | n2=en:elevated urinary phosphoethanolamine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urinary pyridinoline and deoxypyridinoline n1=bilirubinémie | n2=en:elevated urinary pyridinoline and deoxypyridinoline | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated urine ceramide levels n1=bilirubinémie | n2=en:elevated urine ceramide levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:elevated white blood cell cystine n1=bilirubinémie | n2=en:elevated white blood cell cystine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:enzymatic disease n1=bilirubinémie | n2=en:enzymatic disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:enzyme replacement therapy has not been effective n1=bilirubinémie | n2=en:enzyme replacement therapy has not been effective | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:eosinophilia, mild n1=bilirubinémie | n2=en:eosinophilia, mild | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:erythroblastosis n1=bilirubinémie | n2=en:erythroblastosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency n1=bilirubinémie | n2=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) n1=bilirubinémie | n2=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:erythroid colony-forming units show spontaneous growth in the absence of epo n1=bilirubinémie | n2=en:erythroid colony-forming units show spontaneous growth in the absence of epo | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ethylmalonic aciduria n1=bilirubinémie | n2=en:ethylmalonic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:euvolemia n1=bilirubinémie | n2=en:euvolemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:excessive iodide trapping n1=bilirubinémie | n2=en:excessive iodide trapping | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:excessive thirst n1=bilirubinémie | n2=en:excessive thirst | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:excessive urinary 5-oxo-l-proline n1=bilirubinémie | n2=en:excessive urinary 5-oxo-l-proline | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:excretion of dermatan sulfate and heparan sulfate in urine n1=bilirubinémie | n2=en:excretion of dermatan sulfate and heparan sulfate in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:exercise-induced myoglobinuria n1=bilirubinémie | n2=en:exercise-induced myoglobinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:exercise-induced myoglobinuria in adults n1=bilirubinémie | n2=en:exercise-induced myoglobinuria in adults | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:extremely low creatine excretion n1=bilirubinémie | n2=en:extremely low creatine excretion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:factor vii deficiency n1=bilirubinémie | n2=en:factor vii deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:factor viii deficiency n1=bilirubinémie | n2=en:factor viii deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:farber lipogranulomatosis n1=bilirubinémie | n2=en:farber lipogranulomatosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fasting chylomicronemia n1=bilirubinémie | n2=en:fasting chylomicronemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fasting hyperinsulinemia n1=bilirubinémie | n2=en:fasting hyperinsulinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fasting hypoglycemia (early in disease course) n1=bilirubinémie | n2=en:fasting hypoglycemia (early in disease course) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fasting ketosis n1=bilirubinémie | n2=en:fasting ketosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid n1=bilirubinémie | n2=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts n1=bilirubinémie | n2=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ferritin decreased n1=bilirubinémie | n2=en:ferritin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibrinogen decreased n1=bilirubinémie | n2=en:fibrinogen decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibrinogen in blood above reference range n1=bilirubinémie | n2=en:fibrinogen in blood above reference range | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts accumulate dol-pp-glcnac2man5 n1=bilirubinémie | n2=en:fibroblasts accumulate dol-pp-glcnac2man5 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts attach poorly n1=bilirubinémie | n2=en:fibroblasts attach poorly | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts demonstrate rapid growth with increased dna synthesis n1=bilirubinémie | n2=en:fibroblasts demonstrate rapid growth with increased dna synthesis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside n1=bilirubinémie | n2=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) n1=bilirubinémie | n2=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v n1=bilirubinémie | n2=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show decreased mitochondrial complex v activity n1=bilirubinémie | n2=en:fibroblasts show decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show decreased peroxisomes arranged in rows n1=bilirubinémie | n2=en:fibroblasts show decreased peroxisomes arranged in rows | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show elongated, tangled, tubular mitochondria n1=bilirubinémie | n2=en:fibroblasts show elongated, tangled, tubular mitochondria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities n1=bilirubinémie | n2=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) n1=bilirubinémie | n2=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show increased sensitivity to apoptosis n1=bilirubinémie | n2=en:fibroblasts show increased sensitivity to apoptosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts show lamellar lysosomal inclusions on electron microscopy n1=bilirubinémie | n2=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibroblasts shows defects in oxidative phosphorylation n1=bilirubinémie | n2=en:fibroblasts shows defects in oxidative phosphorylation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fibronectin decreased n1=bilirubinémie | n2=en:fibronectin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:finding of serum bilirubin level n1=bilirubinémie | n2=en:finding of serum bilirubin level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material n1=bilirubinémie | n2=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fluid overload n1=bilirubinémie | n2=en:fluid overload | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fluorescence in situ hybridization specific probe for mds critical region n1=bilirubinémie | n2=en:fluorescence in situ hybridization specific probe for mds critical region | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fluorescence of red blood cells by uv microscopy n1=bilirubinémie | n2=en:fluorescence of red blood cells by uv microscopy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy n1=bilirubinémie | n2=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:foam cells in bone marrow and renal glomeruli n1=bilirubinémie | n2=en:foam cells in bone marrow and renal glomeruli | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:folate-dependent fragile site at xq28 n1=bilirubinémie | n2=en:folate-dependent fragile site at xq28 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:folic acid deficiency n1=bilirubinémie | n2=en:folic acid deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:for life n1=bilirubinémie | n2=en:for life | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fragmentation of the mitochondrial network n1=bilirubinémie | n2=en:fragmentation of the mitochondrial network | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:frequent deletions of chromosome 9 in melanoma n1=bilirubinémie | n2=en:frequent deletions of chromosome 9 in melanoma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc n1=bilirubinémie | n2=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fucosidosis n1=bilirubinémie | n2=en:fucosidosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fumarase activity (mitochondrial and cytosolic) is decreased n1=bilirubinémie | n2=en:fumarase activity (mitochondrial and cytosolic) is decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fumarase deficiency n1=bilirubinémie | n2=en:fumarase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fumarylacetoacetate hydrolase (fah) deficiency n1=bilirubinémie | n2=en:fumarylacetoacetate hydrolase (fah) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fungaemia n1=bilirubinémie | n2=en:fungaemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fungal septicaemia n1=bilirubinémie | n2=en:fungal septicaemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:fungemia n1=bilirubinémie | n2=en:fungemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts n1=bilirubinémie | n2=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactose elimination capacity test n1=bilirubinémie | n2=en:galactose elimination capacity test | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactose elimination capacity test abnormal n1=bilirubinémie | n2=en:galactose elimination capacity test abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactose elimination capacity test increased n1=bilirubinémie | n2=en:galactose elimination capacity test increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactosuria n1=bilirubinémie | n2=en:galactosuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactosuria without galactosemia n1=bilirubinémie | n2=en:galactosuria without galactosemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactosylation defects n1=bilirubinémie | n2=en:galactosylation defects | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:galactosyltransferase i deficiency in fibroblasts n1=bilirubinémie | n2=en:galactosyltransferase i deficiency in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gallbladder pain, ctcae 3.0 n1=bilirubinémie | n2=en:gallbladder pain, ctcae 3.0 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gamma-glutamylcysteine deficiency n1=bilirubinémie | n2=en:gamma-glutamylcysteine deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency n1=bilirubinémie | n2=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gamma-glutamyltransferase decreased n1=bilirubinémie | n2=en:gamma-glutamyltransferase decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gangrene n1=bilirubinémie | n2=en:gangrene | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system n1=bilirubinémie | n2=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gaucher disease, type 1 n1=bilirubinémie | n2=en:gaucher disease, type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:general paralysis n1=bilirubinémie | n2=en:general paralysis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:general paresis n1=bilirubinémie | n2=en:general paresis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:generalized aminoaciduria n1=bilirubinémie | n2=en:generalized aminoaciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:generalized amyloid deposition n1=bilirubinémie | n2=en:generalized amyloid deposition | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:genetic disorder of skin pigmentation n1=bilirubinémie | n2=en:genetic disorder of skin pigmentation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ggtp abnormal n1=bilirubinémie | n2=en:ggtp abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage n1=bilirubinémie | n2=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells n1=bilirubinémie | n2=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glomerular filtration rate decreased n1=bilirubinémie | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glucose breath hydrogen test shows malabsorption of glucose and galactose n1=bilirubinémie | n2=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glucose-6-phosphate deficiency n1=bilirubinémie | n2=en:glucose-6-phosphate deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glucosidase i deficiency in liver and fibroblasts n1=bilirubinémie | n2=en:glucosidase i deficiency in liver and fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glucosuria, mild, intermittent n1=bilirubinémie | n2=en:glucosuria, mild, intermittent | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutaric acidemia type 1 n1=bilirubinémie | n2=en:glutaric acidemia type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutaric aciduria n1=bilirubinémie | n2=en:glutaric aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutaric aciduria type 1 n1=bilirubinémie | n2=en:glutaric aciduria type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutaric aciduria, type 1 n1=bilirubinémie | n2=en:glutaric aciduria, type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutathione deficiency n1=bilirubinémie | n2=en:glutathione deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glutathione synthetase deficiency n1=bilirubinémie | n2=en:glutathione synthetase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycoamino aciduria n1=bilirubinémie | n2=en:glycoamino aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycogen accumulation in both liver and muscle n1=bilirubinémie | n2=en:glycogen accumulation in both liver and muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycogen storage disease type v n1=bilirubinémie | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycogen storage disease type vi n1=bilirubinémie | n2=en:glycogen storage disease type vi | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycogen storage disease type vii n1=bilirubinémie | n2=en:glycogen storage disease type vii | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glycosuria (less common) n1=bilirubinémie | n2=en:glycosuria (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:glyoxalase deficiency n1=bilirubinémie | n2=en:glyoxalase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gm2-ganglioside accumulation n1=bilirubinémie | n2=en:gm2-ganglioside accumulation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gonadotrophin increased n1=bilirubinémie | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells n1=bilirubinémie | n2=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells n1=bilirubinémie | n2=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic deposits (grod) in cells n1=bilirubinémie | n2=en:granular osmiophilic deposits (grod) in cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally n1=bilirubinémie | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally n1=bilirubinémie | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally n1=bilirubinémie | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) n1=bilirubinémie | n2=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:green serum n1=bilirubinémie | n2=en:green serum | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:green urine n1=bilirubinémie | n2=en:green urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement n1=bilirubinémie | n2=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:guanidinoacetate methyltransferase (gamt) deficiency n1=bilirubinémie | n2=en:guanidinoacetate methyltransferase (gamt) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:gustation n1=bilirubinémie | n2=en:gustation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:haemochromatosis n1=bilirubinémie | n2=en:haemochromatosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:haemoglobinaemia n1=bilirubinémie | n2=en:haemoglobinaemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hair bulb tyrosinase present n1=bilirubinémie | n2=en:hair bulb tyrosinase present | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hair bulbs will pigment when incubated with tyrosine n1=bilirubinémie | n2=en:hair bulbs will pigment when incubated with tyrosine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:haptoglobin decreased n1=bilirubinémie | n2=en:haptoglobin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hawkinsinuria n1=bilirubinémie | n2=en:hawkinsinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:heart rhythm disorder n1=bilirubinémie | n2=en:heart rhythm disorder | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hematuria n1=bilirubinémie | n2=en:hematuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hematuria (less common) n1=bilirubinémie | n2=en:hematuria (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hematuria, macroscopic and microscopic n1=bilirubinémie | n2=en:hematuria, macroscopic and microscopic | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemizygous deletion at 4p16.3 n1=bilirubinémie | n2=en:hemizygous deletion at 4p16.3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemizygous deletion at 7q11.23 n1=bilirubinémie | n2=en:hemizygous deletion at 7q11.23 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemochromatosis n1=bilirubinémie | n2=en:hemochromatosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemoglobin f increased n1=bilirubinémie | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemophilia b n1=bilirubinémie | n2=en:hemophilia b | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hemophilia B n1=bilirubinémie | n2=en:hemophilia B | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepaplastin abnormal n1=bilirubinémie | n2=en:hepaplastin abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepaplastin decreased n1=bilirubinémie | n2=en:hepaplastin decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepaplastin increased n1=bilirubinémie | n2=en:hepaplastin increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepaplastin normal n1=bilirubinémie | n2=en:hepaplastin normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepaplastin test n1=bilirubinémie | n2=en:hepaplastin test | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:heparan sulfate excretion in urine n1=bilirubinémie | n2=en:heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:heparin cofactor ii deficiency (disorder) n1=bilirubinémie | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic argininosuccinase deficiency n1=bilirubinémie | n2=en:hepatic argininosuccinase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic argininosuccinate synthetase deficiency n1=bilirubinémie | n2=en:hepatic argininosuccinate synthetase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic carbamoylphosphate synthetase i deficiency n1=bilirubinémie | n2=en:hepatic carbamoylphosphate synthetase i deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic coma n1=bilirubinémie | n2=en:hepatic coma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic glycine cleavage defect n1=bilirubinémie | n2=en:hepatic glycine cleavage defect | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic lipase deficiency (disorder) n1=bilirubinémie | n2=en:hepatic lipase deficiency (disorder) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hepatic ornithine transcarbamylase deficiency n1=bilirubinémie | n2=en:hepatic ornithine transcarbamylase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hereditary angioedema n1=bilirubinémie | n2=en:hereditary angioedema | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hereditary factor x deficiency n1=bilirubinémie | n2=en:hereditary factor x deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hereditary fructose intolerance n1=bilirubinémie | n2=en:hereditary fructose intolerance | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:heteroplasmic partial duplication of mtdna n1=bilirubinémie | n2=en:heteroplasmic partial duplication of mtdna | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high deoxypyridinoline/creatinine (in some patients) n1=bilirubinémie | n2=en:high deoxypyridinoline/creatinine (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high ebv viral load n1=bilirubinémie | n2=en:high ebv viral load | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high ft3/ft4 ratio n1=bilirubinémie | n2=en:high ft3/ft4 ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high m-component n1=bilirubinémie | n2=en:high m-component | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high newborn serum levels of immunoreactive trypsinogen n1=bilirubinémie | n2=en:high newborn serum levels of immunoreactive trypsinogen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high nonceruloplasmin-bound serum copper n1=bilirubinémie | n2=en:high nonceruloplasmin-bound serum copper | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high ornithine n1=bilirubinémie | n2=en:high ornithine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high plasma asparagine n1=bilirubinémie | n2=en:high plasma asparagine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high plasma citrulline (100-300 micromolar) n1=bilirubinémie | n2=en:high plasma citrulline (100-300 micromolar) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high plasma citrulline (1000-5000 micromolar) n1=bilirubinémie | n2=en:high plasma citrulline (1000-5000 micromolar) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high plasma triglyceride levels n1=bilirubinémie | n2=en:high plasma triglyceride levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q n1=bilirubinémie | n2=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high serum guanosine levels n1=bilirubinémie | n2=en:high serum guanosine levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high serum inosine levels n1=bilirubinémie | n2=en:high serum inosine levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high serum osmolality n1=bilirubinémie | n2=en:high serum osmolality | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high sister chromatid exchange (sce) rate n1=bilirubinémie | n2=en:high sister chromatid exchange (sce) rate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high sweat sodium and chloride n1=bilirubinémie | n2=en:high sweat sodium and chloride | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high urinary copper n1=bilirubinémie | n2=en:high urinary copper | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine n1=bilirubinémie | n2=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high urinary orotic acid n1=bilirubinémie | n2=en:high urinary orotic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:high-normal plasma triglyceride concentration (in heterozygotes) n1=bilirubinémie | n2=en:high-normal plasma triglyceride concentration (in heterozygotes) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:histiocytic infiltration of liver, spleen, and lungs n1=bilirubinémie | n2=en:histiocytic infiltration of liver, spleen, and lungs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:histiocytosis X n1=bilirubinémie | n2=en:histiocytosis X | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:histiocytosis x n1=bilirubinémie | n2=en:histiocytosis x | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:histiocytosis, langerhans-cell n1=bilirubinémie | n2=en:histiocytosis, langerhans-cell | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hla-b27 haplotype association (95% patients) n1=bilirubinémie | n2=en:hla-b27 haplotype association (95% patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hla-dqw6 association (dqb1*0602) n1=bilirubinémie | n2=en:hla-dqw6 association (dqb1*0602) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:holocarboxylase synthetase deficiency n1=bilirubinémie | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:homocitrullinuria n1=bilirubinémie | n2=en:homocitrullinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:homocysteinemia n1=bilirubinémie | n2=en:homocysteinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:homocysteinemia (in some patients) n1=bilirubinémie | n2=en:homocysteinemia (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:homocystinuria (in some patients) n1=bilirubinémie | n2=en:homocystinuria (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:homozygous 122kb deletion 11p15-p14 n1=bilirubinémie | n2=en:homozygous 122kb deletion 11p15-p14 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:howell-jolly bodies seen in peripheral blood smear n1=bilirubinémie | n2=en:howell-jolly bodies seen in peripheral blood smear | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:human death n1=bilirubinémie | n2=en:human death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hydrocortisone decreased n1=bilirubinémie | n2=en:hydrocortisone decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperammonemia after protein intake n1=bilirubinémie | n2=en:hyperammonemia after protein intake | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperammonemia, asymptomatic (2-5 times normal) n1=bilirubinémie | n2=en:hyperammonemia, asymptomatic (2-5 times normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperarginemia n1=bilirubinémie | n2=en:hyperarginemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperbilirubinemia in those with liver failure n1=bilirubinémie | n2=en:hyperbilirubinemia in those with liver failure | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) n1=bilirubinémie | n2=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperbilirubinemia, unconjugated, <20mg/dl n1=bilirubinémie | n2=en:hyperbilirubinemia, unconjugated, <20mg/dl | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperbilirubinemia, unconjugated, 20-30mg/dl n1=bilirubinémie | n2=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercalcemia n1=bilirubinémie | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercalciuria n1=bilirubinémie | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercalciuria (in childhood) n1=bilirubinémie | n2=en:hypercalciuria (in childhood) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercarbia n1=bilirubinémie | n2=en:hypercarbia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperchloremia (mean >110 mm in both dominant and recessive) n1=bilirubinémie | n2=en:hyperchloremia (mean >110 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperchloremia (mean 109 mm) n1=bilirubinémie | n2=en:hyperchloremia (mean 109 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperchloremia (mean 111 mm) n1=bilirubinémie | n2=en:hyperchloremia (mean 111 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperchloremia (mean 114 mm) n1=bilirubinémie | n2=en:hyperchloremia (mean 114 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperchloridura n1=bilirubinémie | n2=en:hyperchloridura | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia n1=bilirubinémie | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia (10%) n1=bilirubinémie | n2=en:hypercholesterolemia (10%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia (disorder) n1=bilirubinémie | n2=en:hypercholesterolemia (disorder) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia (in 75%) n1=bilirubinémie | n2=en:hypercholesterolemia (in 75%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia (reported in 2 patients) n1=bilirubinémie | n2=en:hypercholesterolemia (reported in 2 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes n1=bilirubinémie | n2=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperglutaminemia n1=bilirubinémie | n2=en:hyperglutaminemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperglycemias, postprandial n1=bilirubinémie | n2=en:hyperglycemias, postprandial | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperglycinemia (1 patient) n1=bilirubinémie | n2=en:hyperglycinemia (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperglycinuria (disorder) n1=bilirubinémie | n2=en:hyperglycinuria (disorder) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperglycolic aciduria n1=bilirubinémie | n2=en:hyperglycolic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperhomocystinemia n1=bilirubinémie | n2=en:hyperhomocystinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperinsulinemic hypoglycemia, familial, 7 n1=bilirubinémie | n2=en:hyperinsulinemic hypoglycemia, familial, 7 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia n1=bilirubinémie | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia (>6.2 mm in both dominant and recessive) n1=bilirubinémie | n2=en:hyperkalemia (>6.2 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia (5.8 +/- 0.8 mm) n1=bilirubinémie | n2=en:hyperkalemia (5.8 +/- 0.8 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia (6.4 +/- 0.7 mm) n1=bilirubinémie | n2=en:hyperkalemia (6.4 +/- 0.7 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia (7.5 +/- 0.9 mm) n1=bilirubinémie | n2=en:hyperkalemia (7.5 +/- 0.9 mm) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperkalemia during attacks n1=bilirubinémie | n2=en:hyperkalemia during attacks | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipasemia n1=bilirubinémie | n2=en:hyperlipasemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipemia n1=bilirubinémie | n2=en:hyperlipemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipidaemia n1=bilirubinémie | n2=en:hyperlipidaemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipoproteinemia type i n1=bilirubinémie | n2=en:hyperlipoproteinemia type i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipoproteinemia type I n1=bilirubinémie | n2=en:hyperlipoproteinemia type I | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperlipoproteinemia type iib n1=bilirubinémie | n2=en:hyperlipoproteinemia type iib | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypermethioninemia, progressive n1=bilirubinémie | n2=en:hypermethioninemia, progressive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperphenylalaninemia n1=bilirubinémie | n2=en:hyperphenylalaninemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperphosphatemia n1=bilirubinémie | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperphosphatemia, transient n1=bilirubinémie | n2=en:hyperphosphatemia, transient | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperprolactinemia n1=bilirubinémie | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperprolinemia (10-15 times normal) n1=bilirubinémie | n2=en:hyperprolinemia (10-15 times normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperprolinemia (5-10 times normal) n1=bilirubinémie | n2=en:hyperprolinemia (5-10 times normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperprolinemia type 1 n1=bilirubinémie | n2=en:hyperprolinemia type 1 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperprostaglandinuria n1=bilirubinémie | n2=en:hyperprostaglandinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperthreoninemia n1=bilirubinémie | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyperthreoninuria n1=bilirubinémie | n2=en:hyperthreoninuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypertriglyceridemia n1=bilirubinémie | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypertriglyceridemia (in some patients) n1=bilirubinémie | n2=en:hypertriglyceridemia (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypertriglyceridemia (rare) n1=bilirubinémie | n2=en:hypertriglyceridemia (rare) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypertriglyceridemia, transient n1=bilirubinémie | n2=en:hypertriglyceridemia, transient | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypertryptophanemia n1=bilirubinémie | n2=en:hypertryptophanemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypervolemy n1=bilirubinémie | n2=en:hypervolemy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoalbuminemia n1=bilirubinémie | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoalbuminemia (in 83%) n1=bilirubinémie | n2=en:hypoalbuminemia (in 83%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoaldosteronism n1=bilirubinémie | n2=en:hypoaldosteronism | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypobetalipoproteinemias n1=bilirubinémie | n2=en:hypobetalipoproteinemias | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypocalcemia n1=bilirubinémie | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypocalcemia (64% of adults) n1=bilirubinémie | n2=en:hypocalcemia (64% of adults) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypocalcemia (male) n1=bilirubinémie | n2=en:hypocalcemia (male) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypocalcemia, transient n1=bilirubinémie | n2=en:hypocalcemia, transient | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypocalciuria or normocalciuria n1=bilirubinémie | n2=en:hypocalciuria or normocalciuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypochromia n1=bilirubinémie | n2=en:hypochromia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypofibrinogenemia n1=bilirubinémie | n2=en:hypofibrinogenemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypogammaglobulinemia n1=bilirubinémie | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypogammaglobulinemia (in some patients) n1=bilirubinémie | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypogammaglobulinemia, profound n1=bilirubinémie | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoglycemia, fasting n1=bilirubinémie | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoglycorrhachia (low glucose in csf) n1=bilirubinémie | n2=en:hypoglycorrhachia (low glucose in csf) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoglycosylated serum transferrin n1=bilirubinémie | n2=en:hypoglycosylated serum transferrin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoglycosylation of plasma glycoproteins n1=bilirubinémie | n2=en:hypoglycosylation of plasma glycoproteins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypokalemia during attacks n1=bilirubinémie | n2=en:hypokalemia during attacks | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypokalemia during periodic paralysis (most patients) n1=bilirubinémie | n2=en:hypokalemia during periodic paralysis (most patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypokalemia occurs during paralytic attacks n1=bilirubinémie | n2=en:hypokalemia occurs during paralytic attacks | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoketotic dicarboxylic aciduria (in some patients) n1=bilirubinémie | n2=en:hypoketotic dicarboxylic aciduria (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoketotic hypoglycemia n1=bilirubinémie | n2=en:hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypomethylation of alpha-satellite repeats on chromosome 9 n1=bilirubinémie | n2=en:hypomethylation of alpha-satellite repeats on chromosome 9 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 n1=bilirubinémie | n2=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyponatremia in infancy n1=bilirubinémie | n2=en:hyponatremia in infancy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyponatremic dehydration, rarely n1=bilirubinémie | n2=en:hyponatremic dehydration, rarely | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypophosphatasia infantile n1=bilirubinémie | n2=en:hypophosphatasia infantile | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypophosphatemia n1=bilirubinémie | n2=en:hypophosphatemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypophosphatemia (less common) n1=bilirubinémie | n2=en:hypophosphatemia (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoprebetalipoproteinemia n1=bilirubinémie | n2=en:hypoprebetalipoproteinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoprolactinemia n1=bilirubinémie | n2=en:hypoprolactinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoproteinemia (in 1 patient) n1=bilirubinémie | n2=en:hypoproteinemia (in 1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypoproteinemia due to hypercatabolism n1=bilirubinémie | n2=en:hypoproteinemia due to hypercatabolism | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hyposthenuria (inability to concentrate urine normally) n1=bilirubinémie | n2=en:hyposthenuria (inability to concentrate urine normally) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypothyreosis n1=bilirubinémie | n2=en:hypothyreosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypothyroidy n1=bilirubinémie | n2=en:hypothyroidy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:hypouricemia n1=bilirubinémie | n2=en:hypouricemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:i-cell disease n1=bilirubinémie | n2=en:i-cell disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:I-cell disease n1=bilirubinémie | n2=en:I-cell disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells n1=bilirubinémie | n2=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iga antiendomysial antibodies (ema) n1=bilirubinémie | n2=en:iga antiendomysial antibodies (ema) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:igg, decreased n1=bilirubinémie | n2=en:igg, decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:igg, elevated n1=bilirubinémie | n2=en:igg, elevated | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:igm deficiency n1=bilirubinémie | n2=en:igm deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iiga and igg antigliadin antibodies (aga) n1=bilirubinémie | n2=en:iiga and igg antigliadin antibodies (aga) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:immediate (type i) skin test reactivity n1=bilirubinémie | n2=en:immediate (type i) skin test reactivity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:immotile or weakly motile cilia n1=bilirubinémie | n2=en:immotile or weakly motile cilia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:immunoglobulin a decreased n1=bilirubinémie | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:immunoreactive pc protein n1=bilirubinémie | n2=en:immunoreactive pc protein | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes n1=bilirubinémie | n2=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired creatine uptake in fibroblasts n1=bilirubinémie | n2=en:impaired creatine uptake in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise n1=bilirubinémie | n2=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired mitochondrial translation n1=bilirubinémie | n2=en:impaired mitochondrial translation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired n-glycosylation n1=bilirubinémie | n2=en:impaired n-glycosylation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired oxidation of pyruvate n1=bilirubinémie | n2=en:impaired oxidation of pyruvate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired response to gm-csf n1=bilirubinémie | n2=en:impaired response to gm-csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impaired synthesis of fibroblast sulfated proteoglycans n1=bilirubinémie | n2=en:impaired synthesis of fibroblast sulfated proteoglycans | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:impairment of urinary concentration n1=bilirubinémie | n2=en:impairment of urinary concentration | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria n1=bilirubinémie | n2=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inactive mutant form of red cell carbonic anhydrase b in one sibship n1=bilirubinémie | n2=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inappropriately low urine osmolality n1=bilirubinémie | n2=en:inappropriately low urine osmolality | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inappropriately normal serum 1,25-dihydroxyvitamin d3 n1=bilirubinémie | n2=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 n1=bilirubinémie | n2=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inclusion bodies (membrane-bound vacuoles) in fibroblasts n1=bilirubinémie | n2=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased 11-deoxycortisol n1=bilirubinémie | n2=en:increased 11-deoxycortisol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased 18-hydroxycortisol n1=bilirubinémie | n2=en:increased 18-hydroxycortisol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased 18-ohb to aldosterone ratio n1=bilirubinémie | n2=en:increased 18-ohb to aldosterone ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased 18-oxocortisol n1=bilirubinémie | n2=en:increased 18-oxocortisol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased acetylcholinesterase (ache) in amniotic fluid n1=bilirubinémie | n2=en:increased acetylcholinesterase (ache) in amniotic fluid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased activity of the prpp synthetase 1 enzyme n1=bilirubinémie | n2=en:increased activity of the prpp synthetase 1 enzyme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus n1=bilirubinémie | n2=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased ammonia with exercise n1=bilirubinémie | n2=en:increased ammonia with exercise | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased bile acid intermediates (dhca and thca) n1=bilirubinémie | n2=en:increased bile acid intermediates (dhca and thca) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased biopterin in urine and csf n1=bilirubinémie | n2=en:increased biopterin in urine and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased blood alanine n1=bilirubinémie | n2=en:increased blood alanine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased bone serum acid phosphatase n1=bilirubinémie | n2=en:increased bone serum acid phosphatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased c10:2-carnitine n1=bilirubinémie | n2=en:increased c10:2-carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased cancer antigen 125 n1=bilirubinémie | n2=en:increased cancer antigen 125 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased cerebrospinal fluid (csf) protein (>100mg/dl) n1=bilirubinémie | n2=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased cholesterol n1=bilirubinémie | n2=en:increased cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation n1=bilirubinémie | n2=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased chromosomal rearrangements (bone marrow and fibroblast culture) n1=bilirubinémie | n2=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased ck-mb n1=bilirubinémie | n2=en:increased ck-mb | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased creatine kinase, mild to moderate n1=bilirubinémie | n2=en:increased creatine kinase, mild to moderate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased creatinine n1=bilirubinémie | n2=en:increased creatinine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf and plasma ghb n1=bilirubinémie | n2=en:increased csf and plasma ghb | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf homovanillic acid (hva) n1=bilirubinémie | n2=en:increased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf immunoglobulin levels n1=bilirubinémie | n2=en:increased csf immunoglobulin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf lactate during acute episodes n1=bilirubinémie | n2=en:increased csf lactate during acute episodes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf protein during acute illness n1=bilirubinémie | n2=en:increased csf protein during acute illness | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf taurine n1=bilirubinémie | n2=en:increased csf taurine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf threonine n1=bilirubinémie | n2=en:increased csf threonine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf transferrin despite normal serum transferrin levels n1=bilirubinémie | n2=en:increased csf transferrin despite normal serum transferrin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) n1=bilirubinémie | n2=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased csf, plasma, and urinary l-dopa n1=bilirubinémie | n2=en:increased csf, plasma, and urinary l-dopa | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased d-glyceric acid in serum, urine, and csf n1=bilirubinémie | n2=en:increased d-glyceric acid in serum, urine, and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased disialotransferrin and asialotransferrin levels n1=bilirubinémie | n2=en:increased disialotransferrin and asialotransferrin levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased erythrocyte sedimentation rate, episodic n1=bilirubinémie | n2=en:increased erythrocyte sedimentation rate, episodic | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased erythrocyte-membrane calcium-magnesium-atpase n1=bilirubinémie | n2=en:increased erythrocyte-membrane calcium-magnesium-atpase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased excretion of urobilinogen n1=bilirubinémie | n2=en:increased excretion of urobilinogen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased ferritin n1=bilirubinémie | n2=en:increased ferritin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased fibroblast free sialic acid n1=bilirubinémie | n2=en:increased fibroblast free sialic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased fractional excretion of urate (greater than 50%) n1=bilirubinémie | n2=en:increased fractional excretion of urate (greater than 50%) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased fractional excretion of uric acid n1=bilirubinémie | n2=en:increased fractional excretion of uric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased free erythrocyte protoporphyrin n1=bilirubinémie | n2=en:increased free erythrocyte protoporphyrin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 n1=bilirubinémie | n2=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) n1=bilirubinémie | n2=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased globulin n1=bilirubinémie | n2=en:increased globulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased growth hormone (in 1 of 2 patients) n1=bilirubinémie | n2=en:increased growth hormone (in 1 of 2 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased hepatic parenchymal cell stainable iron n1=bilirubinémie | n2=en:increased hepatic parenchymal cell stainable iron | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased ige level n1=bilirubinémie | n2=en:increased ige level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased igg level n1=bilirubinémie | n2=en:increased igg level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased igm level n1=bilirubinémie | n2=en:increased igm level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased il-6 n1=bilirubinémie | n2=en:increased il-6 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased immunoglobulin n1=bilirubinémie | n2=en:increased immunoglobulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased interferon-alpha signal n1=bilirubinémie | n2=en:increased interferon-alpha signal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased interleukin 10 n1=bilirubinémie | n2=en:increased interleukin 10 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased intracellular fmrp mrna n1=bilirubinémie | n2=en:increased intracellular fmrp mrna | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased ketone body or lactate/pyruvate plasma ratios n1=bilirubinémie | n2=en:increased ketone body or lactate/pyruvate plasma ratios | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased l-2-hydroxyglutaric acid in urine, serum, and csf n1=bilirubinémie | n2=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased lactate in spinal fluid n1=bilirubinémie | n2=en:increased lactate in spinal fluid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased lactate: pyruvate ratio (group b) n1=bilirubinémie | n2=en:increased lactate: pyruvate ratio (group b) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased lactic acid level n1=bilirubinémie | n2=en:increased lactic acid level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells n1=bilirubinémie | n2=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased lipid n1=bilirubinémie | n2=en:increased lipid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased long-chain acylcarnitine n1=bilirubinémie | n2=en:increased long-chain acylcarnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased lysine in serum and csf n1=bilirubinémie | n2=en:increased lysine in serum and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood n1=bilirubinémie | n2=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased nasal-potential difference (1 of 3 patients) n1=bilirubinémie | n2=en:increased nasal-potential difference (1 of 3 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased neopterin in urine and csf n1=bilirubinémie | n2=en:increased neopterin in urine and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased npn n1=bilirubinémie | n2=en:increased npn | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased osmotic fragility n1=bilirubinémie | n2=en:increased osmotic fragility | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) n1=bilirubinémie | n2=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased phytanic acid in body tissues and fluids n1=bilirubinémie | n2=en:increased phytanic acid in body tissues and fluids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma 2-methylbutyrylcarnitine n1=bilirubinémie | n2=en:increased plasma 2-methylbutyrylcarnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma and urinary pipecolic acid n1=bilirubinémie | n2=en:increased plasma and urinary pipecolic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma dihydroxyphenylacetic acid (dopac) n1=bilirubinémie | n2=en:increased plasma dihydroxyphenylacetic acid (dopac) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma free cholesterol n1=bilirubinémie | n2=en:increased plasma free cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma long-chain acylcarnitines n1=bilirubinémie | n2=en:increased plasma long-chain acylcarnitines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma phytanic acid n1=bilirubinémie | n2=en:increased plasma phytanic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma pristanic acid n1=bilirubinémie | n2=en:increased plasma pristanic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma proglucagon n1=bilirubinémie | n2=en:increased plasma proglucagon | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased plasma renin activity n1=bilirubinémie | n2=en:increased plasma renin activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased platelet aggregation with ristocetin n1=bilirubinémie | n2=en:increased platelet aggregation with ristocetin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased prv-1 (162860) mrna n1=bilirubinémie | n2=en:increased prv-1 (162860) mrna | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased pyruvate in serum and csf n1=bilirubinémie | n2=en:increased pyruvate in serum and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased renal tubular phosphate reabsorption n1=bilirubinémie | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased sensitivity to adrenergic and cholinergic agents n1=bilirubinémie | n2=en:increased sensitivity to adrenergic and cholinergic agents | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum 1,25-dihydroxyvitamin d n1=bilirubinémie | n2=en:increased serum 1,25-dihydroxyvitamin d | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum 1,25-dihydroxyvitamin d3 n1=bilirubinémie | n2=en:increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum 18-hydroxycorticosterone (18-ohb) n1=bilirubinémie | n2=en:increased serum 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum acyl carnitines n1=bilirubinémie | n2=en:increased serum acyl carnitines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum acylcarnitine during febrile crisis n1=bilirubinémie | n2=en:increased serum acylcarnitine during febrile crisis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum acylcarnitines n1=bilirubinémie | n2=en:increased serum acylcarnitines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum alkaline phosphatase activity of skeletal origin n1=bilirubinémie | n2=en:increased serum alkaline phosphatase activity of skeletal origin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum alpha-interferon (ifna1, 147660) n1=bilirubinémie | n2=en:increased serum alpha-interferon (ifna1, 147660) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum alpha-mannosidase n1=bilirubinémie | n2=en:increased serum alpha-mannosidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum and cerebrospinal fluid levels of pipecolic acid n1=bilirubinémie | n2=en:increased serum and cerebrospinal fluid levels of pipecolic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum and csf lactate n1=bilirubinémie | n2=en:increased serum and csf lactate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum and urinary 2-oxoglutarate n1=bilirubinémie | n2=en:increased serum and urinary 2-oxoglutarate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum aryl-sulfatase a (10-20x) n1=bilirubinémie | n2=en:increased serum aryl-sulfatase a (10-20x) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum arylsulfatase a (10-20x) n1=bilirubinémie | n2=en:increased serum arylsulfatase a (10-20x) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum beta-carotene n1=bilirubinémie | n2=en:increased serum beta-carotene | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum beta-hexosaminidase n1=bilirubinémie | n2=en:increased serum beta-hexosaminidase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum bile acid concentration during pregnancy, resolves postpartum n1=bilirubinémie | n2=en:increased serum bile acid concentration during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum bile acids n1=bilirubinémie | n2=en:increased serum bile acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum bilirubin due to hemolysis n1=bilirubinémie | n2=en:increased serum bilirubin due to hemolysis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum butyryl carnitine n1=bilirubinémie | n2=en:increased serum butyryl carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum c-reactive protein, episodic n1=bilirubinémie | n2=en:increased serum c-reactive protein, episodic | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum c26-bile-acid intermediates n1=bilirubinémie | n2=en:increased serum c26-bile-acid intermediates | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum c4 and c5 acylcarnitine esters n1=bilirubinémie | n2=en:increased serum c4 and c5 acylcarnitine esters | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum cholesterol (in 3 of 10 patients) n1=bilirubinémie | n2=en:increased serum cholesterol (in 3 of 10 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum citrulline (group b) n1=bilirubinémie | n2=en:increased serum citrulline (group b) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum creatine kinase (1 family) n1=bilirubinémie | n2=en:increased serum creatine kinase (1 family) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum creatine kinase (less common) n1=bilirubinémie | n2=en:increased serum creatine kinase (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum creatine kinase during episodes n1=bilirubinémie | n2=en:increased serum creatine kinase during episodes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum creatine kinase in acute stage n1=bilirubinémie | n2=en:increased serum creatine kinase in acute stage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum creatine kinase, mild n1=bilirubinémie | n2=en:increased serum creatine kinase, mild | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum erythropoietin (epo, 133170) n1=bilirubinémie | n2=en:increased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum fgf23 n1=bilirubinémie | n2=en:increased serum fgf23 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum gamma-ggt (231950) n1=bilirubinémie | n2=en:increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum glutamine n1=bilirubinémie | n2=en:increased serum glutamine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum iduronate sulfatase (10-20x) n1=bilirubinémie | n2=en:increased serum iduronate sulfatase (10-20x) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum ige n1=bilirubinémie | n2=en:increased serum ige | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lactate n1=bilirubinémie | n2=en:increased serum lactate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lactate dehydrogenase (in 1 family) n1=bilirubinémie | n2=en:increased serum lactate dehydrogenase (in 1 family) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lactate dehydrogenase (ldh) n1=bilirubinémie | n2=en:increased serum lactate dehydrogenase (ldh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lactate during metabolic crisis n1=bilirubinémie | n2=en:increased serum lactate during metabolic crisis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lactate in acute stage n1=bilirubinémie | n2=en:increased serum lactate in acute stage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum levels of free plasma thyroid hormones n1=bilirubinémie | n2=en:increased serum levels of free plasma thyroid hormones | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lipoproteins n1=bilirubinémie | n2=en:increased serum lipoproteins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum lysine (group b) n1=bilirubinémie | n2=en:increased serum lysine (group b) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum methionine (reported in 2 cases) n1=bilirubinémie | n2=en:increased serum methionine (reported in 2 cases) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum osteocalcin n1=bilirubinémie | n2=en:increased serum osteocalcin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum pancreatic secretory trypsin inhibitor (psti) n1=bilirubinémie | n2=en:increased serum pancreatic secretory trypsin inhibitor (psti) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum parathyroid hormone (pth) n1=bilirubinémie | n2=en:increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) n1=bilirubinémie | n2=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum pyruvate n1=bilirubinémie | n2=en:increased serum pyruvate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum pyruvate in acute stage n1=bilirubinémie | n2=en:increased serum pyruvate in acute stage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum s-adenosylhomocysteine n1=bilirubinémie | n2=en:increased serum s-adenosylhomocysteine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum serotonin in 25% n1=bilirubinémie | n2=en:increased serum serotonin in 25% | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum thrombopoietin may occur n1=bilirubinémie | n2=en:increased serum thrombopoietin may occur | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum thymidine n1=bilirubinémie | n2=en:increased serum thymidine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum thyroid-stimulating hormone (tsh) n1=bilirubinémie | n2=en:increased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum total cholesterol n1=bilirubinémie | n2=en:increased serum total cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum transaminases (in 1 of 3 patients) n1=bilirubinémie | n2=en:increased serum transaminases (in 1 of 3 patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum triglycerides (in some patients) n1=bilirubinémie | n2=en:increased serum triglycerides (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum triiodothyronine (t3) n1=bilirubinémie | n2=en:increased serum triiodothyronine (t3) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum unconjugated bilirubin n1=bilirubinémie | n2=en:increased serum unconjugated bilirubin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum uric acid n1=bilirubinémie | n2=en:increased serum uric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum vitamin b12 n1=bilirubinémie | n2=en:increased serum vitamin b12 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde n1=bilirubinémie | n2=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased serum, urinary, and csf lysine n1=bilirubinémie | n2=en:increased serum, urinary, and csf lysine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased sodium-potassium pump activity n1=bilirubinémie | n2=en:increased sodium-potassium pump activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased succinyladenosine (s-ado) in serum, urine, and csf n1=bilirubinémie | n2=en:increased succinyladenosine (s-ado) in serum, urine, and csf | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased thymine and dihydrothymine in bodily fluids n1=bilirubinémie | n2=en:increased thymine and dihydrothymine in bodily fluids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased thyroid-stimulating hormone (tsh) n1=bilirubinémie | n2=en:increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased tissue levels of free fatty acids n1=bilirubinémie | n2=en:increased tissue levels of free fatty acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased tissue levels of triglycerides n1=bilirubinémie | n2=en:increased tissue levels of triglycerides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased tissue long-chain acylcarnitines n1=bilirubinémie | n2=en:increased tissue long-chain acylcarnitines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased total bilirubin may occur n1=bilirubinémie | n2=en:increased total bilirubin may occur | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs n1=bilirubinémie | n2=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased triglycerides (less common) n1=bilirubinémie | n2=en:increased triglycerides (less common) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased uracil and dihydrouracil in bodily fluids n1=bilirubinémie | n2=en:increased uracil and dihydrouracil in bodily fluids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-butanone n1=bilirubinémie | n2=en:increased urinary 2-butanone | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-hydroxybutyrate n1=bilirubinémie | n2=en:increased urinary 2-hydroxybutyrate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-methyl-3 hydroxybutyrate n1=bilirubinémie | n2=en:increased urinary 2-methyl-3 hydroxybutyrate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-methyl-3-hydroxybutyric acid n1=bilirubinémie | n2=en:increased urinary 2-methyl-3-hydroxybutyric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-methylacetoacetic acid n1=bilirubinémie | n2=en:increased urinary 2-methylacetoacetic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-methylbutyryl glycine n1=bilirubinémie | n2=en:increased urinary 2-methylbutyryl glycine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 2-oxoglutaric acid n1=bilirubinémie | n2=en:increased urinary 2-oxoglutaric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 3-methylglutaconic acid n1=bilirubinémie | n2=en:increased urinary 3-methylglutaconic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary 7-biopterin (primapterin) n1=bilirubinémie | n2=en:increased urinary 7-biopterin (primapterin) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary acetoacetic acid n1=bilirubinémie | n2=en:increased urinary acetoacetic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary adenosine n1=bilirubinémie | n2=en:increased urinary adenosine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary alpha-ketoglutaric acid, intermittent n1=bilirubinémie | n2=en:increased urinary alpha-ketoglutaric acid, intermittent | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary and serum glycine n1=bilirubinémie | n2=en:increased urinary and serum glycine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary carnitine n1=bilirubinémie | n2=en:increased urinary carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary carnitine esters n1=bilirubinémie | n2=en:increased urinary carnitine esters | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary catecholamines n1=bilirubinémie | n2=en:increased urinary catecholamines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary citric acid cycle intermediates n1=bilirubinémie | n2=en:increased urinary citric acid cycle intermediates | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation n1=bilirubinémie | n2=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary creatine-to-creatinine ratio n1=bilirubinémie | n2=en:increased urinary creatine-to-creatinine ratio | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary cross-linked n-telopetide of type i collagen n1=bilirubinémie | n2=en:increased urinary cross-linked n-telopetide of type i collagen | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary cyclic amp (camp) in response to ddavp administration n1=bilirubinémie | n2=en:increased urinary cyclic amp (camp) in response to ddavp administration | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) n1=bilirubinémie | n2=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks n1=bilirubinémie | n2=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary dicarboxylic acid, transient n1=bilirubinémie | n2=en:increased urinary dicarboxylic acid, transient | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary dihydropyrimidines n1=bilirubinémie | n2=en:increased urinary dihydropyrimidines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary dopamine n1=bilirubinémie | n2=en:increased urinary dopamine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary dopamine and dopamine metabolites (paradoxical) n1=bilirubinémie | n2=en:increased urinary dopamine and dopamine metabolites (paradoxical) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary excretion of camp n1=bilirubinémie | n2=en:increased urinary excretion of camp | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary excretion of coproporphyrin i n1=bilirubinémie | n2=en:increased urinary excretion of coproporphyrin i | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary excretion of cystine n1=bilirubinémie | n2=en:increased urinary excretion of cystine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary formiminoglutamic acid (figlu) n1=bilirubinémie | n2=en:increased urinary formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) n1=bilirubinémie | n2=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary glycerol n1=bilirubinémie | n2=en:increased urinary glycerol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary hga n1=bilirubinémie | n2=en:increased urinary hga | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary homovanillic acid (hva) n1=bilirubinémie | n2=en:increased urinary homovanillic acid (hva) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary hydroxyisovaleric acid n1=bilirubinémie | n2=en:increased urinary hydroxyisovaleric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary hypoxanthine n1=bilirubinémie | n2=en:increased urinary hypoxanthine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary ketones n1=bilirubinémie | n2=en:increased urinary ketones | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary levels of maoa substrates (endogenous bioamines) n1=bilirubinémie | n2=en:increased urinary levels of maoa substrates (endogenous bioamines) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary malic acid n1=bilirubinémie | n2=en:increased urinary malic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary n-acetylated amino acids n1=bilirubinémie | n2=en:increased urinary n-acetylated amino acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary neopterin n1=bilirubinémie | n2=en:increased urinary neopterin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine n1=bilirubinémie | n2=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary o-linked sialopeptides n1=bilirubinémie | n2=en:increased urinary o-linked sialopeptides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary oligosaccharides n1=bilirubinémie | n2=en:increased urinary oligosaccharides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary organic acids (in some patients) n1=bilirubinémie | n2=en:increased urinary organic acids (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary orotic acid (in some patients) n1=bilirubinémie | n2=en:increased urinary orotic acid (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary oxylate n1=bilirubinémie | n2=en:increased urinary oxylate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks n1=bilirubinémie | n2=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary potassium n1=bilirubinémie | n2=en:increased urinary potassium | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary prostaglandin e2 n1=bilirubinémie | n2=en:increased urinary prostaglandin e2 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary sialylglycopeptides n1=bilirubinémie | n2=en:increased urinary sialylglycopeptides | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary succinic acid n1=bilirubinémie | n2=en:increased urinary succinic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary thiosulfate n1=bilirubinémie | n2=en:increased urinary thiosulfate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary thymine n1=bilirubinémie | n2=en:increased urinary thymine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary tricarboxylic acid intermediates n1=bilirubinémie | n2=en:increased urinary tricarboxylic acid intermediates | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary uracil n1=bilirubinémie | n2=en:increased urinary uracil | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary vanillylmandelic acid (vma) n1=bilirubinémie | n2=en:increased urinary vanillylmandelic acid (vma) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid n1=bilirubinémie | n2=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary, plasma, and csf dihydrothymine n1=bilirubinémie | n2=en:increased urinary, plasma, and csf dihydrothymine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urinary, plasma, and csf n-carbamyl-beta-alanine n1=bilirubinémie | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased urine vanillactic acid (vla) n1=bilirubinémie | n2=en:increased urine vanillactic acid (vla) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased vitamin b>12< n1=bilirubinémie | n2=en:increased vitamin b>12< | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:increased vitamin e (alpha-tocopherol) levels n1=bilirubinémie | n2=en:increased vitamin e (alpha-tocopherol) levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:incresased urinary pyruvate n1=bilirubinémie | n2=en:incresased urinary pyruvate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:indirect bilirubin increased n1=bilirubinémie | n2=en:indirect bilirubin increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:indirect reacting bilirubin n1=bilirubinémie | n2=en:indirect reacting bilirubin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:infantile hypophosphatasia n1=bilirubinémie | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:innocent tumor n1=bilirubinémie | n2=en:innocent tumor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:inr increased n1=bilirubinémie | n2=en:inr increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intermediate level of cellular sensitivity to uv light n1=bilirubinémie | n2=en:intermediate level of cellular sensitivity to uv light | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intermittent 3-methylglutaconic aciduria n1=bilirubinémie | n2=en:intermittent 3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intermittent ethylmalonic aciduria n1=bilirubinémie | n2=en:intermittent ethylmalonic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intermittent increase of urinary ethylmalonic acid n1=bilirubinémie | n2=en:intermittent increase of urinary ethylmalonic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:interstitial deletion of 17p11.2 (most common is 3.7mb) n1=bilirubinémie | n2=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:interstitial or terminal deletion of 18q n1=bilirubinémie | n2=en:interstitial or terminal deletion of 18q | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intracellular accumulation of unesterified cholesterol n1=bilirubinémie | n2=en:intracellular accumulation of unesterified cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intracellular fingerprint profiles on ultrastructural analysis n1=bilirubinémie | n2=en:intracellular fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intracellular glycosphingolipid deposition in all tissues of the body n1=bilirubinémie | n2=en:intracellular glycosphingolipid deposition in all tissues of the body | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) n1=bilirubinémie | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) n1=bilirubinémie | n2=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iodine depletion n1=bilirubinémie | n2=en:iodine depletion | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iron low n1=bilirubinémie | n2=en:iron low | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:iron overload (in some patients) n1=bilirubinémie | n2=en:iron overload (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation n1=bilirubinémie | n2=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:isochromosome 12p (i(12p)) n1=bilirubinémie | n2=en:isochromosome 12p (i(12p)) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:isochromosome often missing in lymphocyte n1=bilirubinémie | n2=en:isochromosome often missing in lymphocyte | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:isovaleric acidemia n1=bilirubinémie | n2=en:isovaleric acidemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:isovalericaciduria n1=bilirubinémie | n2=en:isovalericaciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:isovalerylglycinuria n1=bilirubinémie | n2=en:isovalerylglycinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:jaundice, obstructive n1=bilirubinémie | n2=en:jaundice, obstructive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:karyomegaly may be found in other visceral organs n1=bilirubinémie | n2=en:karyomegaly may be found in other visceral organs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:karyotype analysis normal finding n1=bilirubinémie | n2=en:karyotype analysis normal finding | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:keratan sulfate excretion in urine that decreases with age n1=bilirubinémie | n2=en:keratan sulfate excretion in urine that decreases with age | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:keratan sulfaturia in some patients n1=bilirubinémie | n2=en:keratan sulfaturia in some patients | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ketoacidosis n1=bilirubinémie | n2=en:ketoacidosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ketonuria (1 patient) n1=bilirubinémie | n2=en:ketonuria (1 patient) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ketonuria, acute n1=bilirubinémie | n2=en:ketonuria, acute | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:ketoses, metabolic n1=bilirubinémie | n2=en:ketoses, metabolic | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:kypokalemia n1=bilirubinémie | n2=en:kypokalemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lack of ciliary motility n1=bilirubinémie | n2=en:lack of ciliary motility | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lack of excessive parenchymal iron storage n1=bilirubinémie | n2=en:lack of excessive parenchymal iron storage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lack of lysosomal inclusions in visceral organs n1=bilirubinémie | n2=en:lack of lysosomal inclusions in visceral organs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lactate dehydrogenase increased n1=bilirubinémie | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lactate high n1=bilirubinémie | n2=en:lactate high | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lactic acidemia (2p21del) n1=bilirubinémie | n2=en:lactic acidemia (2p21del) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lacunar halos around chondrocytes in skeletal cartilage n1=bilirubinémie | n2=en:lacunar halos around chondrocytes in skeletal cartilage | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Langerhans cell granulomatosis n1=bilirubinémie | n2=en:Langerhans cell granulomatosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Langerhans cell-histiocytosis n1=bilirubinémie | n2=en:Langerhans cell-histiocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Langerhans histiocytosis n1=bilirubinémie | n2=en:Langerhans histiocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:large spermatozoa n1=bilirubinémie | n2=en:large spermatozoa | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Leroy's i-cell disease n1=bilirubinémie | n2=en:Leroy's i-cell disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:leucine aminopeptidase measurement n1=bilirubinémie | n2=en:leucine aminopeptidase measurement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm n1=bilirubinémie | n2=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lifetime n1=bilirubinémie | n2=en:lifetime | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:little to absent aspartylglucosaminuria activity n1=bilirubinémie | n2=en:little to absent aspartylglucosaminuria activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:liver enzymes abnormal n1=bilirubinémie | n2=en:liver enzymes abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:liver phosphorylase kinase (phk) deficiency n1=bilirubinémie | n2=en:liver phosphorylase kinase (phk) deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:long-chain dicarboxylic aciduria n1=bilirubinémie | n2=en:long-chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas n1=bilirubinémie | n2=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:loss of human life n1=bilirubinémie | n2=en:loss of human life | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:loss of life n1=bilirubinémie | n2=en:loss of life | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low 25-oh-vitamin d level n1=bilirubinémie | n2=en:low 25-oh-vitamin d level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low acth level n1=bilirubinémie | n2=en:low acth level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low alkaline phosphatase n1=bilirubinémie | n2=en:low alkaline phosphatase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low cholesterol esterification rates n1=bilirubinémie | n2=en:low cholesterol esterification rates | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low copper and ceruloplasmin n1=bilirubinémie | n2=en:low copper and ceruloplasmin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low csf creatine n1=bilirubinémie | n2=en:low csf creatine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low csf creatinine n1=bilirubinémie | n2=en:low csf creatinine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low fasting glucose (in some patients) n1=bilirubinémie | n2=en:low fasting glucose (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low free carnitine n1=bilirubinémie | n2=en:low free carnitine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low growth hormone levels n1=bilirubinémie | n2=en:low growth hormone levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low ldl cholesterol n1=bilirubinémie | n2=en:low ldl cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low leukocyte alkaline phosphatase activity n1=bilirubinémie | n2=en:low leukocyte alkaline phosphatase activity | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low level of c4 and c2 n1=bilirubinémie | n2=en:low level of c4 and c2 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low levels of serum mg(2+) in the absence of other electrolyte disturbances n1=bilirubinémie | n2=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low maximal oxygen uptake on exercise testing n1=bilirubinémie | n2=en:low maximal oxygen uptake on exercise testing | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent adrenocorticotropic hormone (acth) in some patients n1=bilirubinémie | n2=en:low or absent adrenocorticotropic hormone (acth) in some patients | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent follicle stimulating hormone (fsh) n1=bilirubinémie | n2=en:low or absent follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent iga levels n1=bilirubinémie | n2=en:low or absent iga levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent prolactin (pl) n1=bilirubinémie | n2=en:low or absent prolactin (pl) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent thyroid-stimulating hormone (tsh) n1=bilirubinémie | n2=en:low or absent thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or absent thyrotropin (tsh) n1=bilirubinémie | n2=en:low or absent thyrotropin (tsh) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or low-normal serum t4 n1=bilirubinémie | n2=en:low or low-normal serum t4 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or normal serum calcium n1=bilirubinémie | n2=en:low or normal serum calcium | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or normal serum erythropoietin n1=bilirubinémie | n2=en:low or normal serum erythropoietin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or normal serum igm n1=bilirubinémie | n2=en:low or normal serum igm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or undetectable c-peptide n1=bilirubinémie | n2=en:low or undetectable c-peptide | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low or undetectable insulin n1=bilirubinémie | n2=en:low or undetectable insulin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low plasma arginine n1=bilirubinémie | n2=en:low plasma arginine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low plasma citrulline n1=bilirubinémie | n2=en:low plasma citrulline | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low plasma methionine n1=bilirubinémie | n2=en:low plasma methionine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low plasma triglyceride level n1=bilirubinémie | n2=en:low plasma triglyceride level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low plasma tryptophan (inflammatory type b) n1=bilirubinémie | n2=en:low plasma tryptophan (inflammatory type b) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low pyruvate carboxylase activity in liver and cultured fibroblasts n1=bilirubinémie | n2=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low rai (radioactive iodine) uptake n1=bilirubinémie | n2=en:low rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum alkaline phosphatase in heterozygotes n1=bilirubinémie | n2=en:low serum alkaline phosphatase in heterozygotes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum alpha-fetoprotein (recessive) n1=bilirubinémie | n2=en:low serum alpha-fetoprotein (recessive) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum ceruloplasmin n1=bilirubinémie | n2=en:low serum ceruloplasmin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum igg and iga n1=bilirubinémie | n2=en:low serum igg and iga | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum levels of branched-chain amino acids n1=bilirubinémie | n2=en:low serum levels of branched-chain amino acids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum levels of ketone bodies n1=bilirubinémie | n2=en:low serum levels of ketone bodies | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low serum magnesium n1=bilirubinémie | n2=en:low serum magnesium | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low to normal plasma methionine n1=bilirubinémie | n2=en:low to normal plasma methionine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low to normal tsh (values may vary depending on the measurement methods used) n1=bilirubinémie | n2=en:low to normal tsh (values may vary depending on the measurement methods used) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low to very low hdl cholesterol n1=bilirubinémie | n2=en:low to very low hdl cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low urinary excretion of neutral 17-ketosteroids n1=bilirubinémie | n2=en:low urinary excretion of neutral 17-ketosteroids | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low urinary orotic acid n1=bilirubinémie | n2=en:low urinary orotic acid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low-molecular-weight proteinuria n1=bilirubinémie | n2=en:low-molecular-weight proteinuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low-normal igm n1=bilirubinémie | n2=en:low-normal igm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low-normal platelet count (89-290 x 10(9)/l) n1=bilirubinémie | n2=en:low-normal platelet count (89-290 x 10(9)/l) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:low-to-normal platelet count n1=bilirubinémie | n2=en:low-to-normal platelet count | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lower total cholesterol n1=bilirubinémie | n2=en:lower total cholesterol | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lymphocytosis n1=bilirubinémie | n2=en:lymphocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lysosomal-like storage vacuoles in various tissues n1=bilirubinémie | n2=en:lysosomal-like storage vacuoles in various tissues | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:lysyl hydroxylase deficiency n1=bilirubinémie | n2=en:lysyl hydroxylase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:marked elevation of erythrocyte sedimentation rate n1=bilirubinémie | n2=en:marked elevation of erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:marked elevation of serum c-reactive protein level (crp 123260) n1=bilirubinémie | n2=en:marked elevation of serum c-reactive protein level (crp 123260) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:marked hypoalphalipoproteinemia (in some patients) n1=bilirubinémie | n2=en:marked hypoalphalipoproteinemia (in some patients) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:marked hypobetalipoproteinemia n1=bilirubinémie | n2=en:marked hypobetalipoproteinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) n1=bilirubinémie | n2=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 n1=bilirubinémie | n2=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:markedly increased serum creatine kinase n1=bilirubinémie | n2=en:markedly increased serum creatine kinase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:markedly reduced igg levels n1=bilirubinémie | n2=en:markedly reduced igg levels | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:mcv - raised n1=bilirubinémie | n2=en:mcv - raised | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:mean platelet volume (mpv) 12.6fl n1=bilirubinémie | n2=en:mean platelet volume (mpv) 12.6fl | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:mechanical jaundice n1=bilirubinémie | n2=en:mechanical jaundice | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:median mean platelet volume (mpv) 12.5fl n1=bilirubinémie | n2=en:median mean platelet volume (mpv) 12.5fl | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:median mean platelet volume (mpv) 18fl n1=bilirubinémie | n2=en:median mean platelet volume (mpv) 18fl | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:medical procedure n1=bilirubinémie | n2=en:medical procedure | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:medicine n1=bilirubinémie | n2=en:medicine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:metastatic tumor n1=bilirubinémie | n2=en:metastatic tumor | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:methemoglobinemia n1=bilirubinémie | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:methylmalonyl-coenzyme a mutase deficiency n1=bilirubinémie | n2=en:methylmalonyl-coenzyme a mutase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:microscopic hematuria n1=bilirubinémie | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:molar ratio of total branched-chain amino acid to tyrosine n1=bilirubinémie | n2=en:molar ratio of total branched-chain amino acid to tyrosine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:muscular weakness n1=bilirubinémie | n2=en:muscular weakness | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:myxoedema coma n1=bilirubinémie | n2=en:myxoedema coma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:nasal alar hypoplasia n1=bilirubinémie | n2=en:nasal alar hypoplasia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:neovascularisation n1=bilirubinémie | n2=en:neovascularisation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:neutrophil leukocytosis n1=bilirubinémie | n2=en:neutrophil leukocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:neutrophilia n1=bilirubinémie | n2=en:neutrophilia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:nonketotic hypoglycemia n1=bilirubinémie | n2=en:nonketotic hypoglycemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:occupationally-acquired disorder of skin pigmentation n1=bilirubinémie | n2=en:occupationally-acquired disorder of skin pigmentation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:overactive thyroid n1=bilirubinémie | n2=en:overactive thyroid | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pancreatic enzymes decreased n1=bilirubinémie | n2=en:pancreatic enzymes decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:paralytic dementia n1=bilirubinémie | n2=en:paralytic dementia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:parathyroid hormone level increased n1=bilirubinémie | n2=en:parathyroid hormone level increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:paresis n1=bilirubinémie | n2=en:paresis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:patient problem n1=bilirubinémie | n2=en:patient problem | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:patient problem codes fda cdrh n1=bilirubinémie | n2=en:patient problem codes fda cdrh | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pediatric adverse events terminology n1=bilirubinémie | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pediatric terminology n1=bilirubinémie | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:peripheral vascular collapse n1=bilirubinémie | n2=en:peripheral vascular collapse | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pigment dispersion syndrome of bilateral eyes n1=bilirubinémie | n2=en:pigment dispersion syndrome of bilateral eyes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pigmentation disorder of lip n1=bilirubinémie | n2=en:pigmentation disorder of lip | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:plasma aldosterone normal n1=bilirubinémie | n2=en:plasma aldosterone normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:platelet aggregation decreased n1=bilirubinémie | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:platelet function test normal n1=bilirubinémie | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:polycythemia n1=bilirubinémie | n2=en:polycythemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:portal systemic encephalopathy n1=bilirubinémie | n2=en:portal systemic encephalopathy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:positive antinuclear antibody test n1=bilirubinémie | n2=en:positive antinuclear antibody test | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:premature separation of centromeric heterochromatin n1=bilirubinémie | n2=en:premature separation of centromeric heterochromatin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:primitive hemochromatosis n1=bilirubinémie | n2=en:primitive hemochromatosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:prolidase deficiency n1=bilirubinémie | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:prolonged partial thromboplastin time n1=bilirubinémie | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:propionic acidemia n1=bilirubinémie | n2=en:propionic acidemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:prothrombin time increased n1=bilirubinémie | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:pure red cell aplasia n1=bilirubinémie | n2=en:pure red cell aplasia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:raised serum calcium level n1=bilirubinémie | n2=en:raised serum calcium level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:raised tsh level n1=bilirubinémie | n2=en:raised tsh level | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:reactive hypoglycemia n1=bilirubinémie | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:red blood cell count raised n1=bilirubinémie | n2=en:red blood cell count raised | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:renal tubulopathy n1=bilirubinémie | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:resistance to activated protein c due to factor v leiden n1=bilirubinémie | n2=en:resistance to activated protein c due to factor v leiden | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:reticulocytosis n1=bilirubinémie | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:secondary neoplasm n1=bilirubinémie | n2=en:secondary neoplasm | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum bicarbonate increased n1=bilirubinémie | n2=en:serum bicarbonate increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum bilirubin borderline high n1=bilirubinémie | n2=en:serum bilirubin borderline high | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum bilirubin borderline low n1=bilirubinémie | n2=en:serum bilirubin borderline low | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum cholesterol raised n1=bilirubinémie | n2=en:serum cholesterol raised | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum growth hormone increased n1=bilirubinémie | n2=en:serum growth hormone increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum iron normal n1=bilirubinémie | n2=en:serum iron normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:serum transaminase increased n1=bilirubinémie | n2=en:serum transaminase increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:sideroblastic anemia n1=bilirubinémie | n2=en:sideroblastic anemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:sign or symptom n1=bilirubinémie | n2=en:sign or symptom | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:signs and symptoms n1=bilirubinémie | n2=en:signs and symptoms | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:state of shock n1=bilirubinémie | n2=en:state of shock | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:sugar diabetes n1=bilirubinémie | n2=en:sugar diabetes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:sweat test normal n1=bilirubinémie | n2=en:sweat test normal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:syphilitic meningoencephalitis n1=bilirubinémie | n2=en:syphilitic meningoencephalitis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:systemic mycosis n1=bilirubinémie | n2=en:systemic mycosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:taste perception n1=bilirubinémie | n2=en:taste perception | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:tay-sachs disease n1=bilirubinémie | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:Tay-Sachs disease n1=bilirubinémie | n2=en:Tay-Sachs disease | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:the death n1=bilirubinémie | n2=en:the death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:thrombocytopenia n1=bilirubinémie | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:thrombopenia n1=bilirubinémie | n2=en:thrombopenia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:thrombopeny n1=bilirubinémie | n2=en:thrombopeny | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:thyroid dyshormonogenesis 4 n1=bilirubinémie | n2=en:thyroid dyshormonogenesis 4 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:thyroid dyshormonogenesis 5 n1=bilirubinémie | n2=en:thyroid dyshormonogenesis 5 | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:to death n1=bilirubinémie | n2=en:to death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:to the death n1=bilirubinémie | n2=en:to the death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:tofus n1=bilirubinémie | n2=en:tofus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:toxic melanoderma of Hoffmann-Habermann n1=bilirubinémie | n2=en:toxic melanoderma of Hoffmann-Habermann | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:transaminases abnormal n1=bilirubinémie | n2=en:transaminases abnormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:transaminitis n1=bilirubinémie | n2=en:transaminitis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:transcobalamin ii deficiency n1=bilirubinémie | n2=en:transcobalamin ii deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:transferase deficiency galactosemia n1=bilirubinémie | n2=en:transferase deficiency galactosemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:transferrin saturation increased n1=bilirubinémie | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:triglyceride decreased n1=bilirubinémie | n2=en:triglyceride decreased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:tumour lysis syndrome n1=bilirubinémie | n2=en:tumour lysis syndrome | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until dead n1=bilirubinémie | n2=en:until dead | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until dead dead dead n1=bilirubinémie | n2=en:until dead dead dead | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until death n1=bilirubinémie | n2=en:until death | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until death do you part n1=bilirubinémie | n2=en:until death do you part | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until death you do part n1=bilirubinémie | n2=en:until death you do part | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until I die n1=bilirubinémie | n2=en:until I die | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:until you die n1=bilirubinémie | n2=en:until you die | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:urine bilirubin increased n1=bilirubinémie | n2=en:urine bilirubin increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:urobilinogen urine increased n1=bilirubinémie | n2=en:urobilinogen urine increased | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:urocanase deficiency n1=bilirubinémie | n2=en:urocanase deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:vascular collapse n1=bilirubinémie | n2=en:vascular collapse | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:vasodepression n1=bilirubinémie | n2=en:vasodepression | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:viral infection n1=bilirubinémie | n2=en:viral infection | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:viremia n1=bilirubinémie | n2=en:viremia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:virose n1=bilirubinémie | n2=en:virose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:virosis n1=bilirubinémie | n2=en:virosis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:vitamin d deficiency n1=bilirubinémie | n2=en:vitamin d deficiency | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:vulval melanotic macule n1=bilirubinémie | n2=en:vulval melanotic macule | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:xanthine nephrolithiasis n1=bilirubinémie | n2=en:xanthine nephrolithiasis | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> en:yellow nail n1=bilirubinémie | n2=en:yellow nail | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> encéphalopathie hépatique n1=bilirubinémie | n2=encéphalopathie hépatique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> encéphalopathie hépato-cérébrale n1=bilirubinémie | n2=encéphalopathie hépato-cérébrale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> encéphalopathie porto-cave n1=bilirubinémie | n2=encéphalopathie porto-cave | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> enzymologie n1=bilirubinémie | n2=enzymologie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> enzymology n1=bilirubinémie | n2=enzymology | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> enzymopathie n1=bilirubinémie | n2=enzymopathie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> épidémiologique n1=bilirubinémie | n2=épidémiologique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> érythroblastose n1=bilirubinémie | n2=érythroblastose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> état de choc n1=bilirubinémie | n2=état de choc | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> excès de liquide organique n1=bilirubinémie | n2=excès de liquide organique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> excès de volume liquidien n1=bilirubinémie | n2=excès de volume liquidien | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> extravasation n1=bilirubinémie | n2=extravasation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> faiblesse de muscle n1=bilirubinémie | n2=faiblesse de muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> faiblesse du muscle n1=bilirubinémie | n2=faiblesse du muscle | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> faiblesse musculaire n1=bilirubinémie | n2=faiblesse musculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> fongémie n1=bilirubinémie | n2=fongémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> fongémies n1=bilirubinémie | n2=fongémies | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> fucosidose n1=bilirubinémie | n2=fucosidose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> galactosurie n1=bilirubinémie | n2=galactosurie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> gamma-glutamyl-transférase anormale n1=bilirubinémie | n2=gamma-glutamyl-transférase anormale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> gammaglutamyltranspeptidase anormale n1=bilirubinémie | n2=gammaglutamyltranspeptidase anormale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> gliose n1=bilirubinémie | n2=gliose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> gout n1=bilirubinémie | n2=gout | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> goût n1=bilirubinémie | n2=goût | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> goutte n1=bilirubinémie | n2=goutte | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> goutte (maladie) n1=bilirubinémie | n2=goutte (maladie) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> granulome inflammatoire n1=bilirubinémie | n2=granulome inflammatoire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hæmorrhagie n1=bilirubinémie | n2=hæmorrhagie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hématurie macroscopique n1=bilirubinémie | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hématurie microscopique n1=bilirubinémie | n2=hématurie microscopique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémine n1=bilirubinémie | n2=hémine | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémochromatose n1=bilirubinémie | n2=hémochromatose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémochromatose primitive n1=bilirubinémie | n2=hémochromatose primitive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémochromatoses primitives n1=bilirubinémie | n2=hémochromatoses primitives | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémoglobinémie n1=bilirubinémie | n2=hémoglobinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémoglobinurie d'effort n1=bilirubinémie | n2=hémoglobinurie d'effort | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémolyse intra-vasculaire n1=bilirubinémie | n2=hémolyse intra-vasculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hemorragie n1=bilirubinémie | n2=hemorragie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémorrhagie n1=bilirubinémie | n2=hémorrhagie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémosidérinurie n1=bilirubinémie | n2=hémosidérinurie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hémosidérose n1=bilirubinémie | n2=hémosidérose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose à cellules de Langerhans n1=bilirubinémie | n2=histiocytose à cellules de Langerhans | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose à cellules de langerhans n1=bilirubinémie | n2=histiocytose à cellules de langerhans | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose langerhansienne n1=bilirubinémie | n2=histiocytose langerhansienne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose Langerhansienne n1=bilirubinémie | n2=histiocytose Langerhansienne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose X n1=bilirubinémie | n2=histiocytose X | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> histiocytose x n1=bilirubinémie | n2=histiocytose x | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> homocystéinémie n1=bilirubinémie | n2=homocystéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hydrocortisone diminuée n1=bilirubinémie | n2=hydrocortisone diminuée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperamylasémie n1=bilirubinémie | n2=hyperamylasémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypercalcémie n1=bilirubinémie | n2=hypercalcémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypercalciurie n1=bilirubinémie | n2=hypercalciurie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypercapnie n1=bilirubinémie | n2=hypercapnie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypercarbie n1=bilirubinémie | n2=hypercarbie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypercholestérolémie n1=bilirubinémie | n2=hypercholestérolémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperlipémie n1=bilirubinémie | n2=hyperlipémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperlipidémie n1=bilirubinémie | n2=hyperlipidémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperoxalémie n1=bilirubinémie | n2=hyperoxalémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperphosphatémie n1=bilirubinémie | n2=hyperphosphatémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperthyroïdie n1=bilirubinémie | n2=hyperthyroïdie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyperthyroïdisme n1=bilirubinémie | n2=hyperthyroïdisme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypertriglycéridémie n1=bilirubinémie | n2=hypertriglycéridémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypervolémie n1=bilirubinémie | n2=hypervolémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-albuminémie n1=bilirubinémie | n2=hypo-albuminémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-aldostéronisme n1=bilirubinémie | n2=hypo-aldostéronisme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-bêta-lipoprotéinémie n1=bilirubinémie | n2=hypo-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-bêtalipoprotéinémie n1=bilirubinémie | n2=hypo-bêtalipoprotéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-intense (signal IRM) n1=bilirubinémie | n2=hypo-intense (signal IRM) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypo-uricémie n1=bilirubinémie | n2=hypo-uricémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypoalbuminémie n1=bilirubinémie | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypoaldostéronisme n1=bilirubinémie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypobêtalipoprotéinémie n1=bilirubinémie | n2=hypobêtalipoprotéinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypocalcémie n1=bilirubinémie | n2=hypocalcémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypochromie n1=bilirubinémie | n2=hypochromie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypofibrinogénémie n1=bilirubinémie | n2=hypofibrinogénémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypogammaglobulinémie n1=bilirubinémie | n2=hypogammaglobulinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hyponatrémie n1=bilirubinémie | n2=hyponatrémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypophosphatasie foetale n1=bilirubinémie | n2=hypophosphatasie foetale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypophosphatasie infantile n1=bilirubinémie | n2=hypophosphatasie infantile | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypoplasie n1=bilirubinémie | n2=hypoplasie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale n1=bilirubinémie | n2=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypoplasie médullaire n1=bilirubinémie | n2=hypoplasie médullaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypothyroïdie n1=bilirubinémie | n2=hypothyroïdie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hypothyroïdisme n1=bilirubinémie | n2=hypothyroïdisme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> hystiocytose à cellules de langerhans n1=bilirubinémie | n2=hystiocytose à cellules de langerhans | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ictère du nouveau-né n1=bilirubinémie | n2=ictère du nouveau-né | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ictère gravidique n1=bilirubinémie | n2=ictère gravidique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ictère par obstruction n1=bilirubinémie | n2=ictère par obstruction | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ictère récidivant de la grossesse n1=bilirubinémie | n2=ictère récidivant de la grossesse | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> incontinentia pigmenti n1=bilirubinémie | n2=incontinentia pigmenti | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> infection due au rétrovirus n1=bilirubinémie | n2=infection due au rétrovirus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> infection mycosique systémique n1=bilirubinémie | n2=infection mycosique systémique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> infection virale n1=bilirubinémie | n2=infection virale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> infections virales n1=bilirubinémie | n2=infections virales | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> insuffisance cardiovasculaire aiguë n1=bilirubinémie | n2=insuffisance cardiovasculaire aiguë | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> insuffisance circulatoire aiguë n1=bilirubinémie | n2=insuffisance circulatoire aiguë | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> insuffisance circulatoire périphérique n1=bilirubinémie | n2=insuffisance circulatoire périphérique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> insuffisance hépatique transitoire n1=bilirubinémie | n2=insuffisance hépatique transitoire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> insuffisance surrénalienne chronique primaire n1=bilirubinémie | n2=insuffisance surrénalienne chronique primaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> intolérance au fructose n1=bilirubinémie | n2=intolérance au fructose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> intolérance au lactose n1=bilirubinémie | n2=intolérance au lactose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> Intolérance au lactose n1=bilirubinémie | n2=Intolérance au lactose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> jaunisse néonatale n1=bilirubinémie | n2=jaunisse néonatale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> jusqu'à ce que mort s'en suive n1=bilirubinémie | n2=jusqu'à ce que mort s'en suive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> jusqu'à ce que mort s'ensuive n1=bilirubinémie | n2=jusqu'à ce que mort s'ensuive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> jusqu'à la mort n1=bilirubinémie | n2=jusqu'à la mort | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> lactate augmenté n1=bilirubinémie | n2=lactate augmenté | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> lactate élevé n1=bilirubinémie | n2=lactate élevé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> lifetime n1=bilirubinémie | n2=lifetime | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> lymphocytose n1=bilirubinémie | n2=lymphocytose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> macro-amylasémie n1=bilirubinémie | n2=macro-amylasémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> macroamylasémie n1=bilirubinémie | n2=macroamylasémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie à cytomégalovirus n1=bilirubinémie | n2=maladie à cytomégalovirus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie aigüe n1=bilirubinémie | n2=maladie aigüe | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie d'addison n1=bilirubinémie | n2=maladie d'addison | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie d'Addison n1=bilirubinémie | n2=maladie d'Addison | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie de Gaucher n1=bilirubinémie | n2=maladie de Gaucher | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie de Tay-Sachs n1=bilirubinémie | n2=maladie de Tay-Sachs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie de Tay-sachs n1=bilirubinémie | n2=maladie de Tay-sachs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie de tay-sachs n1=bilirubinémie | n2=maladie de tay-sachs | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie due à un virus n1=bilirubinémie | n2=maladie due à un virus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie enzymatique n1=bilirubinémie | n2=maladie enzymatique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie infectieuse virale n1=bilirubinémie | n2=maladie infectieuse virale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie lysosomique de surcharge n1=bilirubinémie | n2=maladie lysosomique de surcharge | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie néoplasique maligne n1=bilirubinémie | n2=maladie néoplasique maligne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladie virale n1=bilirubinémie | n2=maladie virale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladies infectieuses virales n1=bilirubinémie | n2=maladies infectieuses virales | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladies lysosomales n1=bilirubinémie | n2=maladies lysosomales | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> maladies virales n1=bilirubinémie | n2=maladies virales | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> marasme alimentaire n1=bilirubinémie | n2=marasme alimentaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> marasme nutritionnel n1=bilirubinémie | n2=marasme nutritionnel | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mélanodermite toxique d'Hoffmann-Habermann n1=bilirubinémie | n2=mélanodermite toxique d'Hoffmann-Habermann | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mélasma n1=bilirubinémie | n2=mélasma | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métabolisme du glucose anormal n1=bilirubinémie | n2=métabolisme du glucose anormal | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métaplasie n1=bilirubinémie | n2=métaplasie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métastase n1=bilirubinémie | n2=métastase | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métastase tumorale n1=bilirubinémie | n2=métastase tumorale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métastase (médecine) n1=bilirubinémie | n2=métastase (médecine) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> métastase (médecine, cancer) n1=bilirubinémie | n2=métastase (médecine, cancer) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> méthémoglobinémie n1=bilirubinémie | n2=méthémoglobinémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> microbiologique n1=bilirubinémie | n2=microbiologique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> moelle osseuse hypocellulaire n1=bilirubinémie | n2=moelle osseuse hypocellulaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mort d'homme n1=bilirubinémie | n2=mort d'homme | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mort d'hommes n1=bilirubinémie | n2=mort d'hommes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mucolipidose II n1=bilirubinémie | n2=mucolipidose II | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mucolipidose type ii n1=bilirubinémie | n2=mucolipidose type ii | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mucolipidose type II n1=bilirubinémie | n2=mucolipidose type II | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> mycose systémique n1=bilirubinémie | n2=mycose systémique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> neo n1=bilirubinémie | n2=neo | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néo-intima n1=bilirubinémie | n2=néo-intima | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoformation de vaisseaux sanguins n1=bilirubinémie | n2=néoformation de vaisseaux sanguins | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoplasme bénin n1=bilirubinémie | n2=néoplasme bénin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoplasme malin n1=bilirubinémie | n2=néoplasme malin | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoplasme malin non classé n1=bilirubinémie | n2=néoplasme malin non classé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoplasme métastatique n1=bilirubinémie | n2=néoplasme métastatique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> néoplasme secondaire n1=bilirubinémie | n2=néoplasme secondaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> neutrophilie n1=bilirubinémie | n2=neutrophilie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> non précisé, choc n1=bilirubinémie | n2=non précisé, choc | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> non précisée, anémie aplasique n1=bilirubinémie | n2=non précisée, anémie aplasique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> ongles jaunes (syndrome des) n1=bilirubinémie | n2=ongles jaunes (syndrome des) | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> paralysie générale n1=bilirubinémie | n2=paralysie générale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> parasitologie n1=bilirubinémie | n2=parasitologie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> parésie n1=bilirubinémie | n2=parésie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> parésié n1=bilirubinémie | n2=parésié | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> parésie musculaire n1=bilirubinémie | n2=parésie musculaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> perte électrolytique n1=bilirubinémie | n2=perte électrolytique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> pertes humaines n1=bilirubinémie | n2=pertes humaines | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> pigmentation du stroma de la cornée n1=bilirubinémie | n2=pigmentation du stroma de la cornée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> pigmentation mélanique anormale n1=bilirubinémie | n2=pigmentation mélanique anormale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> poïkilodermatomyosite de Petges et Cléjat n1=bilirubinémie | n2=poïkilodermatomyosite de Petges et Cléjat | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> polycythemia n1=bilirubinémie | n2=polycythemia | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> polydipsie n1=bilirubinémie | n2=polydipsie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> polyglobulie n1=bilirubinémie | n2=polyglobulie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> polyurie n1=bilirubinémie | n2=polyurie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> procédure médicale n1=bilirubinémie | n2=procédure médicale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> pseudo-goutte n1=bilirubinémie | n2=pseudo-goutte | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> pseudogoutte n1=bilirubinémie | n2=pseudogoutte | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> radiographique n1=bilirubinémie | n2=radiographique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> réaction allergique n1=bilirubinémie | n2=réaction allergique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> réparation défectueuse de l'ADN n1=bilirubinémie | n2=réparation défectueuse de l'ADN | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> septicémie fongique n1=bilirubinémie | n2=septicémie fongique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> septicémie mycosique n1=bilirubinémie | n2=septicémie mycosique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> shock n1=bilirubinémie | n2=shock | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> signes et symptômes n1=bilirubinémie | n2=signes et symptômes | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> soif excessive n1=bilirubinémie | n2=soif excessive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> sphingolipidose n1=bilirubinémie | n2=sphingolipidose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> surcharge liquidienne n1=bilirubinémie | n2=surcharge liquidienne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome cachectique n1=bilirubinémie | n2=syndrome cachectique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome cachectique dû au vih n1=bilirubinémie | n2=syndrome cachectique dû au vih | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome d'intoxication par l'eau n1=bilirubinémie | n2=syndrome d'intoxication par l'eau | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de cachexie n1=bilirubinémie | n2=syndrome de cachexie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de cachexie progressive n1=bilirubinémie | n2=syndrome de cachexie progressive | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de dépérissement n1=bilirubinémie | n2=syndrome de dépérissement | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de Dubin-Johnson n1=bilirubinémie | n2=syndrome de Dubin-Johnson | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de dubin-johnson n1=bilirubinémie | n2=syndrome de dubin-johnson | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de lyse tumorale n1=bilirubinémie | n2=syndrome de lyse tumorale | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome de malabsorption n1=bilirubinémie | n2=syndrome de malabsorption | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> syndrome métabolique n1=bilirubinémie | n2=syndrome métabolique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> synéchie n1=bilirubinémie | n2=synéchie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> thrombocytopénie n1=bilirubinémie | n2=thrombocytopénie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> thrombopénie n1=bilirubinémie | n2=thrombopénie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tophus n1=bilirubinémie | n2=tophus | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tophus goutteux n1=bilirubinémie | n2=tophus goutteux | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble chromosomique n1=bilirubinémie | n2=trouble chromosomique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble de la conduction du coeur n1=bilirubinémie | n2=trouble de la conduction du coeur | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble de la nutrition n1=bilirubinémie | n2=trouble de la nutrition | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble de la pigmentation n1=bilirubinémie | n2=trouble de la pigmentation | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble du métabolisme des minéraux n1=bilirubinémie | n2=trouble du métabolisme des minéraux | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble du métabolisme du fer n1=bilirubinémie | n2=trouble du métabolisme du fer | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> trouble du rythme cardiaque n1=bilirubinémie | n2=trouble du rythme cardiaque | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial n1=bilirubinémie | n2=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> Tumeur bénigne n1=bilirubinémie | n2=Tumeur bénigne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur bénigne n1=bilirubinémie | n2=tumeur bénigne | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur maligne de siège non précisé n1=bilirubinémie | n2=tumeur maligne de siège non précisé | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur maligne de siège primitif inconnu n1=bilirubinémie | n2=tumeur maligne de siège primitif inconnu | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur maligne non classée n1=bilirubinémie | n2=tumeur maligne non classée | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur maligne sans précision de site n1=bilirubinémie | n2=tumeur maligne sans précision de site | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur métastasique n1=bilirubinémie | n2=tumeur métastasique | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> tumeur secondaire n1=bilirubinémie | n2=tumeur secondaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> viémies n1=bilirubinémie | n2=viémies | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> virémie n1=bilirubinémie | n2=virémie | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> vireux n1=bilirubinémie | n2=vireux | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> virose n1=bilirubinémie | n2=virose | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> viroses n1=bilirubinémie | n2=viroses | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> Xeroderma pigmentosum n1=bilirubinémie | n2=Xeroderma pigmentosum | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> xeroderma pigmentosum n1=bilirubinémie | n2=xeroderma pigmentosum | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> xérodermite pigmentaire n1=bilirubinémie | n2=xérodermite pigmentaire | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 10 / 0.035 -> yellow nail syndrome n1=bilirubinémie | n2=yellow nail syndrome | rel=r_associated | relid=0 | w=10 bilirubinémie -- r_associated #0: 6 / 0.021 -> urine n1=bilirubinémie | n2=urine | rel=r_associated | relid=0 | w=6 bilirubinémie -- r_associated #0: 5 / 0.017 -> -émie n1=bilirubinémie | n2=-émie | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> acide glucuronique n1=bilirubinémie | n2=acide glucuronique | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> anatomie n1=bilirubinémie | n2=anatomie | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> bilirubine non-conjuguée n1=bilirubinémie | n2=bilirubine non-conjuguée | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> biliverdines n1=bilirubinémie | n2=biliverdines | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> cholangiographie intraveineuse n1=bilirubinémie | n2=cholangiographie intraveineuse | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> conjuguée n1=bilirubinémie | n2=conjuguée | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> en:alpha, biliverdin ix n1=bilirubinémie | n2=en:alpha, biliverdin ix | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> en:biliverdin n1=bilirubinémie | n2=en:biliverdin | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> en:biliverdinoglobin n1=bilirubinémie | n2=en:biliverdinoglobin | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> en:ix, biliverdin n1=bilirubinémie | n2=en:ix, biliverdin | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> en:pigments and dyes n1=bilirubinémie | n2=en:pigments and dyes | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> excrétion n1=bilirubinémie | n2=excrétion | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> hyperbilirubinémie II n1=bilirubinémie | n2=hyperbilirubinémie II | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> hyperbilirubinémie non conjuguée non hémolytique héréditaire n1=bilirubinémie | n2=hyperbilirubinémie non conjuguée non hémolytique héréditaire | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> hyperbilirubinémie non conjuguée, non hémolytique, héréditaire n1=bilirubinémie | n2=hyperbilirubinémie non conjuguée, non hémolytique, héréditaire | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> maladie de Gilbert n1=bilirubinémie | n2=maladie de Gilbert | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> Médecine n1=bilirubinémie | n2=Médecine | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> phénomène n1=bilirubinémie | n2=phénomène | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> Syn. hyperbilirubinémie non conjuguée non hémolytique héréditaire n1=bilirubinémie | n2=Syn. hyperbilirubinémie non conjuguée non hémolytique héréditaire | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> syndrome d'hyperbilirubinémie chronique n1=bilirubinémie | n2=syndrome d'hyperbilirubinémie chronique | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> UGT1A1 gen e n1=bilirubinémie | n2=UGT1A1 gen e | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> UGT1A1 gene n1=bilirubinémie | n2=UGT1A1 gene | rel=r_associated | relid=0 | w=5 bilirubinémie -- r_associated #0: 5 / 0.017 -> verdoglobine n1=bilirubinémie | n2=verdoglobine | rel=r_associated | relid=0 | w=5

≈ 839 relations entrantes en:hyperbilirubinemia --- r_associated #0: 165 --> bilirubinémie n1=en:hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=165 hyperbilirubinémie --- r_associated #0: 163 --> bilirubinémie n1=hyperbilirubinémie | n2=bilirubinémie | rel=r_associated | relid=0 | w=163 médecine --- r_associated #0: 154 --> bilirubinémie n1=médecine | n2=bilirubinémie | rel=r_associated | relid=0 | w=154 bilirubine --- r_associated #0: 56 --> bilirubinémie n1=bilirubine | n2=bilirubinémie | rel=r_associated | relid=0 | w=56 en:bilirubin --- r_associated #0: 55 --> bilirubinémie n1=en:bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=55 bilirubinémie du nouveau-né --- r_associated #0: 53 --> bilirubinémie n1=bilirubinémie du nouveau-né | n2=bilirubinémie | rel=r_associated | relid=0 | w=53 bilirubine libre --- r_associated #0: 51 --> bilirubinémie n1=bilirubine libre | n2=bilirubinémie | rel=r_associated | relid=0 | w=51 en:indirect-reacting bilirubin --- r_associated #0: 50 --> bilirubinémie n1=en:indirect-reacting bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=50 bilieuse hémoglobinurique (fièvre) --- r_associated #0: 46 --> bilirubinémie n1=bilieuse hémoglobinurique (fièvre) | n2=bilirubinémie | rel=r_associated | relid=0 | w=46 en:increased bilirubin level (finding) --- r_associated #0: 34 --> bilirubinémie n1=en:increased bilirubin level (finding) | n2=bilirubinémie | rel=r_associated | relid=0 | w=34 en:hyperbilirubinaemia --- r_associated #0: 33 --> bilirubinémie n1=en:hyperbilirubinaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=33 hyperbilirubinémies --- r_associated #0: 32 --> bilirubinémie n1=hyperbilirubinémies | n2=bilirubinémie | rel=r_associated | relid=0 | w=32 hyperbilirubinémie acquise --- r_associated #0: 31 --> bilirubinémie n1=hyperbilirubinémie acquise | n2=bilirubinémie | rel=r_associated | relid=0 | w=31 hyperbilirubinémie néonatale --- r_associated #0: 31 --> bilirubinémie n1=hyperbilirubinémie néonatale | n2=bilirubinémie | rel=r_associated | relid=0 | w=31 augmentation du taux de bilirubine --- r_associated #0: 30 --> bilirubinémie n1=augmentation du taux de bilirubine | n2=bilirubinémie | rel=r_associated | relid=0 | w=30 en:neonatal hyperbilirubinemia --- r_associated #0: 30 --> bilirubinémie n1=en:neonatal hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=30 foie (anatomie) --- r_associated #0: 30 --> bilirubinémie n1=foie (anatomie) | n2=bilirubinémie | rel=r_associated | relid=0 | w=30 hyperbilirubinémie du nouveau-né --- r_associated #0: 30 --> bilirubinémie n1=hyperbilirubinémie du nouveau-né | n2=bilirubinémie | rel=r_associated | relid=0 | w=30 M --- r_associated #0: 29 --> bilirubinémie n1=M | n2=bilirubinémie | rel=r_associated | relid=0 | w=29 bilirubine augmentée --- r_associated #0: 29 --> bilirubinémie n1=bilirubine augmentée | n2=bilirubinémie | rel=r_associated | relid=0 | w=29 en:bilieuse hemoglobinurique fever --- r_associated #0: 29 --> bilirubinémie n1=en:bilieuse hemoglobinurique fever | n2=bilirubinémie | rel=r_associated | relid=0 | w=29 hyperbilirubinémique --- r_associated #0: 29 --> bilirubinémie n1=hyperbilirubinémique | n2=bilirubinémie | rel=r_associated | relid=0 | w=29 élévation de bilirubine --- r_associated #0: 29 --> bilirubinémie n1=élévation de bilirubine | n2=bilirubinémie | rel=r_associated | relid=0 | w=29 bilirubinémique --- r_associated #0: 28 --> bilirubinémie n1=bilirubinémique | n2=bilirubinémie | rel=r_associated | relid=0 | w=28 jaunisse --- r_associated #0: 28 --> bilirubinémie n1=jaunisse | n2=bilirubinémie | rel=r_associated | relid=0 | w=28 un/le mal --- r_associated #0: 28 --> bilirubinémie n1= un/le mal | n2=bilirubinémie | rel=r_associated | relid=0 | w=28 bilirubinémies --- r_associated #0: 27 --> bilirubinémie n1=bilirubinémies | n2=bilirubinémie | rel=r_associated | relid=0 | w=27 en:acquired hyperbilirubinemia --- r_associated #0: 27 --> bilirubinémie n1=en:acquired hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=27 augmentation de la bilirubine --- r_associated #0: 26 --> bilirubinémie n1=augmentation de la bilirubine | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 bilirubine élevée --- r_associated #0: 26 --> bilirubinémie n1=bilirubine élevée | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 en:bilirubinemia --- r_associated #0: 26 --> bilirubinémie n1=en:bilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 medecine --- r_associated #0: 26 --> bilirubinémie n1=medecine | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 medicament --- r_associated #0: 26 --> bilirubinémie n1=medicament | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 médicament --- r_associated #0: 26 --> bilirubinémie n1=médicament | n2=bilirubinémie | rel=r_associated | relid=0 | w=26 B --- r_associated #0: 25 --> bilirubinémie n1=B | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 b --- r_associated #0: 25 --> bilirubinémie n1=b | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 bilirubinémie indirecte --- r_associated #0: 25 --> bilirubinémie n1=bilirubinémie indirecte | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 excès de liquide organique --- r_associated #0: 25 --> bilirubinémie n1=excès de liquide organique | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 excès de volume liquidien --- r_associated #0: 25 --> bilirubinémie n1=excès de volume liquidien | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 hyperbilirubinémie des nouveau-nés --- r_associated #0: 25 --> bilirubinémie n1=hyperbilirubinémie des nouveau-nés | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 m --- r_associated #0: 25 --> bilirubinémie n1=m | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 maladie --- r_associated #0: 25 --> bilirubinémie n1=maladie | n2=bilirubinémie | rel=r_associated | relid=0 | w=25 foie --- r_associated #0: 21 --> bilirubinémie n1=foie | n2=bilirubinémie | rel=r_associated | relid=0 | w=21 processus pathologique --- r_associated #0: 21 --> bilirubinémie n1=processus pathologique | n2=bilirubinémie | rel=r_associated | relid=0 | w=21 acide glycuronique --- r_associated #0: 20 --> bilirubinémie n1=acide glycuronique | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 amaigrissement pathologique --- r_associated #0: 20 --> bilirubinémie n1=amaigrissement pathologique | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 atrophie généralisée --- r_associated #0: 20 --> bilirubinémie n1=atrophie généralisée | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 augmentation --- r_associated #0: 20 --> bilirubinémie n1=augmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 bile --- r_associated #0: 20 --> bilirubinémie n1=bile | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 biologie de l'appareil digestif --- r_associated #0: 20 --> bilirubinémie n1=biologie de l'appareil digestif | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 cachexie maligne --- r_associated #0: 20 --> bilirubinémie n1=cachexie maligne | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 cholémie familiale --- r_associated #0: 20 --> bilirubinémie n1=cholémie familiale | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 cholémie familiale congénitale --- r_associated #0: 20 --> bilirubinémie n1=cholémie familiale congénitale | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 concentration sanguine --- r_associated #0: 20 --> bilirubinémie n1=concentration sanguine | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 dysfonctionnement hépatique constitutionnel --- r_associated #0: 20 --> bilirubinémie n1=dysfonctionnement hépatique constitutionnel | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 déficit en phosphatases alcalines --- r_associated #0: 20 --> bilirubinémie n1=déficit en phosphatases alcalines | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:5' 10' methylenetetrahydrofolate reductase deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:5' 10' methylenetetrahydrofolate reductase deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal biliary tract morphology --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal biliary tract morphology | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal biliary tract physiology --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal biliary tract physiology | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal growth and differentiation --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal growth and differentiation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal liver function test --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal liver function test | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal melanin pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal melanin pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal metabolic state in diabetes mellitus --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal metabolic state in diabetes mellitus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal secretion or accumulation --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal secretion or accumulation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:abnormal transit or circulation --- r_associated #0: 20 --> bilirubinémie n1=en:abnormal transit or circulation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acantholysis --- r_associated #0: 20 --> bilirubinémie n1=en:acantholysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acid-base imbalance --- r_associated #0: 20 --> bilirubinémie n1=en:acid-base imbalance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acquired aminoacid metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:acquired aminoacid metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acquired anterior capsular pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:acquired anterior capsular pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acquired disorder of skin color --- r_associated #0: 20 --> bilirubinémie n1=en:acquired disorder of skin color | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acquired hypopigmentation of choroid --- r_associated #0: 20 --> bilirubinémie n1=en:acquired hypopigmentation of choroid | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acquired porphyria --- r_associated #0: 20 --> bilirubinémie n1=en:acquired porphyria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acral overgrowth --- r_associated #0: 20 --> bilirubinémie n1=en:acral overgrowth | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acromegaly --- r_associated #0: 20 --> bilirubinémie n1=en:acromegaly | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acute disease --- r_associated #0: 20 --> bilirubinémie n1=en:acute disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:acute metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:acute metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:addison's disease --- r_associated #0: 20 --> bilirubinémie n1=en:addison's disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:adrenal atrophy --- r_associated #0: 20 --> bilirubinémie n1=en:adrenal atrophy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:adrenal crisis --- r_associated #0: 20 --> bilirubinémie n1=en:adrenal crisis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:adrenal insufficiency neonatal --- r_associated #0: 20 --> bilirubinémie n1=en:adrenal insufficiency neonatal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:adrenocortical insufficiency --- r_associated #0: 20 --> bilirubinémie n1=en:adrenocortical insufficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:adrenocortical insufficiency neonatal --- r_associated #0: 20 --> bilirubinémie n1=en:adrenocortical insufficiency neonatal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:albinism --- r_associated #0: 20 --> bilirubinémie n1=en:albinism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:albinotic fundus --- r_associated #0: 20 --> bilirubinémie n1=en:albinotic fundus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:alcohol intolerance --- r_associated #0: 20 --> bilirubinémie n1=en:alcohol intolerance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:alcohol-induced pseudo-cushing's syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:alcohol-induced pseudo-cushing's syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:alkalosis --- r_associated #0: 20 --> bilirubinémie n1=en:alkalosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:alkaptonuric ochronosis --- r_associated #0: 20 --> bilirubinémie n1=en:alkaptonuric ochronosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:allergic reaction --- r_associated #0: 20 --> bilirubinémie n1=en:allergic reaction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:alstrom syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:alstrom syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:amelogenesis imperfecta pigmented hypomaturation type --- r_associated #0: 20 --> bilirubinémie n1=en:amelogenesis imperfecta pigmented hypomaturation type | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:amino acid metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:amino acid metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:amyloidogenesis --- r_associated #0: 20 --> bilirubinémie n1=en:amyloidogenesis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:amyloidosis --- r_associated #0: 20 --> bilirubinémie n1=en:amyloidosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:anemia --- r_associated #0: 20 --> bilirubinémie n1=en:anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:anemia due to vitamin b>6< deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:anemia due to vitamin b>6< deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:anemia hemolytic indirect coombs positive --- r_associated #0: 20 --> bilirubinémie n1=en:anemia hemolytic indirect coombs positive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:anemia, hereditary spherocytic hemolytic --- r_associated #0: 20 --> bilirubinémie n1=en:anemia, hereditary spherocytic hemolytic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:anterior corneal pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:anterior corneal pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:aplastic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:aplastic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:application site pigmentation changes --- r_associated #0: 20 --> bilirubinémie n1=en:application site pigmentation changes | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:argyria --- r_associated #0: 20 --> bilirubinémie n1=en:argyria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:argyria of skin --- r_associated #0: 20 --> bilirubinémie n1=en:argyria of skin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:arrhythmia --- r_associated #0: 20 --> bilirubinémie n1=en:arrhythmia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:arterial thrombosis --- r_associated #0: 20 --> bilirubinémie n1=en:arterial thrombosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ascites --- r_associated #0: 20 --> bilirubinémie n1=en:ascites | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:aspects of mortality statistics --- r_associated #0: 20 --> bilirubinémie n1=en:aspects of mortality statistics | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:aspects of radionuclide imaging --- r_associated #0: 20 --> bilirubinémie n1=en:aspects of radionuclide imaging | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:atrial remodeling --- r_associated #0: 20 --> bilirubinémie n1=en:atrial remodeling | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:atypical pigmented lesion --- r_associated #0: 20 --> bilirubinémie n1=en:atypical pigmented lesion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:autoimmune --- r_associated #0: 20 --> bilirubinémie n1=en:autoimmune | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:autoimmune process --- r_associated #0: 20 --> bilirubinémie n1=en:autoimmune process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:avitaminosis --- r_associated #0: 20 --> bilirubinémie n1=en:avitaminosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:azotemia --- r_associated #0: 20 --> bilirubinémie n1=en:azotemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:benign neoplasm --- r_associated #0: 20 --> bilirubinémie n1=en:benign neoplasm | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:biliary tract abnormality --- r_associated #0: 20 --> bilirubinémie n1=en:biliary tract abnormality | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:bilirubin test kit --- r_associated #0: 20 --> bilirubinémie n1=en:bilirubin test kit | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:bilirubin value increased --- r_associated #0: 20 --> bilirubinémie n1=en:bilirubin value increased | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:bilirubinemia aggravated --- r_associated #0: 20 --> bilirubinémie n1=en:bilirubinemia aggravated | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:biliuria --- r_associated #0: 20 --> bilirubinémie n1=en:biliuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:blood bilirubin measurement --- r_associated #0: 20 --> bilirubinémie n1=en:blood bilirubin measurement | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:blood pigmentation of cornea --- r_associated #0: 20 --> bilirubinémie n1=en:blood pigmentation of cornea | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:brain diseases, metabolic --- r_associated #0: 20 --> bilirubinémie n1=en:brain diseases, metabolic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:bsp test abnormal --- r_associated #0: 20 --> bilirubinémie n1=en:bsp test abnormal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cachexia --- r_associated #0: 20 --> bilirubinémie n1=en:cachexia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cafe au lait spot --- r_associated #0: 20 --> bilirubinémie n1=en:cafe au lait spot | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:calcium metabolism disorders --- r_associated #0: 20 --> bilirubinémie n1=en:calcium metabolism disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:calcium/phosphate abnormality --- r_associated #0: 20 --> bilirubinémie n1=en:calcium/phosphate abnormality | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cancer cell growth regulation --- r_associated #0: 20 --> bilirubinémie n1=en:cancer cell growth regulation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cantu syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:cantu syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:carbohydrate metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:carbohydrate metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:carcinogen effect in offspring --- r_associated #0: 20 --> bilirubinémie n1=en:carcinogen effect in offspring | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cardiotoxicity --- r_associated #0: 20 --> bilirubinémie n1=en:cardiotoxicity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:carnosinemia --- r_associated #0: 20 --> bilirubinémie n1=en:carnosinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:carotene pigmentation of skin --- r_associated #0: 20 --> bilirubinémie n1=en:carotene pigmentation of skin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:carotenemia --- r_associated #0: 20 --> bilirubinémie n1=en:carotenemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:catabolic state --- r_associated #0: 20 --> bilirubinémie n1=en:catabolic state | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cell death process --- r_associated #0: 20 --> bilirubinémie n1=en:cell death process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cell stress process --- r_associated #0: 20 --> bilirubinémie n1=en:cell stress process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:central hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:central hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:channelopathies --- r_associated #0: 20 --> bilirubinémie n1=en:channelopathies | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chemically induced --- r_associated #0: 20 --> bilirubinémie n1=en:chemically induced | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholangitis --- r_associated #0: 20 --> bilirubinémie n1=en:cholangitis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholangitis, sclerosing --- r_associated #0: 20 --> bilirubinémie n1=en:cholangitis, sclerosing | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholecystitis --- r_associated #0: 20 --> bilirubinémie n1=en:cholecystitis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholelithiasis --- r_associated #0: 20 --> bilirubinémie n1=en:cholelithiasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholestasis --- r_associated #0: 20 --> bilirubinémie n1=en:cholestasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholestasis and jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:cholestasis and jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholestasis in newborn --- r_associated #0: 20 --> bilirubinémie n1=en:cholestasis in newborn | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholestasis of pregnancy --- r_associated #0: 20 --> bilirubinémie n1=en:cholestasis of pregnancy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cholestatic hepatitis --- r_associated #0: 20 --> bilirubinémie n1=en:cholestatic hepatitis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chromatolysis --- r_associated #0: 20 --> bilirubinémie n1=en:chromatolysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chromatosis --- r_associated #0: 20 --> bilirubinémie n1=en:chromatosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chromosome disorder --- r_associated #0: 20 --> bilirubinémie n1=en:chromosome disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chronic disease --- r_associated #0: 20 --> bilirubinémie n1=en:chronic disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:chronic metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:chronic metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:circumscribed hypermelanosis --- r_associated #0: 20 --> bilirubinémie n1=en:circumscribed hypermelanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:citrate toxicity --- r_associated #0: 20 --> bilirubinémie n1=en:citrate toxicity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:clinical manifestation of enzyme deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:clinical manifestation of enzyme deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:col1a1 associated connective tissue disorder --- r_associated #0: 20 --> bilirubinémie n1=en:col1a1 associated connective tissue disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:collagen-vascular disease --- r_associated #0: 20 --> bilirubinémie n1=en:collagen-vascular disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:combined oxidative phosphorylation deficiency 1 --- r_associated #0: 20 --> bilirubinémie n1=en:combined oxidative phosphorylation deficiency 1 | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:comorbidity --- r_associated #0: 20 --> bilirubinémie n1=en:comorbidity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:complication aspects --- r_associated #0: 20 --> bilirubinémie n1=en:complication aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:congenital hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:congenital hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:congenital hypopigmentation of choroid --- r_associated #0: 20 --> bilirubinémie n1=en:congenital hypopigmentation of choroid | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:congenital hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:congenital hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:congenital metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:congenital metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:congenital pigmentary skin anomalies --- r_associated #0: 20 --> bilirubinémie n1=en:congenital pigmentary skin anomalies | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:conjugated bilirubinaemia --- r_associated #0: 20 --> bilirubinémie n1=en:conjugated bilirubinaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:conjunctival pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:conjunctival pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cortisol deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:cortisol deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:crystal arthropathy --- r_associated #0: 20 --> bilirubinémie n1=en:crystal arthropathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:crystal nephropathy --- r_associated #0: 20 --> bilirubinémie n1=en:crystal nephropathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cushing syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:cushing syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cushingoid --- r_associated #0: 20 --> bilirubinémie n1=en:cushingoid | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cystic fibrosis --- r_associated #0: 20 --> bilirubinémie n1=en:cystic fibrosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:cytogenetic abnormality --- r_associated #0: 20 --> bilirubinémie n1=en:cytogenetic abnormality | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:death --- r_associated #0: 20 --> bilirubinémie n1=en:death | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:deficiency of bile secretion --- r_associated #0: 20 --> bilirubinémie n1=en:deficiency of bile secretion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:degeneration --- r_associated #0: 20 --> bilirubinémie n1=en:degeneration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dehydration --- r_associated #0: 20 --> bilirubinémie n1=en:dehydration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:delayed graft function --- r_associated #0: 20 --> bilirubinémie n1=en:delayed graft function | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:depigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:depigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:deterioration of body part --- r_associated #0: 20 --> bilirubinémie n1=en:deterioration of body part | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:diabetes mellitus --- r_associated #0: 20 --> bilirubinémie n1=en:diabetes mellitus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:diagnosis aspect --- r_associated #0: 20 --> bilirubinémie n1=en:diagnosis aspect | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dihydrouracil dehydrogenase deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:dihydrouracil dehydrogenase deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:direct bilirubin measurement --- r_associated #0: 20 --> bilirubinémie n1=en:direct bilirubin measurement | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:direct coombs test positive --- r_associated #0: 20 --> bilirubinémie n1=en:direct coombs test positive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:direct hyperbilirubinemia --- r_associated #0: 20 --> bilirubinémie n1=en:direct hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:direct reacting bilirubin --- r_associated #0: 20 --> bilirubinémie n1=en:direct reacting bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disabling disease --- r_associated #0: 20 --> bilirubinémie n1=en:disabling disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disease attributes --- r_associated #0: 20 --> bilirubinémie n1=en:disease attributes | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disease of mucous membrane --- r_associated #0: 20 --> bilirubinémie n1=en:disease of mucous membrane | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disease or disorder --- r_associated #0: 20 --> bilirubinémie n1=en:disease or disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disease progression --- r_associated #0: 20 --> bilirubinémie n1=en:disease progression | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of acid-base balance --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of acid-base balance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of aromatic amino acid metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of aromatic amino acid metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of beta alanine, carnosine and/or homocarnosine metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of beta alanine, carnosine and/or homocarnosine metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of blood gas --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of blood gas | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of fluid and/or electrolyte --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of fluid and/or electrolyte | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of glycoprotein metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of glycoprotein metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of glycosaminoglycan metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of glycosaminoglycan metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of iodine metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of iodine metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of ketone metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of ketone metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of lipoprotein and/or lipid metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of lipoprotein and/or lipid metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of mineral metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of mineral metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of neurometabolic regulation --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of neurometabolic regulation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of osmoregulation --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of osmoregulation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of protein metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of protein metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of pyrimidine metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of pyrimidine metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorder of steroid metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorder of steroid metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorders of bilirubin excretion --- r_associated #0: 20 --> bilirubinémie n1=en:disorders of bilirubin excretion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorders of lipoprotein metabolism and other lipidaemias --- r_associated #0: 20 --> bilirubinémie n1=en:disorders of lipoprotein metabolism and other lipidaemias | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorders of porphyrin and bilirubin metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:disorders of porphyrin and bilirubin metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disorders of sphingolipid metabolism and other lipid storage disorders --- r_associated #0: 20 --> bilirubinémie n1=en:disorders of sphingolipid metabolism and other lipid storage disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:disseminated intravascular coagulation adverse event --- r_associated #0: 20 --> bilirubinémie n1=en:disseminated intravascular coagulation adverse event | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:distortion or displacement of body part --- r_associated #0: 20 --> bilirubinémie n1=en:distortion or displacement of body part | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dna repair-deficiency disorders --- r_associated #0: 20 --> bilirubinémie n1=en:dna repair-deficiency disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:drug pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:drug pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:drug-induced pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:drug-induced pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:drugs in tissues --- r_associated #0: 20 --> bilirubinémie n1=en:drugs in tissues | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dubin-johnson syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:dubin-johnson syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dysbiosis --- r_associated #0: 20 --> bilirubinémie n1=en:dysbiosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:dysmotility --- r_associated #0: 20 --> bilirubinémie n1=en:dysmotility | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ectasia --- r_associated #0: 20 --> bilirubinémie n1=en:ectasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ectopic hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:ectopic hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:electrolyte depletion --- r_associated #0: 20 --> bilirubinémie n1=en:electrolyte depletion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:electrolyte disorder --- r_associated #0: 20 --> bilirubinémie n1=en:electrolyte disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:electrolytes abnormal --- r_associated #0: 20 --> bilirubinémie n1=en:electrolytes abnormal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:elevated alkaline phosphatase --- r_associated #0: 20 --> bilirubinémie n1=en:elevated alkaline phosphatase | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:emaciation --- r_associated #0: 20 --> bilirubinémie n1=en:emaciation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:embryologic --- r_associated #0: 20 --> bilirubinémie n1=en:embryologic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:endocrine and metabolic disturbances specific to the fetus and newborn --- r_associated #0: 20 --> bilirubinémie n1=en:endocrine and metabolic disturbances specific to the fetus and newborn | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:endocrine and/or metabolic disorder specific to the fetus or newborn --- r_associated #0: 20 --> bilirubinémie n1=en:endocrine and/or metabolic disorder specific to the fetus or newborn | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:enzyme abnormality (nos) --- r_associated #0: 20 --> bilirubinémie n1=en:enzyme abnormality (nos) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:enzyme induction --- r_associated #0: 20 --> bilirubinémie n1=en:enzyme induction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:enzyme inhibition disorder --- r_associated #0: 20 --> bilirubinémie n1=en:enzyme inhibition disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:enzymology --- r_associated #0: 20 --> bilirubinémie n1=en:enzymology | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:enzymopathy --- r_associated #0: 20 --> bilirubinémie n1=en:enzymopathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:epidemiologic --- r_associated #0: 20 --> bilirubinémie n1=en:epidemiologic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:erythrocyte vacuolization --- r_associated #0: 20 --> bilirubinémie n1=en:erythrocyte vacuolization | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:erythrocytic maturation arrest --- r_associated #0: 20 --> bilirubinémie n1=en:erythrocytic maturation arrest | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:erythromelanosis follicularis of face and/or neck --- r_associated #0: 20 --> bilirubinémie n1=en:erythromelanosis follicularis of face and/or neck | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:erythropenia --- r_associated #0: 20 --> bilirubinémie n1=en:erythropenia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ethanol metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:ethanol metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ethnologic --- r_associated #0: 20 --> bilirubinémie n1=en:ethnologic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:etiology aspects --- r_associated #0: 20 --> bilirubinémie n1=en:etiology aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:exposure as collected domain --- r_associated #0: 20 --> bilirubinémie n1=en:exposure as collected domain | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:extravasation --- r_associated #0: 20 --> bilirubinémie n1=en:extravasation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:extravasation of diagnostic and therapeutic materials --- r_associated #0: 20 --> bilirubinémie n1=en:extravasation of diagnostic and therapeutic materials | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:extravascular hemolysis --- r_associated #0: 20 --> bilirubinémie n1=en:extravascular hemolysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:femoracetabular impingement --- r_associated #0: 20 --> bilirubinémie n1=en:femoracetabular impingement | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:fibroplasia --- r_associated #0: 20 --> bilirubinémie n1=en:fibroplasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:fibrosis --- r_associated #0: 20 --> bilirubinémie n1=en:fibrosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:fluid imbalance --- r_associated #0: 20 --> bilirubinémie n1=en:fluid imbalance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:fluid overload --- r_associated #0: 20 --> bilirubinémie n1=en:fluid overload | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:gallbladder pain adverse event --- r_associated #0: 20 --> bilirubinémie n1=en:gallbladder pain adverse event | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:gamma-glutamyltransferase increased --- r_associated #0: 20 --> bilirubinémie n1=en:gamma-glutamyltransferase increased | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:general pathology --- r_associated #0: 20 --> bilirubinémie n1=en:general pathology | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:genetic aspects --- r_associated #0: 20 --> bilirubinémie n1=en:genetic aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:genomic instability --- r_associated #0: 20 --> bilirubinémie n1=en:genomic instability | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:germ cell depletion --- r_associated #0: 20 --> bilirubinémie n1=en:germ cell depletion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:gilbert syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:gilbert syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:gliosis --- r_associated #0: 20 --> bilirubinémie n1=en:gliosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:glucocorticoid deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:glucocorticoid deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:glucose metabolism abnormal --- r_associated #0: 20 --> bilirubinémie n1=en:glucose metabolism abnormal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:glucose metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:glucose metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:glucose-6-phosphate dehydrogenase deficiency anemia --- r_associated #0: 20 --> bilirubinémie n1=en:glucose-6-phosphate dehydrogenase deficiency anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:goiter --- r_associated #0: 20 --> bilirubinémie n1=en:goiter | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:gout --- r_associated #0: 20 --> bilirubinémie n1=en:gout | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:graft-versus-tumor induction --- r_associated #0: 20 --> bilirubinémie n1=en:graft-versus-tumor induction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:granuloma --- r_associated #0: 20 --> bilirubinémie n1=en:granuloma | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:granulomatosis, orofacial --- r_associated #0: 20 --> bilirubinémie n1=en:granulomatosis, orofacial | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:growth disorders --- r_associated #0: 20 --> bilirubinémie n1=en:growth disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:haemolyses nec --- r_associated #0: 20 --> bilirubinémie n1=en:haemolyses nec | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:haemolysis neonatal --- r_associated #0: 20 --> bilirubinémie n1=en:haemolysis neonatal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hematologic and lymphocytic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:hematologic and lymphocytic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemoglobinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hemoglobinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemoglobinuria --- r_associated #0: 20 --> bilirubinémie n1=en:hemoglobinuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemolytic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:hemolytic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemolytic anemia direct coombs negative --- r_associated #0: 20 --> bilirubinémie n1=en:hemolytic anemia direct coombs negative | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemolytic anemia direct coombs positive --- r_associated #0: 20 --> bilirubinémie n1=en:hemolytic anemia direct coombs positive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemolytic anemia indirect coombs neg --- r_associated #0: 20 --> bilirubinémie n1=en:hemolytic anemia indirect coombs neg | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemolytic jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:hemolytic jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemorrhage --- r_associated #0: 20 --> bilirubinémie n1=en:hemorrhage | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemorrhagic disorders --- r_associated #0: 20 --> bilirubinémie n1=en:hemorrhagic disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemosiderin pigmentation of skin due to venous insufficiency --- r_associated #0: 20 --> bilirubinémie n1=en:hemosiderin pigmentation of skin due to venous insufficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemosiderinuria --- r_associated #0: 20 --> bilirubinémie n1=en:hemosiderinuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hemosiderosis --- r_associated #0: 20 --> bilirubinémie n1=en:hemosiderosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hepatic encephalopathy --- r_associated #0: 20 --> bilirubinémie n1=en:hepatic encephalopathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hepatic: obstructive --- r_associated #0: 20 --> bilirubinémie n1=en:hepatic: obstructive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hepatocellular jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:hepatocellular jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hereditary hyperbilirubinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hereditary hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:heterotopic ossification --- r_associated #0: 20 --> bilirubinémie n1=en:heterotopic ossification | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:historical aspects qualifier --- r_associated #0: 20 --> bilirubinémie n1=en:historical aspects qualifier | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:host-parasite relationship --- r_associated #0: 20 --> bilirubinémie n1=en:host-parasite relationship | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:host-tumor interaction --- r_associated #0: 20 --> bilirubinémie n1=en:host-tumor interaction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyalinization --- r_associated #0: 20 --> bilirubinémie n1=en:hyalinization | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperammonemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperammonemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperamylasemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperamylasemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypercatabolism --- r_associated #0: 20 --> bilirubinémie n1=en:hypercatabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperchloremia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperchloremia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperchromic lesions of pinta --- r_associated #0: 20 --> bilirubinémie n1=en:hyperchromic lesions of pinta | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypercortisolemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypercortisolemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypercreatinaemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypercreatinaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypercreatininaemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypercreatininaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperlactemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperlactemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperlipasaemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperlipasaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperlipidemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperlipidemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperlipoproteinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperlipoproteinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperlysinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperlysinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypermagnesemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypermagnesemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypermelanosis due to hodgkin's disease --- r_associated #0: 20 --> bilirubinémie n1=en:hypermelanosis due to hodgkin's disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypermelanosis following phototherapy for neonatal jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:hypermelanosis following phototherapy for neonatal jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypermelanosis of the eyelids due to hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:hypermelanosis of the eyelids due to hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypermetabolism --- r_associated #0: 20 --> bilirubinémie n1=en:hypermetabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypernatremia --- r_associated #0: 20 --> bilirubinémie n1=en:hypernatremia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperoxalaemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperoxalaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperphosphatasaemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperphosphatasaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperpigmentation of eyelids --- r_associated #0: 20 --> bilirubinémie n1=en:hyperpigmentation of eyelids | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperpipecolatemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperpipecolatemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperplasia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperplasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypersensitivity process --- r_associated #0: 20 --> bilirubinémie n1=en:hypersensitivity process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyperuricemia --- r_associated #0: 20 --> bilirubinémie n1=en:hyperuricemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypervolemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypervolemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypoaldosteronemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypoaldosteronemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypoalphalipoproteinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypoalphalipoproteinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypocellular bone marrow --- r_associated #0: 20 --> bilirubinémie n1=en:hypocellular bone marrow | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypochloremia (disorder) --- r_associated #0: 20 --> bilirubinémie n1=en:hypochloremia (disorder) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypochromic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypochromic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypomagnesemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypomagnesemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypometabolism --- r_associated #0: 20 --> bilirubinémie n1=en:hypometabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hyponatremia --- r_associated #0: 20 --> bilirubinémie n1=en:hyponatremia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypophosphatasia --- r_associated #0: 20 --> bilirubinémie n1=en:hypophosphatasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypopigmentation of eyelid --- r_associated #0: 20 --> bilirubinémie n1=en:hypopigmentation of eyelid | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypoplasia --- r_associated #0: 20 --> bilirubinémie n1=en:hypoplasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypoplastic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypoplastic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypoproteinemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypoproteinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypothyroidic goitre --- r_associated #0: 20 --> bilirubinémie n1=en:hypothyroidic goitre | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:hypovolemia --- r_associated #0: 20 --> bilirubinémie n1=en:hypovolemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:iatrogenic --- r_associated #0: 20 --> bilirubinémie n1=en:iatrogenic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:iatrogenic disease --- r_associated #0: 20 --> bilirubinémie n1=en:iatrogenic disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:icterus gravis of pregnancy --- r_associated #0: 20 --> bilirubinémie n1=en:icterus gravis of pregnancy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ictotest (bilirubin) tab (not for oral use) --- r_associated #0: 20 --> bilirubinémie n1=en:ictotest (bilirubin) tab (not for oral use) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:idarubicin --- r_associated #0: 20 --> bilirubinémie n1=en:idarubicin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:idarubicin hydrochloride --- r_associated #0: 20 --> bilirubinémie n1=en:idarubicin hydrochloride | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:idarubicin hydrochloride 10mg powder for injection solution vial --- r_associated #0: 20 --> bilirubinémie n1=en:idarubicin hydrochloride 10mg powder for injection solution vial | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:idiopathic --- r_associated #0: 20 --> bilirubinémie n1=en:idiopathic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:immunology aspects --- r_associated #0: 20 --> bilirubinémie n1=en:immunology aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:impaired cell membrane integrity --- r_associated #0: 20 --> bilirubinémie n1=en:impaired cell membrane integrity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:impaired cytoskeletal integrity --- r_associated #0: 20 --> bilirubinémie n1=en:impaired cytoskeletal integrity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:impaired healing --- r_associated #0: 20 --> bilirubinémie n1=en:impaired healing | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:impaired tissue integrity --- r_associated #0: 20 --> bilirubinémie n1=en:impaired tissue integrity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:in blood --- r_associated #0: 20 --> bilirubinémie n1=en:in blood | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:in cerebrospinal fluid --- r_associated #0: 20 --> bilirubinémie n1=en:in cerebrospinal fluid | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:in urine --- r_associated #0: 20 --> bilirubinémie n1=en:in urine | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:incontinentia pigmenti --- r_associated #0: 20 --> bilirubinémie n1=en:incontinentia pigmenti | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:increased biliverdin --- r_associated #0: 20 --> bilirubinémie n1=en:increased biliverdin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:indirect coombs test positive --- r_associated #0: 20 --> bilirubinémie n1=en:indirect coombs test positive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:indirect hyperbilirubinemia --- r_associated #0: 20 --> bilirubinémie n1=en:indirect hyperbilirubinemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:induced termination of pregnancy complicated by metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:induced termination of pregnancy complicated by metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:infection --- r_associated #0: 20 --> bilirubinémie n1=en:infection | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:infectious process --- r_associated #0: 20 --> bilirubinémie n1=en:infectious process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:inflammation --- r_associated #0: 20 --> bilirubinémie n1=en:inflammation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:inflammation or infection --- r_associated #0: 20 --> bilirubinémie n1=en:inflammation or infection | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:inherited disorder of bilirubin metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:inherited disorder of bilirubin metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:injection site pigmentation change --- r_associated #0: 20 --> bilirubinémie n1=en:injection site pigmentation change | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:injection site reaction --- r_associated #0: 20 --> bilirubinémie n1=en:injection site reaction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:intoxication --- r_associated #0: 20 --> bilirubinémie n1=en:intoxication | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:intraoperative complication --- r_associated #0: 20 --> bilirubinémie n1=en:intraoperative complication | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:intravasation --- r_associated #0: 20 --> bilirubinémie n1=en:intravasation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:intravascular hemolysis --- r_associated #0: 20 --> bilirubinémie n1=en:intravascular hemolysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:invasion --- r_associated #0: 20 --> bilirubinémie n1=en:invasion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:iron metabolism disorders --- r_associated #0: 20 --> bilirubinémie n1=en:iron metabolism disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:iron-deficiency anemia --- r_associated #0: 20 --> bilirubinémie n1=en:iron-deficiency anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:irritation/irritant --- r_associated #0: 20 --> bilirubinémie n1=en:irritation/irritant | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ischemia --- r_associated #0: 20 --> bilirubinémie n1=en:ischemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:jaundice (not of newborn) --- r_associated #0: 20 --> bilirubinémie n1=en:jaundice (not of newborn) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:jaundice extrahepatic obstructive --- r_associated #0: 20 --> bilirubinémie n1=en:jaundice extrahepatic obstructive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:karyomegaly --- r_associated #0: 20 --> bilirubinémie n1=en:karyomegaly | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:kernicterus --- r_associated #0: 20 --> bilirubinémie n1=en:kernicterus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:kidney crystallization --- r_associated #0: 20 --> bilirubinémie n1=en:kidney crystallization | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lab error false positive --- r_associated #0: 20 --> bilirubinémie n1=en:lab error false positive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:labial melanin incontinence --- r_associated #0: 20 --> bilirubinémie n1=en:labial melanin incontinence | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:laboratory abnormalities --- r_associated #0: 20 --> bilirubinémie n1=en:laboratory abnormalities | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lactose intolerance --- r_associated #0: 20 --> bilirubinémie n1=en:lactose intolerance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:langerhans cell histiocytosis --- r_associated #0: 20 --> bilirubinémie n1=en:langerhans cell histiocytosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lentigo --- r_associated #0: 20 --> bilirubinémie n1=en:lentigo | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lentigo - freckle --- r_associated #0: 20 --> bilirubinémie n1=en:lentigo - freckle | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:leukoaraiosis --- r_associated #0: 20 --> bilirubinémie n1=en:leukoaraiosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:leukocytosis --- r_associated #0: 20 --> bilirubinémie n1=en:leukocytosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:leukoderma --- r_associated #0: 20 --> bilirubinémie n1=en:leukoderma | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lipid metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:lipid metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lipids abnormal --- r_associated #0: 20 --> bilirubinémie n1=en:lipids abnormal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lipodystrophy --- r_associated #0: 20 --> bilirubinémie n1=en:lipodystrophy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lithiasis --- r_associated #0: 20 --> bilirubinémie n1=en:lithiasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:liver function test --- r_associated #0: 20 --> bilirubinémie n1=en:liver function test | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:liver tender --- r_associated #0: 20 --> bilirubinémie n1=en:liver tender | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:local exogenous pigmentation of oral soft tissue --- r_associated #0: 20 --> bilirubinémie n1=en:local exogenous pigmentation of oral soft tissue | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:localized metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:localized metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:long term adverse effects --- r_associated #0: 20 --> bilirubinémie n1=en:long term adverse effects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:lysosomal storage disease --- r_associated #0: 20 --> bilirubinémie n1=en:lysosomal storage disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:macroamylasemia --- r_associated #0: 20 --> bilirubinémie n1=en:macroamylasemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:macrocytic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:macrocytic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:macular pigment deposit --- r_associated #0: 20 --> bilirubinémie n1=en:macular pigment deposit | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:malabsorption syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:malabsorption syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:malakoplakia --- r_associated #0: 20 --> bilirubinémie n1=en:malakoplakia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:malarial pigment deposition --- r_associated #0: 20 --> bilirubinémie n1=en:malarial pigment deposition | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:maleformatio ectodermalis generalisata of bafverstedt --- r_associated #0: 20 --> bilirubinémie n1=en:maleformatio ectodermalis generalisata of bafverstedt | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:malignant neoplasm --- r_associated #0: 20 --> bilirubinémie n1=en:malignant neoplasm | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:march hemoglobinuria --- r_associated #0: 20 --> bilirubinémie n1=en:march hemoglobinuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:marine lenhart syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:marine lenhart syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:medical complication --- r_associated #0: 20 --> bilirubinémie n1=en:medical complication | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:medulloadrenal hyperfunction --- r_associated #0: 20 --> bilirubinémie n1=en:medulloadrenal hyperfunction | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:megaloblastic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:megaloblastic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:megaloblastic anemia due to folate deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:megaloblastic anemia due to folate deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:melanin pigmentation of eye --- r_associated #0: 20 --> bilirubinémie n1=en:melanin pigmentation of eye | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:melanoderma (disorder) --- r_associated #0: 20 --> bilirubinémie n1=en:melanoderma (disorder) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:melanodermatitis toxica lichenoides --- r_associated #0: 20 --> bilirubinémie n1=en:melanodermatitis toxica lichenoides | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:melanosis --- r_associated #0: 20 --> bilirubinémie n1=en:melanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:melasma --- r_associated #0: 20 --> bilirubinémie n1=en:melasma | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:menstrual disorder --- r_associated #0: 20 --> bilirubinémie n1=en:menstrual disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mercury pigmentation of skin --- r_associated #0: 20 --> bilirubinémie n1=en:mercury pigmentation of skin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mesangiolysis --- r_associated #0: 20 --> bilirubinémie n1=en:mesangiolysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic acidosis --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic acidosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic and genetic disorder affecting the liver --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic and genetic disorder affecting the liver | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic aspects --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic bone disorder --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic bone disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorder following molar and/or ectopic pregnancy --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorder following molar and/or ectopic pregnancy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorder of fetus --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorder of fetus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorder of transport --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorder of transport | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorders following abortion and ectopic and molar pregnancy --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorders following abortion and ectopic and molar pregnancy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic disorders nec --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic disorders nec | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic renal disease --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic renal disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metabolic syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:metabolic syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metal metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:metal metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metaplasia --- r_associated #0: 20 --> bilirubinémie n1=en:metaplasia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:metastasis --- r_associated #0: 20 --> bilirubinémie n1=en:metastasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:methionine adenosyltransferase deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:methionine adenosyltransferase deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:microbiological --- r_associated #0: 20 --> bilirubinémie n1=en:microbiological | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:microcytic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:microcytic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:microgliosis --- r_associated #0: 20 --> bilirubinémie n1=en:microgliosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mineralocorticoid deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:mineralocorticoid deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mitochondrial cytopathy --- r_associated #0: 20 --> bilirubinémie n1=en:mitochondrial cytopathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mitochondrial damage --- r_associated #0: 20 --> bilirubinémie n1=en:mitochondrial damage | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mitochondrial diseases --- r_associated #0: 20 --> bilirubinémie n1=en:mitochondrial diseases | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mitochondrial enzyme deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:mitochondrial enzyme deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:mottled pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:mottled pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:muscle weakness --- r_associated #0: 20 --> bilirubinémie n1=en:muscle weakness | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:myositic disorders --- r_associated #0: 20 --> bilirubinémie n1=en:myositic disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:myxedema coma --- r_associated #0: 20 --> bilirubinémie n1=en:myxedema coma | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:necrosis adrenal cortex --- r_associated #0: 20 --> bilirubinémie n1=en:necrosis adrenal cortex | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:necrotic process --- r_associated #0: 20 --> bilirubinémie n1=en:necrotic process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neointima --- r_associated #0: 20 --> bilirubinémie n1=en:neointima | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neonatal jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:neonatal jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neonatal transient jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:neonatal transient jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neoplastic processes --- r_associated #0: 20 --> bilirubinémie n1=en:neoplastic processes | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neovascularization --- r_associated #0: 20 --> bilirubinémie n1=en:neovascularization | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nerve degeneration --- r_associated #0: 20 --> bilirubinémie n1=en:nerve degeneration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neurocutaneous melanosis sequence --- r_associated #0: 20 --> bilirubinémie n1=en:neurocutaneous melanosis sequence | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neuronal ceroid lipofuscinosis type 3 --- r_associated #0: 20 --> bilirubinémie n1=en:neuronal ceroid lipofuscinosis type 3 | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:neurotropism --- r_associated #0: 20 --> bilirubinémie n1=en:neurotropism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nickel metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:nickel metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:no drug effect --- r_associated #0: 20 --> bilirubinémie n1=en:no drug effect | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:normocytic anemia --- r_associated #0: 20 --> bilirubinémie n1=en:normocytic anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:north american indian intrahepatic cholestasis --- r_associated #0: 20 --> bilirubinémie n1=en:north american indian intrahepatic cholestasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nursing therapy --- r_associated #0: 20 --> bilirubinémie n1=en:nursing therapy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nutritional and metabolic cardiomyopathy --- r_associated #0: 20 --> bilirubinémie n1=en:nutritional and metabolic cardiomyopathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nutritional and metabolic disorders in diseases classified elsewhere --- r_associated #0: 20 --> bilirubinémie n1=en:nutritional and metabolic disorders in diseases classified elsewhere | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nutritional disorder --- r_associated #0: 20 --> bilirubinémie n1=en:nutritional disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:nutritional management --- r_associated #0: 20 --> bilirubinémie n1=en:nutritional management | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:obstructive jaundice --- r_associated #0: 20 --> bilirubinémie n1=en:obstructive jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ochronosis --- r_associated #0: 20 --> bilirubinémie n1=en:ochronosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ochronotic arthritis --- r_associated #0: 20 --> bilirubinémie n1=en:ochronotic arthritis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ocular icterus --- r_associated #0: 20 --> bilirubinémie n1=en:ocular icterus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:oncosis --- r_associated #0: 20 --> bilirubinémie n1=en:oncosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:onset of illness --- r_associated #0: 20 --> bilirubinémie n1=en:onset of illness | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:organic acid metabolism disorder --- r_associated #0: 20 --> bilirubinémie n1=en:organic acid metabolism disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other disorders of amino-acid metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:other disorders of amino-acid metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other disorders of carbohydrate metabolism --- r_associated #0: 20 --> bilirubinémie n1=en:other disorders of carbohydrate metabolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other disorders of fluid, electrolyte and acid-base balance --- r_associated #0: 20 --> bilirubinémie n1=en:other disorders of fluid, electrolyte and acid-base balance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other metabolic disorders --- r_associated #0: 20 --> bilirubinémie n1=en:other metabolic disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other specified metabolic disorders --- r_associated #0: 20 --> bilirubinémie n1=en:other specified metabolic disorders | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other symptoms concerning nutrition, metabolism, and development --- r_associated #0: 20 --> bilirubinémie n1=en:other symptoms concerning nutrition, metabolism, and development | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:other transitory neonatal endocrine and metabolic disturbances --- r_associated #0: 20 --> bilirubinémie n1=en:other transitory neonatal endocrine and metabolic disturbances | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:oxalosis --- r_associated #0: 20 --> bilirubinémie n1=en:oxalosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pallor --- r_associated #0: 20 --> bilirubinémie n1=en:pallor | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pancreatic trypsinogen deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:pancreatic trypsinogen deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:parasitology --- r_associated #0: 20 --> bilirubinémie n1=en:parasitology | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:parenteral nutrition associated liver disease --- r_associated #0: 20 --> bilirubinémie n1=en:parenteral nutrition associated liver disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathogenesis --- r_associated #0: 20 --> bilirubinémie n1=en:pathogenesis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathologic hemolysis --- r_associated #0: 20 --> bilirubinémie n1=en:pathologic hemolysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathologic process --- r_associated #0: 20 --> bilirubinémie n1=en:pathologic process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathological accumulation of air in tissues --- r_associated #0: 20 --> bilirubinémie n1=en:pathological accumulation of air in tissues | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathological aspects --- r_associated #0: 20 --> bilirubinémie n1=en:pathological aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pathological developmental process --- r_associated #0: 20 --> bilirubinémie n1=en:pathological developmental process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:penile hypermelanosis --- r_associated #0: 20 --> bilirubinémie n1=en:penile hypermelanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:peri-nipple pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:peri-nipple pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:periorbital hypermelanosis --- r_associated #0: 20 --> bilirubinémie n1=en:periorbital hypermelanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:permissiveness --- r_associated #0: 20 --> bilirubinémie n1=en:permissiveness | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:peutz-jeghers syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:peutz-jeghers syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pharmacotherapeutic --- r_associated #0: 20 --> bilirubinémie n1=en:pharmacotherapeutic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:phosphorus metabolic disorder --- r_associated #0: 20 --> bilirubinémie n1=en:phosphorus metabolic disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:physiopathological --- r_associated #0: 20 --> bilirubinémie n1=en:physiopathological | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigment nephropathy --- r_associated #0: 20 --> bilirubinémie n1=en:pigment nephropathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmentary change in skin --- r_associated #0: 20 --> bilirubinémie n1=en:pigmentary change in skin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmentation changes nec --- r_associated #0: 20 --> bilirubinémie n1=en:pigmentation changes nec | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmented oral mucosal lesion --- r_associated #0: 20 --> bilirubinémie n1=en:pigmented oral mucosal lesion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmented purpuric lichenoid dermatitis of gougerot and blum --- r_associated #0: 20 --> bilirubinémie n1=en:pigmented purpuric lichenoid dermatitis of gougerot and blum | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmented scar --- r_associated #0: 20 --> bilirubinémie n1=en:pigmented scar | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pigmented skin lesion --- r_associated #0: 20 --> bilirubinémie n1=en:pigmented skin lesion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pituitary hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:pituitary hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:poikiloderma of civatte --- r_associated #0: 20 --> bilirubinémie n1=en:poikiloderma of civatte | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:poikilodermatomyositis --- r_associated #0: 20 --> bilirubinémie n1=en:poikilodermatomyositis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:polydipsia --- r_associated #0: 20 --> bilirubinémie n1=en:polydipsia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:polysyndactyly --- r_associated #0: 20 --> bilirubinémie n1=en:polysyndactyly | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:polyuria --- r_associated #0: 20 --> bilirubinémie n1=en:polyuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:porphyria --- r_associated #0: 20 --> bilirubinémie n1=en:porphyria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:porphyruria --- r_associated #0: 20 --> bilirubinémie n1=en:porphyruria | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:postcholecystectomy syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:postcholecystectomy syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:postinflammatory skin pigmentation change --- r_associated #0: 20 --> bilirubinémie n1=en:postinflammatory skin pigmentation change | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:postoperative complications --- r_associated #0: 20 --> bilirubinémie n1=en:postoperative complications | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:postprocedural endocrine and metabolic disorders, not elsewhere classified --- r_associated #0: 20 --> bilirubinémie n1=en:postprocedural endocrine and metabolic disorders, not elsewhere classified | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:postprocedural hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:postprocedural hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:potassium abnormality --- r_associated #0: 20 --> bilirubinémie n1=en:potassium abnormality | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pre-fetal/death --- r_associated #0: 20 --> bilirubinémie n1=en:pre-fetal/death | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:precancerous melanosis --- r_associated #0: 20 --> bilirubinémie n1=en:precancerous melanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:primary hyperthyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:primary hyperthyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:primary hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:primary hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:prognosis --- r_associated #0: 20 --> bilirubinémie n1=en:prognosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:progressive familial intrahepatic cholestasis --- r_associated #0: 20 --> bilirubinémie n1=en:progressive familial intrahepatic cholestasis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:protein aggregation, pathological --- r_associated #0: 20 --> bilirubinémie n1=en:protein aggregation, pathological | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:proteinosis --- r_associated #0: 20 --> bilirubinémie n1=en:proteinosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:proteostasis deficiencies --- r_associated #0: 20 --> bilirubinémie n1=en:proteostasis deficiencies | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pseudoatrophoderma colli --- r_associated #0: 20 --> bilirubinémie n1=en:pseudoatrophoderma colli | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pseudogout --- r_associated #0: 20 --> bilirubinémie n1=en:pseudogout | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pseudomembrane formation --- r_associated #0: 20 --> bilirubinémie n1=en:pseudomembrane formation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:pseudophaeochromocytoma --- r_associated #0: 20 --> bilirubinémie n1=en:pseudophaeochromocytoma | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:psychogenic --- r_associated #0: 20 --> bilirubinémie n1=en:psychogenic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:psychology qualifier --- r_associated #0: 20 --> bilirubinémie n1=en:psychology qualifier | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:purine-pyrimidine metabolism, inborn errors --- r_associated #0: 20 --> bilirubinémie n1=en:purine-pyrimidine metabolism, inborn errors | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:radiation damage --- r_associated #0: 20 --> bilirubinémie n1=en:radiation damage | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:radiotherapeutic --- r_associated #0: 20 --> bilirubinémie n1=en:radiotherapeutic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:rbc count low --- r_associated #0: 20 --> bilirubinémie n1=en:rbc count low | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:recurrence (disease attribute) --- r_associated #0: 20 --> bilirubinémie n1=en:recurrence (disease attribute) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:refeeding syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:refeeding syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:refractory anemia --- r_associated #0: 20 --> bilirubinémie n1=en:refractory anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:rehabilitation aspects --- r_associated #0: 20 --> bilirubinémie n1=en:rehabilitation aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:remission/regression --- r_associated #0: 20 --> bilirubinémie n1=en:remission/regression | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:renal secondary osteodystrophia fibrosa --- r_associated #0: 20 --> bilirubinémie n1=en:renal secondary osteodystrophia fibrosa | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:respiratory aspiration --- r_associated #0: 20 --> bilirubinémie n1=en:respiratory aspiration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:retinal depigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:retinal depigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:retropneumoperitoneum --- r_associated #0: 20 --> bilirubinémie n1=en:retropneumoperitoneum | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:riehl's melanosis --- r_associated #0: 20 --> bilirubinémie n1=en:riehl's melanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:roentgenographic --- r_associated #0: 20 --> bilirubinémie n1=en:roentgenographic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:rotor syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:rotor syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:rowley-rosenberg syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:rowley-rosenberg syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:salt-wasting syndrome of infancy --- r_associated #0: 20 --> bilirubinémie n1=en:salt-wasting syndrome of infancy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:schambergs disease --- r_associated #0: 20 --> bilirubinémie n1=en:schambergs disease | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:schistosomal pigment deposition --- r_associated #0: 20 --> bilirubinémie n1=en:schistosomal pigment deposition | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:scleroderma-associated hypermelanosis --- r_associated #0: 20 --> bilirubinémie n1=en:scleroderma-associated hypermelanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:sclerosis --- r_associated #0: 20 --> bilirubinémie n1=en:sclerosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:secondary adrenal insufficiency --- r_associated #0: 20 --> bilirubinémie n1=en:secondary adrenal insufficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:serum bilirubin raised --- r_associated #0: 20 --> bilirubinémie n1=en:serum bilirubin raised | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:serum indirect bilirubin --- r_associated #0: 20 --> bilirubinémie n1=en:serum indirect bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:serum total bilirubin measurement --- r_associated #0: 20 --> bilirubinémie n1=en:serum total bilirubin measurement | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:shock --- r_associated #0: 20 --> bilirubinémie n1=en:shock | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:siadh --- r_associated #0: 20 --> bilirubinémie n1=en:siadh | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin discoloration --- r_associated #0: 20 --> bilirubinémie n1=en:skin discoloration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin diseases, metabolic --- r_associated #0: 20 --> bilirubinémie n1=en:skin diseases, metabolic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin hyperpigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:skin hyperpigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin hypopigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:skin hypopigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:skin pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:skin pigmentation disorder --- r_associated #0: 20 --> bilirubinémie n1=en:skin pigmentation disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:speckled lentiginous nevus --- r_associated #0: 20 --> bilirubinémie n1=en:speckled lentiginous nevus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:sphingolipidosis --- r_associated #0: 20 --> bilirubinémie n1=en:sphingolipidosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:spot pigmented --- r_associated #0: 20 --> bilirubinémie n1=en:spot pigmented | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:stauffer's syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:stauffer's syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:stromal corneal pigmentation --- r_associated #0: 20 --> bilirubinémie n1=en:stromal corneal pigmentation | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:suppuration --- r_associated #0: 20 --> bilirubinémie n1=en:suppuration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:surgical aspects --- r_associated #0: 20 --> bilirubinémie n1=en:surgical aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:symptoms concerning nutrition, metabolism, and development --- r_associated #0: 20 --> bilirubinémie n1=en:symptoms concerning nutrition, metabolism, and development | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:synthetic defect of bile acids --- r_associated #0: 20 --> bilirubinémie n1=en:synthetic defect of bile acids | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:taxonomic --- r_associated #0: 20 --> bilirubinémie n1=en:taxonomic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:teratogenic effect --- r_associated #0: 20 --> bilirubinémie n1=en:teratogenic effect | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tertiary hypothyroidism --- r_associated #0: 20 --> bilirubinémie n1=en:tertiary hypothyroidism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:therapeutic aspects --- r_associated #0: 20 --> bilirubinémie n1=en:therapeutic aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:thyroid associated opthalmopathies --- r_associated #0: 20 --> bilirubinémie n1=en:thyroid associated opthalmopathies | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:thyroid storm --- r_associated #0: 20 --> bilirubinémie n1=en:thyroid storm | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:thyrotoxic cardiomyopathy --- r_associated #0: 20 --> bilirubinémie n1=en:thyrotoxic cardiomyopathy | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:thyrotoxic periodic paralysis --- r_associated #0: 20 --> bilirubinémie n1=en:thyrotoxic periodic paralysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tissue lysis --- r_associated #0: 20 --> bilirubinémie n1=en:tissue lysis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tonicity disorder --- r_associated #0: 20 --> bilirubinémie n1=en:tonicity disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tophus --- r_associated #0: 20 --> bilirubinémie n1=en:tophus | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:toxic goiter --- r_associated #0: 20 --> bilirubinémie n1=en:toxic goiter | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:toxic nodular goiter --- r_associated #0: 20 --> bilirubinémie n1=en:toxic nodular goiter | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:traumatic --- r_associated #0: 20 --> bilirubinémie n1=en:traumatic | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tumor embolism --- r_associated #0: 20 --> bilirubinémie n1=en:tumor embolism | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tumor immunity --- r_associated #0: 20 --> bilirubinémie n1=en:tumor immunity | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tumor lysis syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:tumor lysis syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:tumor-associated process --- r_associated #0: 20 --> bilirubinémie n1=en:tumor-associated process | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:ulceration --- r_associated #0: 20 --> bilirubinémie n1=en:ulceration | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:universal acquired melanosis --- r_associated #0: 20 --> bilirubinémie n1=en:universal acquired melanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn --- r_associated #0: 20 --> bilirubinémie n1=en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:uremia --- r_associated #0: 20 --> bilirubinémie n1=en:uremia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:urine bilirubin tests --- r_associated #0: 20 --> bilirubinémie n1=en:urine bilirubin tests | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:urticaria pigmentosa/maculopapular cutaneous mastocytosis --- r_associated #0: 20 --> bilirubinémie n1=en:urticaria pigmentosa/maculopapular cutaneous mastocytosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:use of ultrasonography --- r_associated #0: 20 --> bilirubinémie n1=en:use of ultrasonography | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:vascular remodeling --- r_associated #0: 20 --> bilirubinémie n1=en:vascular remodeling | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:venous thrombosis --- r_associated #0: 20 --> bilirubinémie n1=en:venous thrombosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:veterinary aspects --- r_associated #0: 20 --> bilirubinémie n1=en:veterinary aspects | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:viruses --- r_associated #0: 20 --> bilirubinémie n1=en:viruses | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:vitamin b12 deficiency anemia --- r_associated #0: 20 --> bilirubinémie n1=en:vitamin b12 deficiency anemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:vitiligo --- r_associated #0: 20 --> bilirubinémie n1=en:vitiligo | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:vitiligo iridis --- r_associated #0: 20 --> bilirubinémie n1=en:vitiligo iridis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:vulvovaginal hypermelanosis --- r_associated #0: 20 --> bilirubinémie n1=en:vulvovaginal hypermelanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:wasting syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:wasting syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:water intoxication --- r_associated #0: 20 --> bilirubinémie n1=en:water intoxication | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:water-electrolyte imbalance --- r_associated #0: 20 --> bilirubinémie n1=en:water-electrolyte imbalance | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:xeroderma pigmentosum --- r_associated #0: 20 --> bilirubinémie n1=en:xeroderma pigmentosum | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:yang deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:yang deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:yellow complexion --- r_associated #0: 20 --> bilirubinémie n1=en:yellow complexion | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:yellow nail syndrome --- r_associated #0: 20 --> bilirubinémie n1=en:yellow nail syndrome | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:yin deficiency --- r_associated #0: 20 --> bilirubinémie n1=en:yin deficiency | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 en:zinc deficiency disorder --- r_associated #0: 20 --> bilirubinémie n1=en:zinc deficiency disorder | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 excès --- r_associated #0: 20 --> bilirubinémie n1=excès | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie aggravée --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie aggravée | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie conjuguée --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de la prématurité --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de la prématurité | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de type 1 --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de type 1 | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de type Rotor --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de type Rotor | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de type i --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de type i | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de type ii --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de type ii | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie de type indirect bénin --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie de type indirect bénin | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie directe du nouveau-né --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie directe du nouveau-né | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie extracorporelle --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie extracorporelle | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie héréditaire --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie héréditaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie indirecte des nouveau-nés --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie indirecte des nouveau-nés | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie indirecte du nouveau-né --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie indirecte du nouveau-né | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie non conjuguée --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie non conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie non conjuguée héréditaire --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie non conjuguée héréditaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie non conjuguée prémenstruelle cyclique --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie non conjuguée prémenstruelle cyclique | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie obstructive --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie obstructive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 hyperbilirubinémie type 2 --- r_associated #0: 20 --> bilirubinémie n1=hyperbilirubinémie type 2 | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 ictère --- r_associated #0: 20 --> bilirubinémie n1=ictère | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 ictère héréditaire de gilbert --- r_associated #0: 20 --> bilirubinémie n1=ictère héréditaire de gilbert | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 ictère nucléaire --- r_associated #0: 20 --> bilirubinémie n1=ictère nucléaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 ictère néonatal --- r_associated #0: 20 --> bilirubinémie n1=ictère néonatal | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 ictère (jaunisse) --- r_associated #0: 20 --> bilirubinémie n1=ictère (jaunisse) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 jaunisse (médecine) --- r_associated #0: 20 --> bilirubinémie n1=jaunisse (médecine) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 maladie de Gilbert --- r_associated #0: 20 --> bilirubinémie n1=maladie de Gilbert | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 maladie (médecine) --- r_associated #0: 20 --> bilirubinémie n1=maladie (médecine) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 maladie (médecine, être humain) --- r_associated #0: 20 --> bilirubinémie n1=maladie (médecine, être humain) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 marasme nutritionnel --- r_associated #0: 20 --> bilirubinémie n1=marasme nutritionnel | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 pathologie --- r_associated #0: 20 --> bilirubinémie n1=pathologie | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 sang --- r_associated #0: 20 --> bilirubinémie n1=sang | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 sang (hémoglobine) --- r_associated #0: 20 --> bilirubinémie n1=sang (hémoglobine) | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 subictère chronique intermittent --- r_associated #0: 20 --> bilirubinémie n1=subictère chronique intermittent | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 syndrome cachectique dû au vih --- r_associated #0: 20 --> bilirubinémie n1=syndrome cachectique dû au vih | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 syndrome de Gilbert --- r_associated #0: 20 --> bilirubinémie n1=syndrome de Gilbert | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 syndrome de cachexie --- r_associated #0: 20 --> bilirubinémie n1=syndrome de cachexie | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 syndrome de cachexie progressive --- r_associated #0: 20 --> bilirubinémie n1=syndrome de cachexie progressive | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 syndrome de dépérissement --- r_associated #0: 20 --> bilirubinémie n1=syndrome de dépérissement | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 système digestif --- r_associated #0: 20 --> bilirubinémie n1=système digestif | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 taux de la bilirubine dans le sang --- r_associated #0: 20 --> bilirubinémie n1=taux de la bilirubine dans le sang | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 vitiligo --- r_associated #0: 20 --> bilirubinémie n1=vitiligo | n2=bilirubinémie | rel=r_associated | relid=0 | w=20 bilirubine conjuguée --- r_associated #0: 16 --> bilirubinémie n1=bilirubine conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=16 altération de l'état général --- r_associated #0: 15 --> bilirubinémie n1=altération de l'état général | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 anémie médullaire --- r_associated #0: 15 --> bilirubinémie n1=anémie médullaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 arrêt de la maturation des globules rouges --- r_associated #0: 15 --> bilirubinémie n1=arrêt de la maturation des globules rouges | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 arrêt de la maturation érythroïde --- r_associated #0: 15 --> bilirubinémie n1=arrêt de la maturation érythroïde | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilifuscine --- r_associated #0: 15 --> bilirubinémie n1=bilifuscine | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 biligraphie --- r_associated #0: 15 --> bilirubinémie n1=biligraphie | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 biligraphie intraveineuse --- r_associated #0: 15 --> bilirubinémie n1=biligraphie intraveineuse | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 biligénèse --- r_associated #0: 15 --> bilirubinémie n1=biligénèse | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilirubinamnie --- r_associated #0: 15 --> bilirubinémie n1=bilirubinamnie | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilirubine directe --- r_associated #0: 15 --> bilirubinémie n1=bilirubine directe | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilirubine indirecte --- r_associated #0: 15 --> bilirubinémie n1=bilirubine indirecte | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilirubine non conjuguée --- r_associated #0: 15 --> bilirubinémie n1=bilirubine non conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 bilirubinurie --- r_associated #0: 15 --> bilirubinémie n1=bilirubinurie | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 biliverdine --- r_associated #0: 15 --> bilirubinémie n1=biliverdine | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 biliverdinoglobine --- r_associated #0: 15 --> bilirubinémie n1=biliverdinoglobine | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 cholémie de gilbert --- r_associated #0: 15 --> bilirubinémie n1=cholémie de gilbert | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 coma hépatique --- r_associated #0: 15 --> bilirubinémie n1=coma hépatique | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 dysrythmie cardiaque --- r_associated #0: 15 --> bilirubinémie n1=dysrythmie cardiaque | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 encéphalopathie hépato-cérébrale --- r_associated #0: 15 --> bilirubinémie n1=encéphalopathie hépato-cérébrale | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 encéphalopathie porto-cave --- r_associated #0: 15 --> bilirubinémie n1=encéphalopathie porto-cave | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 hypophosphatasie --- r_associated #0: 15 --> bilirubinémie n1=hypophosphatasie | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 non précisée, anémie aplasique --- r_associated #0: 15 --> bilirubinémie n1=non précisée, anémie aplasique | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 ossification ectopique --- r_associated #0: 15 --> bilirubinémie n1=ossification ectopique | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 ossification pathologique --- r_associated #0: 15 --> bilirubinémie n1=ossification pathologique | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 parésie musculaire --- r_associated #0: 15 --> bilirubinémie n1=parésie musculaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 soif excessive --- r_associated #0: 15 --> bilirubinémie n1=soif excessive | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 syndrome cachectique --- r_associated #0: 15 --> bilirubinémie n1=syndrome cachectique | n2=bilirubinémie | rel=r_associated | relid=0 | w=15 Bilirubine --- r_associated #0: 11 --> bilirubinémie n1=Bilirubine | n2=bilirubinémie | rel=r_associated | relid=0 | w=11 Biliverdine --- r_associated #0: 10 --> bilirubinémie n1=Biliverdine | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 Chola --- r_associated #0: 10 --> bilirubinémie n1=Chola | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 acromégalie --- r_associated #0: 10 --> bilirubinémie n1=acromégalie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 albinisme --- r_associated #0: 10 --> bilirubinémie n1=albinisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 amyloïdose --- r_associated #0: 10 --> bilirubinémie n1=amyloïdose | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 angiocholite --- r_associated #0: 10 --> bilirubinémie n1=angiocholite | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 angiocholécystographie --- r_associated #0: 10 --> bilirubinémie n1=angiocholécystographie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 angiocholégraphie --- r_associated #0: 10 --> bilirubinémie n1=angiocholégraphie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anomalie chromosomique --- r_associated #0: 10 --> bilirubinémie n1=anomalie chromosomique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anormalité des chromosomes --- r_associated #0: 10 --> bilirubinémie n1=anormalité des chromosomes | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anémie --- r_associated #0: 10 --> bilirubinémie n1=anémie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anémie aplasique --- r_associated #0: 10 --> bilirubinémie n1=anémie aplasique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anémie aplasique non précisée --- r_associated #0: 10 --> bilirubinémie n1=anémie aplasique non précisée | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anémie hypoplasique --- r_associated #0: 10 --> bilirubinémie n1=anémie hypoplasique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 anémie par hypoplasie médullaire --- r_associated #0: 10 --> bilirubinémie n1=anémie par hypoplasie médullaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 aplasie médullaire --- r_associated #0: 10 --> bilirubinémie n1=aplasie médullaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 aplasie érythrocytaire --- r_associated #0: 10 --> bilirubinémie n1=aplasie érythrocytaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 arythmie cardiaque --- r_associated #0: 10 --> bilirubinémie n1=arythmie cardiaque | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 autoimmune --- r_associated #0: 10 --> bilirubinémie n1=autoimmune | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 blocage de maturation érythrocytaire --- r_associated #0: 10 --> bilirubinémie n1=blocage de maturation érythrocytaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 cachexie --- r_associated #0: 10 --> bilirubinémie n1=cachexie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 channelopathies --- r_associated #0: 10 --> bilirubinémie n1=channelopathies | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 cholangio --- r_associated #0: 10 --> bilirubinémie n1=cholangio | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 cholangiographie --- r_associated #0: 10 --> bilirubinémie n1=cholangiographie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 cholangiographies --- r_associated #0: 10 --> bilirubinémie n1=cholangiographies | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 cholélithiase --- r_associated #0: 10 --> bilirubinémie n1=cholélithiase | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 déplétion volémique --- r_associated #0: 10 --> bilirubinémie n1=déplétion volémique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:amniotic bilirubin --- r_associated #0: 10 --> bilirubinémie n1=en:amniotic bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:bilfuscin --- r_associated #0: 10 --> bilirubinémie n1=en:bilfuscin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:biligenesis --- r_associated #0: 10 --> bilirubinémie n1=en:biligenesis | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:biligraphy --- r_associated #0: 10 --> bilirubinémie n1=en:biligraphy | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:bilirubinuria --- r_associated #0: 10 --> bilirubinémie n1=en:bilirubinuria | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:biliverdine --- r_associated #0: 10 --> bilirubinémie n1=en:biliverdine | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:biliverdinoglobin --- r_associated #0: 10 --> bilirubinémie n1=en:biliverdinoglobin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:conjugated bilirubin --- r_associated #0: 10 --> bilirubinémie n1=en:conjugated bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:direct-reacting bilirubin --- r_associated #0: 10 --> bilirubinémie n1=en:direct-reacting bilirubin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:erythroblastosis fetalis --- r_associated #0: 10 --> bilirubinémie n1=en:erythroblastosis fetalis | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:histiocytosis, langerhans-cell --- r_associated #0: 10 --> bilirubinémie n1=en:histiocytosis, langerhans-cell | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:jaundice, obstructive --- r_associated #0: 10 --> bilirubinémie n1=en:jaundice, obstructive | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 en:paresis --- r_associated #0: 10 --> bilirubinémie n1=en:paresis | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 encéphalopathie hépatique --- r_associated #0: 10 --> bilirubinémie n1=encéphalopathie hépatique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 enzymopathie --- r_associated #0: 10 --> bilirubinémie n1=enzymopathie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 faiblesse de muscle --- r_associated #0: 10 --> bilirubinémie n1=faiblesse de muscle | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 faiblesse du muscle --- r_associated #0: 10 --> bilirubinémie n1=faiblesse du muscle | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 faiblesse musculaire --- r_associated #0: 10 --> bilirubinémie n1=faiblesse musculaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 histiocytose à cellules de langerhans --- r_associated #0: 10 --> bilirubinémie n1=histiocytose à cellules de langerhans | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 hyperthyroïdisme --- r_associated #0: 10 --> bilirubinémie n1=hyperthyroïdisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 hypervolémie --- r_associated #0: 10 --> bilirubinémie n1=hypervolémie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 hypométabolisme --- r_associated #0: 10 --> bilirubinémie n1=hypométabolisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 hypophosphatasies --- r_associated #0: 10 --> bilirubinémie n1=hypophosphatasies | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 hypothyroïdisme --- r_associated #0: 10 --> bilirubinémie n1=hypothyroïdisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 ictère obstructif --- r_associated #0: 10 --> bilirubinémie n1=ictère obstructif | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 idarubicine --- r_associated #0: 10 --> bilirubinémie n1=idarubicine | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 incontinentia pigmenti --- r_associated #0: 10 --> bilirubinémie n1=incontinentia pigmenti | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 intravasation --- r_associated #0: 10 --> bilirubinémie n1=intravasation | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 leukoderma --- r_associated #0: 10 --> bilirubinémie n1=leukoderma | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 lipodystrophie --- r_associated #0: 10 --> bilirubinémie n1=lipodystrophie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 maladie enzymatique --- r_associated #0: 10 --> bilirubinémie n1=maladie enzymatique | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 melanosis --- r_associated #0: 10 --> bilirubinémie n1=melanosis | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 mesure de la bilirubine sanguine --- r_associated #0: 10 --> bilirubinémie n1=mesure de la bilirubine sanguine | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 mélasma --- r_associated #0: 10 --> bilirubinémie n1=mélasma | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 métaplasies osseuses --- r_associated #0: 10 --> bilirubinémie n1=métaplasies osseuses | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 néoplasme bénin --- r_associated #0: 10 --> bilirubinémie n1=néoplasme bénin | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 paralysie générale --- r_associated #0: 10 --> bilirubinémie n1=paralysie générale | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 parésie --- r_associated #0: 10 --> bilirubinémie n1=parésie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 peau pigmentée --- r_associated #0: 10 --> bilirubinémie n1=peau pigmentée | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 pigmentation cutanée --- r_associated #0: 10 --> bilirubinémie n1=pigmentation cutanée | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 polysyndactylie --- r_associated #0: 10 --> bilirubinémie n1=polysyndactylie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 polyurie --- r_associated #0: 10 --> bilirubinémie n1=polyurie | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 processus néoplasiques --- r_associated #0: 10 --> bilirubinémie n1=processus néoplasiques | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 radiographie de contraste des voies biliaires --- r_associated #0: 10 --> bilirubinémie n1=radiographie de contraste des voies biliaires | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 suppuration --- r_associated #0: 10 --> bilirubinémie n1=suppuration | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 syndrome de Rathbun --- r_associated #0: 10 --> bilirubinémie n1=syndrome de Rathbun | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 taux de bilirubine dans le sang --- r_associated #0: 10 --> bilirubinémie n1=taux de bilirubine dans le sang | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 tophus --- r_associated #0: 10 --> bilirubinémie n1=tophus | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 trouble de la conduction du coeur --- r_associated #0: 10 --> bilirubinémie n1=trouble de la conduction du coeur | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 trouble du métabolisme des minéraux --- r_associated #0: 10 --> bilirubinémie n1=trouble du métabolisme des minéraux | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 trouble du métabolisme osseux --- r_associated #0: 10 --> bilirubinémie n1=trouble du métabolisme osseux | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 trouble du rythme cardiaque --- r_associated #0: 10 --> bilirubinémie n1=trouble du rythme cardiaque | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 tumeur bénigne --- r_associated #0: 10 --> bilirubinémie n1=tumeur bénigne | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 ulcération --- r_associated #0: 10 --> bilirubinémie n1=ulcération | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 émaciation --- r_associated #0: 10 --> bilirubinémie n1=émaciation | n2=bilirubinémie | rel=r_associated | relid=0 | w=10 bilirubinémie aggravée --- r_associated #0: 9 --> bilirubinémie n1=bilirubinémie aggravée | n2=bilirubinémie | rel=r_associated | relid=0 | w=9 bilirubinémie conjuguée --- r_associated #0: 9 --> bilirubinémie n1=bilirubinémie conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=9 bilirubinémie diminuée --- r_associated #0: 9 --> bilirubinémie n1=bilirubinémie diminuée | n2=bilirubinémie | rel=r_associated | relid=0 | w=9 bilirubinémie augmentée --- r_associated #0: 7 --> bilirubinémie n1=bilirubinémie augmentée | n2=bilirubinémie | rel=r_associated | relid=0 | w=7 bilirubinémie non conjuguée --- r_associated #0: 6 --> bilirubinémie n1=bilirubinémie non conjuguée | n2=bilirubinémie | rel=r_associated | relid=0 | w=6 ictère des nouveau-nés --- r_associated #0: 6 --> bilirubinémie n1=ictère des nouveau-nés | n2=bilirubinémie | rel=r_associated | relid=0 | w=6 Altération de l'état général --- r_associated #0: 5 --> bilirubinémie n1=Altération de l'état général | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 Système digestif --- r_associated #0: 5 --> bilirubinémie n1=Système digestif | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 alcalose --- r_associated #0: 5 --> bilirubinémie n1=alcalose | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anhémie --- r_associated #0: 5 --> bilirubinémie n1=anhémie | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anæmie --- r_associated #0: 5 --> bilirubinémie n1=anæmie | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anémie aplastique --- r_associated #0: 5 --> bilirubinémie n1=anémie aplastique | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anémie hypoplastique --- r_associated #0: 5 --> bilirubinémie n1=anémie hypoplastique | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anémie par aplasie médullaire --- r_associated #0: 5 --> bilirubinémie n1=anémie par aplasie médullaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 anémie par atteinte isolée de la lignée rouge --- r_associated #0: 5 --> bilirubinémie n1=anémie par atteinte isolée de la lignée rouge | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 aplasie de globules rouges purs --- r_associated #0: 5 --> bilirubinémie n1=aplasie de globules rouges purs | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 aplasie des globules rouges purs --- r_associated #0: 5 --> bilirubinémie n1=aplasie des globules rouges purs | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 aplasie isolée de la lignée rouge --- r_associated #0: 5 --> bilirubinémie n1=aplasie isolée de la lignée rouge | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 aplasie primitive de la lignée rouge --- r_associated #0: 5 --> bilirubinémie n1=aplasie primitive de la lignée rouge | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 arrêt de la maturation érythrocytaire --- r_associated #0: 5 --> bilirubinémie n1=arrêt de la maturation érythrocytaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 arythmie --- r_associated #0: 5 --> bilirubinémie n1=arythmie | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 ascites --- r_associated #0: 5 --> bilirubinémie n1=ascites | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 dysrythmie cardiaque non précisée --- r_associated #0: 5 --> bilirubinémie n1=dysrythmie cardiaque non précisée | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 déplétion volumique --- r_associated #0: 5 --> bilirubinémie n1=déplétion volumique | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 en:biliverdin --- r_associated #0: 5 --> bilirubinémie n1=en:biliverdin | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 en:cholangiography --- r_associated #0: 5 --> bilirubinémie n1=en:cholangiography | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 en:hypoaldosteronism --- r_associated #0: 5 --> bilirubinémie n1=en:hypoaldosteronism | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 histiocytose langerhansienne --- r_associated #0: 5 --> bilirubinémie n1=histiocytose langerhansienne | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 histiocytose à cellules de Langerhans --- r_associated #0: 5 --> bilirubinémie n1=histiocytose à cellules de Langerhans | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hypo-aldostéronisme --- r_associated #0: 5 --> bilirubinémie n1=hypo-aldostéronisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme --- r_associated #0: 5 --> bilirubinémie n1=hypoaldostéronisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hypovolémie --- r_associated #0: 5 --> bilirubinémie n1=hypovolémie | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hystiocytose à cellules de langerhans --- r_associated #0: 5 --> bilirubinémie n1=hystiocytose à cellules de langerhans | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hémolyse intravasculaire --- r_associated #0: 5 --> bilirubinémie n1=hémolyse intravasculaire | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 ictère du nouveau-né --- r_associated #0: 5 --> bilirubinémie n1=ictère du nouveau-né | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 immunité tumorale --- r_associated #0: 5 --> bilirubinémie n1=immunité tumorale | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 inflammation des canaux biliaires --- r_associated #0: 5 --> bilirubinémie n1=inflammation des canaux biliaires | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 insuffisance hépatique transitoire --- r_associated #0: 5 --> bilirubinémie n1=insuffisance hépatique transitoire | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 jaunisse néonatale --- r_associated #0: 5 --> bilirubinémie n1=jaunisse néonatale | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 maladie métabolique des os --- r_associated #0: 5 --> bilirubinémie n1=maladie métabolique des os | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 métaplasie osseuse --- r_associated #0: 5 --> bilirubinémie n1=métaplasie osseuse | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 néoplasme malin --- r_associated #0: 5 --> bilirubinémie n1=néoplasme malin | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 ossification hétérotopique --- r_associated #0: 5 --> bilirubinémie n1=ossification hétérotopique | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 pigmentation de la peau --- r_associated #0: 5 --> bilirubinémie n1=pigmentation de la peau | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 pigmentation mélanique anormale --- r_associated #0: 5 --> bilirubinémie n1=pigmentation mélanique anormale | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 polydipsie --- r_associated #0: 5 --> bilirubinémie n1=polydipsie | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 processus associé à la tumeur --- r_associated #0: 5 --> bilirubinémie n1=processus associé à la tumeur | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 surcharge liquidienne --- r_associated #0: 5 --> bilirubinémie n1=surcharge liquidienne | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 trouble chromosomique --- r_associated #0: 5 --> bilirubinémie n1=trouble chromosomique | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 bilirubinémie normale --- r_associated #0: 1 --> bilirubinémie n1=bilirubinémie normale | n2=bilirubinémie | rel=r_associated | relid=0 | w=1 en:Gilbert's cholaemia --- r_associated #0: 1 --> bilirubinémie n1=en:Gilbert's cholaemia | n2=bilirubinémie | rel=r_associated | relid=0 | w=1 en:mechanical jaundice --- r_associated #0: 1 --> bilirubinémie n1=en:mechanical jaundice | n2=bilirubinémie | rel=r_associated | relid=0 | w=1 hyperbilirubinémie de type 2 --- r_associated #0: 1 --> bilirubinémie n1=hyperbilirubinémie de type 2 | n2=bilirubinémie | rel=r_associated | relid=0 | w=1 hyperbilirubinémie directe des nouveau-nés --- r_associated #0: 1 --> bilirubinémie n1=hyperbilirubinémie directe des nouveau-nés | n2=bilirubinémie | rel=r_associated | relid=0 | w=1